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To locate protein sorption on the surface and inside the matrix of soft 
contact lens materials and intraocular lenses (IOL). 
 
Methods 
The proteins albumin and lysozyme were investigated as they are highly 
abundant in blood serum and tears, respectively. Proteins were conjugated with 
organic fluorescent probes and using confocal laser scanning microscopy (CLSM) 
the sorption profile to contact lenses and IOL could be determined. Radiolabeled 
protein was used for quantification purposes. 
• Albumin sorption to etafilcon A and lotrafilcon B was determined (Chapter 3) 
• Different fluorescent probes were used for conjugation and the impact on 
albumin sorption behaviour was investigated (Chapter 4) 
• Lysozyme sorption to nine different pHEMA-based and silicone hydrogel 
contact lenses was determined using two fluorescent probes (Chapter 5) 
• The efficiency of protein removal from contact lenses using contact lens care 
regimens was investigated (Chapter 6) 
• Albumin sorption to IOL materials was quantified and imaged using a 





Albumin and lysozyme sorption profiles differed between materials, and 
were influenced by the fluorescent probes used for conjugation. After one day of 
incubation, both proteins could be located within all contact lens materials, except 
for lotrafilcon A and lotrafilcon B, which primarily allowed deposition on the lens 
surface. An increase in protein accumulation was found for most materials over the 
maximum investigated period of 14 days, using CLSM and radiolabel techniques. 
The efficiency of contact lens care regimens to remove lysozyme and albumin 
depended on the lens material, care regimen and protein type investigated. 
PMMA and silicone IOLs showed protein exclusively on the surface, while a 
hydrophilic acrylic IOL allowed penetration into the lens matrix over time. Despite 
the albumin penetration depth into hydrophilic acrylic, the highest albumin levels 
were determined for the silicone IOL. 
  
Conclusions 
CLSM provides detailed information that can describe the protein distribution 
in transparent biomaterials, with scanning depths up to a few hundred microns. 
However, the CLSM data are primarily of qualitative value, which necessitates a 
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1.1 Contact Lenses 
1.1.1 The development of soft contact lens materials 
In 1960, Otto Wichterle described the essential requirements for plastic 
materials that could remain permanently in contact with living tissue, without 
causing unfavourable reactions to the organism in which it contacted.1 He discussed 
the importance of the material’s permeability to metabolites, polymer stability, the 
use of cross-linking agents to prevent deposition and further proposed the use of 
the copolymer of glycol-mono-methacrylate and glycol-dimethacrylate as a suitable 
hydrophilic material. Although Wichterle rapidly modified this copolymer into poly-
2-hydroxyethyl methacrylate (pHEMA- see Figure 1-1),1 it took another 10 years for 
a manufacturing method (spin-casting) to become proficient that soft lenses could 
become a commercial reality 2,3 
 
Figure 1-1: Chemical structure of HEMA (MW 130) 
2 
PHEMA, with a water content of 38%, appeared to be reasonably 
biocompatible and even today it is still used in a variety of biomedical fields such as 
blood-contacting implants, artificial organs, drug delivery devices and for 
intraocular lenses (IOL).4,5 When used as a contact lens material, various cross-
linking agents are typically incorporated into pHEMA to enable enhanced material 
strength, and specific polymerization and copolymerization further improve water-
swelling properties.2 Methacrylic acid (MAA) and N-vinyl pyrrolidone (NVP) are 
commonly used to increase the water content, which results in improved oxygen 
permeability of the material. Currently, more than 150 different types of soft 
contact lenses are available, most of which are still based on pHEMA compositions.6 
In order to differentiate between lens material characteristics, the Food and 
Drug Administration (FDA) divided contact lens materials into 4 FDA groups. The 
groups are classified by ionicity and water content (FDA 1-4), as described in Table 
1-1. 
 
Table 1-1: FDA Soft Lens Classification 
 Water content Electrostatic charge 
FDA - Group 1 < 50% water Non-ionic (< 0.2% MAA) 
FDA - Group 2 > 50% water Non-ionic (< 0.2% MAA) 
FDA - Group 3 < 50% water Ionic (> 0.2% MAA) 
FDA - Group 4 > 50% water Ionic (> 0.2% MAA) 
 
FDA (Food and Drug Administration); MAA (Methacrylic acid) 
3 
1.1.2 Corneal responses to contact lens wear 
The healthy cornea is an avascular organ, which receives the required oxygen 
and nutrients for appropriate metabolic performance through the tears, with 
atmospheric oxygen being dissolved into the tear film and subsequently transferred 
to the cornea. However, during the wear of pHEMA-based contact lenses, the 
oxygen supply is immediately reduced by the presence of the lens, and the transfer 
of oxygen through the lens is limited by the water phase of the lens polymer. If the 
oxygen transport (or “oxygen permeability” – Dk - (cm2 x ml O
2 
/ (sec x ml x 
mmHg))) is insufficient, the cornea may exhibit a variety of hypoxic complications, 
including limbal hyperemia, corneal neovascularization, epithelial microscysts, 
stromal striae, endothelial polymegethism and suppressed epithelial proliferation 
rates.7-10 The only way to improve the oxygen permeability for pHEMA-based 
materials is to increase the percentage of water in the material, which is solely 
responsible for oxygen transport in this group of materials. The maximum possible 
water content for pHEMA-based contact lenses is approximately 79%, which (in 
lenses of appropriate thickness for this water content) corresponds to an oxygen 
transmissibility (Dk/t) of 40x10-9 (cm x ml O
2 
/ (sec x ml x mmHg)).11 When contact 
lenses are worn overnight, this level of oxygen transmissibility is inadequate to 
limit corneal swelling to that seen with no lens wear and eye closure, of 
approximately 2.6-4% edema.7,12,13 Oxygen transmissibilities (Dk/t) of 125x10-9 or 
higher have recently been proposed to avoid hypoxic-related complications,7,13 
which cannot be achieved with lenses that rely on the water phase for oxygen 
transport. This resulted in the development of new hydrogel materials, based on 
polymers that transport greater amounts of oxygen, such as silicone. 
4 
1.1.3 Silicone hydrogel lens materials 
Pure silicone is highly gas permeable, but due to its hydrophobic character 
silicone-based contact lenses are poorly wettable14 and show high lipid deposition 
rates.15,16 To combine the benefit of the high oxygen permeability of siloxane-
groups with the hydrophilic, ion-transporting property of pHEMA, silicone hydrogel 
(SH) materials were developed and became commercially available in 1999.17,18 To-
date, eight SH materials are commercially available, with oxygen transmissibilities 
ranging from 86 to 175x10-9 Dk/t (Table 1-2). SH lenses have more complex 
monomer compositions compared to pHEMA-based materials.2,6 Typical components 
of silicone hydrogel contact lenses are DMA (N,N-dimethylacrylamide), PDMS 
(polydimethylsiloxane), TPVC (tris-(trimethylsiloxysilyl) propylvinyl carbamate), TRIS 
(trimethylsiloxy silane), PVP (polyvinyl pyrrolidone) and siloxane macromers.6  
1.1.3.1 Surface modifications of silicone hydrogel lenses 
Most silicone hydrogel lens materials require surface modification to 
overcome the hydrophobic nature of the silicone component. Balafilcon A, 
lotrafilcon A, lotrafilcon B and asmofilcon A are modified using different plasma 
treatments.6,19 For balafilcon A, reactive gas plasma transforms the hydrophobic 
siloxane components on the surface of the lenses into hydrophilic silicate 
compounds (‘glassy islands’).6,20 Lotrafilcon A and lotrafilcon B are permanently 
modified by a gas plasma treatment using a mixture of trimethylsilane, oxygen and 
methane to form a 25nm thin hydrophilic coating over the surface.2,17,21 The lens 
surface of asmofilcon A is modified based on “Nanoglass” technology using a new 
plasma treatment, which combines plasma coating and surface oxidation.22 
5 
Galyfilcon A and senofilcon A utilise a different methodology to enhance 
wettability. Hydrophilic high molecular chains of poly(vinylpyrrolidone) (PVP) are 
incorporated during the polymerization process to shield the tear film from 
hydrophobic siloxane components.23-27 The most recent SH materials, comfilcon A 
and enfilcon A, incorporate silicone which is based on siloxy-macromers instead of 
the commonly used TRIS-derivates. These lens materials have been described as 
highly wettable without the need for surface treatment.28 
 
6 
Table 1-2: List of currently available silicone hydrogel contact lenses 
 
BHPEA (2-(4-benzoyl-3-hydroxyphenoxy)ethyl acrylate); DMA (N,N-dimethylacrylamide); EGDMA (ethyleneglycol dimethacrylate); FM0411M (2-ethyl 
[2-[(2-methylprop-2-enoyl)oxy]ethyl]carbamate); HEMA (poly-2-hydroxyethyl methacrylate); HOB ((2RS)-2-hydroxybutyl 2-methylprop-2-enoate); IBM 
(Isobornyl methacrylate); M3U (α-[[3-(2-[[2-(methacryloyloxy)ethyl] carbamoyloxy]ethoxy)propyl]dimethylsilyl]-ω-[3-(2-[[2-(methacryloyloxy)ethyl] 
carbamoyloxy]ethoxy)propyl]poly([oxy[(methyl) [3-[ω-methylpoly(oxyethylene)oxy]propyl]silylene]/[oxy[(methyl)(3,3,3-trifluoropropyl)]silylene]/oxy 
(dimethylsilylene)])); MA (methacrylic acid); MMA (methyl methacrylate); mPDMS (monofunctional polydimethylsiloxane); NCVE (N-carboxyvinyl 
ester); NVP (N-vinyl pyrrolidone); PBVC (poly[dimethysiloxy] di [silylbutanol] bis[vinyl carbamate]); PC (phosphorylcholine); POE 2-(2- 
propenyloxy)ethanol); PVP (poly(vinylpyrrolidone)); TAIC (1,3,5-triprop-2-enyl-1,3,5-triazine-2,4,6(1H,3H,5H)-trione); TEGDMA (tetraethyleneglycol 
dimethacrylate); TPVC (tris-(trimethylsiloxysilyl) propylvinyl carbamate); TREGDMA (triethylene glycol dimethacrylate); TRIS (trimethylsiloxy silane); 
VMA N-Vinyl-N-methylacetamide. *1: Principal monomers will be disclosed after USAN registration. 














ACUVUE® ADVANCE® galyfilcon A I Johnson & Johnson 70 47 86 
mPDMS, DMA, HEMA, EGDMA 
siloxane macromer, PVP 
ACUVUE® OASYSTM senofilcon A I Johnson & Johnson 70 38 147 
mPDMS, DMA, HEMA, TEGDMA  
siloxane macromer, PVP 
Focus® NIGHT & DAY® lotrafilcon A I CIBA Vision 80 24 175 
DMA, TRIS,  
siloxane macromer 
AIR OPTIXTM AQUA lotrafilcon B I CIBA Vision 80 33 138 
DMA, TRIS,  
siloxane macromer 
PureVision® balafilcon A III Bausch & Lomb 90 36 101 NVP, TPVC, NVA, PBVC 
Biofinity® comfilcon A I Cooper Vision 80 48 160 
M3U, FM0411M, HOB, IBM, 
NVP, TAIC, VMA 
AVAIRA® enfilcon A I Cooper Vision 80 46 125 
M3U, BHPEA, MMA, POE, 
TREGDMA, VMA 
PremiO asmofilcon A I Menicon 80 40 161 * 
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1.1.4 Trends in contact lens prescribing 
Contact lens prescribing trends are very country specific and vary between 
the number of total fits as well as the choice of lens material and lens replacement 
frequency.29-31 The first contact lenses were glass-blown scleral lenses, which were 
invented more than 100 years ago, followed by corneal lenses made of rigid 
polymethyl methacrylate (PMMA) and soft pHEMA-based lenses.32 Current materials 
for rigid lenses are highly gas permeable due to silicone-methacrylate and 
fluorosilicone acrylate components, but this material group accounts for less than 
10% of all new lens fits, because of the high success rate of soft lens materials.3,29,33  
Prescribing trends for contact lenses are constantly changing with the 
development of new lens materials and lens designs. Until 1999, soft pHEMA-based 
lenses with intermediate water contents between 40-60% and high water content 
lenses of >60% water were fitted primarily.29,34 However, the number of new fittings 
with pHEMA-based lenses decreased consistently after SH materials became 
available.30,31,35,36 The high oxygen transmissibility of SH lenses allows longer wearing 
times when compared to pHEMA-based materials. Balafilcon A and lotrafilcon A are 
FDA certified to be worn for up to 30 days and nights continuously; lotrafilcon B, 
senofilcon A, comfilcon A and asmofilcon A are licensed to be worn on an extended 
schedule for up to six nights and seven days without cleaning. The remaining 
silicone hydrogel lenses enfilcon A and galyfilcon A are certified for daily wear only, 
with cleaning and disinfection required after each wear. 
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The majority of contact lenses that are prescribed today follow frequent 
replacement schedules and the lenses are replaced, either daily (27%), 1-2weekly 
(19%) or monthly (42%), with varying percentages being seen between countries.37 
1.2 Contact lens care regimens 
Contact lenses require frequent cleaning procedures in order to, primarily, 
disinfect the lens and to remove deposition of air-borne contaminants and tear film 
components.38-43 Other tasks required from care regimens include their ability to 
rinse, store, rehydrate and lubricate the lenses without causing ocular irritation.38 A 
number of care products are available, which are most simply divided into rigid and 
soft lens regimens. 
1.2.1 Care regimens for gas permeable lenses 
Rigid gas permeable (RGP) lenses are typically rubbed manually with an 
alcohol-based solution, which contains both emollient and foam stabilizers and, in 
some cases, microscopic polymeric beads that act to “polish” the lens surface.44,45 
Following this, lenses are soaked overnight in a storage solution that further 
disinfects the lens, rehydrates and rewets the surface. Two step systems and 
multipurpose care solutions (MPS) are available that contain antimicrobial agents, at 
higher concentrations than that contained in soft lens care regimens. This is 
possible because the RGP materials are typically non-ionic and have small pore 
sizes because of the negligible water content. The disinfectants do not penetrate 
into the lens material and adsorbed preservatives can be easily rinsed off the lens 
surface.38 Enzymatic cleaners can periodically be used to remove tightly bound 
protein layers from the lens.45 
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1.2.2 Care regimens for soft lenses 
The majority of cleaning solutions that are currently available have been 
developed to disinfect, clean and rehydrate pHEMA-based lens materials.46,38 The 
two most common care regimens are MPS and hydrogen peroxide systems and the 
primary active ingredient of these regimens are the antimicrobial agents. The 




) is typically 3% (30,000ppm) and this is 
capable of destroying the most common bacteria and fungi; however it shows 





before the lenses can be reinserted onto the ocular surface. The most popular 
technique is catalytic neutralization, using either a time release catalase tablet 
coated in hydroxypropyl methylcellulose or a platinum coated disc. In the past, 
chemical reactions with either sodium pyruvate or sodium thiosulphate were used 




, or the lenses were extensively rinsed with saline.45,46 Despite 
the high tolerance to this preservative-free system,50 it must be considered that as 
soon as the peroxide is decomposed to oxygen and water, the antimicrobial effect 
is eliminated and regrowth and contamination can occur over time. 
Chlorhexidine and thimerosal were the first preservatives that were used as 
disinfectants in MPS systems. However, patients developed a variety of ocular 
complications against these biocides, exhibiting diffuse corneal staining, bulbar 
and palpebral hyperaemia, corneal infiltrates and palpebral conjunctivitis.48,51-54 
Today, two high molecular weight preservatives are typically found in MPS 
regimens: polyhexamethylene biguanide (PHMB) and polyquaternium-1 
(Polyquad™). Both of these high molecular weight biocides attack pathogens by 
binding to the negatively charged phospholipids located in the cell membrane, 
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which results in cell lysis.45,52 Other MPS components include surfactants, chelating 
agents, demulcents and a buffer system, all of which help to support the efficacy of 
the biocide or are involved in removing protein and lipids from the lens.38,52 
Additionally, single- and multi enzymatic cleaners based on papain and pancreatin 
are available to remove tightly bound protein from worn lenses,55,56 although their 
use is now significantly reduced since the introduction of frequent replacement 
lenses.  
 
1.3 Complications during contact lens wear 
Contact lens wear impacts ocular physiology in a number of ways, including 
modifications in tear film composition,57-59 changes in function and structure of the 
cornea and the production of various inflammatory conditions.9,60,61 These changes 
can potentially result in new ocular disorders or exacerbate pre-existing 
conditions.60-62,63 
1.3.1 Hypoxia-related complications 
PHEMA-based lens materials reduce the oxygen supply to the cornea and 
increase the corneal carbon dioxide level.64,65 Although oxygen transport through SH 
lens materials reduce these complications significantly,7 some conditions can still 
be observed and will therefore be discussed in this section. Hypoxia related effects 
seen in the epithelium include suppression of cell proliferation rates, production of 
microcysts and epithelial thinning.66 In the stroma, a decrease in pH,67 increase in 
osmolality,68 edema formation 69 and overall thinning 66 have been reported. In cases 
of clinically significant corneal edema, striae and folds can be observed within the 
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stroma when swelling rates exceed 5% or 10% respectively.70 The innermost corneal 
layer, the endothelium, exhibits an increase in cell polymegethism 71 under hypoxic 
conditions and although this is typically asymptomatic, it may result in long-term 
contact lens intolerance.62 
Limbal hyperemia is also closely related to the low oxygen transmissibility of 
contact lens materials. Limbal injection results from the local dilation of blood 
vessels and the development of new vessels (neovascularization) in normally 
avascular corneal regions.72 Finally, hypoxia may be a predisposing factor for 
myopic shifts in refractive error.73 
1.3.2 Inflammatory complications/infections 
The development of inflammatory complications during contact lens wear 
typically start with redness, dryness, ocular discomfort and contact lens 
awareness.9,74 Contact lens induced acute red eye (CLARE) is related to increased 
levels of (typically) gram negative bacteria on the ocular surface and the contact 
lens. This often causes marked conjunctival injection and multiple peripheral sterile 
corneal infiltrates.60,75 Other inflammatory complications induced by contact lens 
wear (typically due to gram positive organisms) include contact lens peripheral 
ulcers (CLPUs) and symptomatic peripheral infiltrates.60,75 If the cornea becomes 
infected with pathogenic organisms then it is termed microbial keratitis. 
Polymorphonuclear leucocytes have been identified in these infiltrates, which is an 
indicator that an inflammatory event has occurred.76 It has been reported that 
certain combinations of contact lens materials and care regimens may be 
associated with infiltrates, particularly under hypoxic conditions.60 
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Microbial keratitis is the most severe potential complication during contact 
lens wear and is often caused by gram-negative bacteria, particularly Pseudomonas 
aeruginosa.77 Various microorganisms are part of the normal tear film, and an 
increase in bacteria is typically measured after sleep.78 This results in a higher risk 
of microbial keratitis, particularly when contact lenses are worn overnight.79,80 
Higher incidence rates of this potentially sight-threatening disease have been 
reported for SH lens wear, when worn for up to 30 days continuously when 
compared to pHEMA-based lenses that are worn for up to 6 nights and 7 days.79  
1.3.3 Mechanical complications 
Corneal deformation during lens wear has primarily been described with 
rigid lenses, and less often with pHEMA-based materials.81,82 The ‘first generation’ of 
SH lenses however, showed signs of corneal reshaping due to the higher rigidity of 
these materials.83 Mechanically induced lesions in the superior cornea, known as 
superior epithelial arcuate lesions (SEALs), were also observed with ‘first 
generation’ SH lenses, but are expected to occur less often with newer SH materials 
that exhibit a lower modulus.63,75,84 Corneal erosions of the epithelium and outer 
stromal layer caused by a trauma or foreign body have been seen with all types of 
contact lenses.61 Finally, the development of mucin balls between the cornea and 
the back surface of the contact lens may give rise to circular “imprints” in the 
epithelium.85  
1.3.3.1 Giant papillary conjunctivitis 
Giant papillary conjunctivitis (GPC) is an inflammatory condition of the upper 
tarsal conjunctiva and, if caused by contact lens wear, it is described as contact 
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lens-associated papillary conjunctivitis (CLPC).75 A recent study by Forister has 
shown that neovascularization, papillae and CLPC account for the majority of 
contact lens induced complications.86 CLPC is characterized by mucus discharge, 
increased hyperemia, and the development of polygonal or irregular papillae, which 
can either be localized or distributed across the tarsal plate.61 CLPC has been 
reported with all kinds of lens materials, however, higher incidence rates have been 
observed with soft contact lenses, including silicone hydrogels, particularly if worn 
on an extended wear schedule.87,88 51 Typical symptoms of this condition are ocular 
discomfort, including itching, excessive lens movement, increased lens deposition 
and blurred vision, which finally leads to lens intolerance.75 
The etiology of CLPC is multifactorial and is caused by a combination of 
mechanical lens rubbing on the tarsal conjunctiva and/or is an immune response 
caused by deposition on the lens surface.89 In SH lens wear, papillae are typically 
isolated rather than distributed over the tarsal conjunctiva, which may be explained 
by mechanical lens-edge rubbing rather than an immunological response.61,90,91 In 
addition, elevated levels of tear immunoglobulins (IgE, IgG), inflammatory 
mediators from the complement system and chemotactic factors have been 
detected in GPC, which provides evidence for an immunological basis in this 
inflammatory complication.88,89 
Deposition of tear film proteins on contact lenses can be a factor that 
triggers this immune response, as they may act as antigenic stimuli.91-95 This results 
in an increased production of tear immunoglobulins and activates the complement 
system. IgE antibodies are produced by B-lymphocytes and bind to stromal mast 
cells and circulating basophis. This interaction sensitizes the mast cells, which 
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respond with an immediate release of vasoactive amines (such as histamine), 
followed by eosinophilic chemotactic factors and tryptase.88 Other immunological 
defense mechanisms are the release of arachidonic acid from plasma membranes 
and the production of prostaglandins and leukotrienes B4 and C4, which produce 
an inflammatory response. This immunological event is categorized as a Type I 
immediate hypersensitivity reaction (IgE mediated). CLPC is further accompanied by 
a cell mediated reaction, in which T-lymphocytes respond with a release of 
lymphokines and interleukins, within 24-48 hours of exposure. This delayed 
hypersensitivity reaction is categorized as a Type IV (T-cell mediated) response.96 
SH contact lenses accumulate lower amounts of protein compared to 
conventional pHEMA-based materials.97-99 However, the percentage of denatured 
protein is higher for SH materials, which increases the risk of an inflammatory 
response.100-104 It is possible that surface-deposited proteins have a stronger impact 
on the development of CLPC, which raises the need for a better understanding of 
the protein location on the contact lens. 
 
1.4 Proteins in the tear film 
Proteins are a major component of the human tear film and perform a variety 
of important tasks to defend the ocular surface from microorganisms, have 
functions in transport, metabolism, immune response, cell structure, antioxidation, 
and act as protease inhibitors.105 More than 100 different proteins have been 
identified in the human tear film 106,107 with a total concentration of 6.5-9.6 mg/ml.108 
But this concentration may change over the day,109 during sleep 110 and under 
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specific conditions, including stimulated tearing,111,112 age,113 contact lens wear 114 
and in various eye diseases such as Sjögren’s syndrome.115  
Lysozyme is of particular interest due to its high concentration and 
antimicrobial activity in the tear film.111,112,116 It is overall positively charged with an 
IEP pH =11.1 and is constituted of 129 amino acids, which results in a molecular 
weight of 14.5 kDa.117 Lysozyme is produced by the lacrimal glands and has a 
concentration in the tear film of 1.9 mg/ml.110,112 It deposits in higher amounts to 
pHEMA-based contact lens materials that contain MAA as compared to pure 
pHEMA.97,102,118,119 With the addition of MAA, the hydrogel material becomes 
negatively charged, which explains the attraction of the positively charged 
lysozyme.120 The larger protein serum albumin (66kDa) is found in lower 
concentrations in the tear film and its overall negative charge (IEP pH= 4.7) shows a 
different sorption behaviour compared to lysozyme.57,120-122 Albumin is highly 
abundant in blood serum and is therefore involved in the initial response to 
implanted biomaterials.104  
Due to the relative lack of knowledge on albumin interactions with 
biomaterials, and its importance in the initial interaction with hydrogel 
biomaterials, albumin will be the major focus of this thesis and an extensive review 
describing albumin structure and sorption behaviour to contact lenses and other 




1.5 Albumin adsorption to contact lens materials: A review 
 
This section is published as follows: 
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1.5.1 Overview 
During contact lens wear, tear film components such as lipids, mucins and 
proteins tend to deposit on and within the lens material and may cause discomfort, 
reduced vision and inflammatory reactions. The tear film protein that has attracted 
most interest when studying contact lens deposition is the small (14 kDa), 
positively charged protein lysozyme. Albumin, which is a much larger protein (66 
kDa) with an overall net negative charge is also of interest, and shows very different 
adsorption patterns to lysozyme. 
The concentration of albumin in the tear film is relatively low compared to 
the concentration in blood serum, but this value increases markedly under various 
conditions, including when the eye is closed, during contact lens wear and in 
various dry eye states. 
Gaining an understanding of the manner in which albumin deposits on 
biomaterials is of importance for contact lens wear, as well as for other medical 
applications where HEMA-based materials are used for implants, artificial blood 
vessels or drug delivery devices. 
This review paper summarizes the impact of individual material 
compositions, water content, hydrophobicity and electrostatic attraction on the 




Contact lens deposition with substances from the human tear film has been 
extensively studied.15,16,43,92,94,120-144 The majority of published studies have reported on 
the in vivo or in vitro deposition of either “total protein” 138,145,146 or, more 
specifically, lysozyme.97,98,131 However, lysozyme only accounts for a proportion of 
the proteins in the tears, with other major tear film proteins such as lactoferrin, 
albumin and lipocalin being also present in high quantities.57,106,110,147-152 To-date, little 
has been published on the interaction between contact lenses and albumin and the 
purpose of this review article is to describe the factors that influence the degree to 
which this protein interacts with various materials used for contact lenses. 
Albumin is synthesized in the liver and has an estimated lifetime of 27 
days.153,154 It is the most abundant protein in human serum and is also the most 
prominent soluble protein in the body of all vertebrates.153 Hippocrates (circa 460 to 
370 BC) was probably the first scientist to mention some distinctive properties of 
albumin in the human body. Serum albumin keeps the osmotic blood pressure and 
blood pH value constant and transports various molecules, including hormones, 
fatty acids and drugs.155 In a human body weighing 70kg, 41% of the total 
extravascular albumin is found in the skin (100g) and 40% in the muscles (96g), 
with small amounts being detected in the liver, gut and subcutaneous region.156 In 
the serum (intravascular), an average albumin concentration of 45.1-49.9 ±         
2.6 mg/ml has been reported,155 which approximates to 118g for a typical 70kg 
bodyweight.153  
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Over the last 60 years information concerning the structure of human serum 
albumin (HSA) has continually been updated and refined. In 1956 Tanford et al.154 
and Loeb et al.157 described the hydrated protein as a compact spheroid particle, 
whereas twelve years later Squire et al.158 reported a cigar-shaped model of 140 x 
40 Å. This was the accepted textbook model until 1990, when Carter and He 
presented the first low-resolution crystallographic data for HSA.159 Using this 
method at a resolution of 4 Å they found a three-dimensional heart-shaped 
structure for HSA in a crystallized format, which was confirmed ten years later for 
bovine serum albumin (BSA) in a hydrated state.160 (Figure 1-2) 
 
Figure 1-2: Overall dimension of the heart-shaped structure for albumin, as 
described by Carter and He159 
 
The shape and physicochemical properties of albumin from human and 
bovine serum are very similar (Table 1-3). The secondary structure of albumin 
consists of three very similar domains (I, II, III) arranged in nine loops with 17 
disulfide bridges to stabilize the native form. Each domain has two subdomains (A 






α-helix. The helices range in size from 5 to 31 amino acids in length.153,161,162 Due to 
the similarity of HSA and BSA, and the relative availability and lower cost of BSA, 
many in vitro studies have used BSA as a surrogate for HSA.163-165 
 
Table 1-3: Comparison in structure between HSA and BSA153 
 
1.5.3 Albumin in the preocular tear film 
Far more than 100 different proteins have been identified in the human tear 
film.106,107 Specific tear proteins such as lysozyme, lactoferrin and lipocalin are 
synthesized by the lacrimal gland; however albumin is a serum protein and 
becomes mixed with the tear film by leakage from the conjunctival capillaries. The 
concentration of HSA in the tear film has been investigated by a number of 
researchers, using a variety of different analytical techniques. In 1993, Bright and 
Tighe reviewed 9 tear film studies and found a vast range of published 
concentrations, between 0.0103 mg/ml and 390 mg/ml.108 
Tears may be collected using “stimulated methods”, such as those involving 
an “eye-flushing” technique or by stimulating a “sneeze”, as compared with an 
“unstimulated method”, where tears are collected via a capillary tube which does 
not touch the ocular surface.109,111,166,167 Generally, higher HSA concentrations are 
found during sleep,57,110 in unstimulated tears 109,111 and in patients with symptoms of 
 Molecular weight (Da) Isoionic point Number of fatty acids 
Human (HSA) 66,438 5.16 585 
Bovine (BSA) 66,411 5.15 583 
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dry eye 168 or when wearing contact lenses.57,169 Table 1-4 summarizes typical 
reported albumin levels in the preocular tear film under various conditions. 
 
Table 1-4: Albumin concentrations in the human tear film 
Albumin concentration in the tear film (mg/ml) 
Nonstimulated tears 0.042 ± 0.012 111 0.023 ± 0.015 109 0.06 ± 0.02 110 
Stimulated tears 0.012 ± 0.004 111 0.008 ± 0.001 112 0.02 ± 0.01 110 
During sleep 0.20 (0.15-0.58) 57 1.1 ± 0.76 110 1.0 ± 0.5 150 
Dry eyes Increase 17% 115 3.7 mg/ml (0.2-22.6) 168 4.74 ± 0.72 170 
 
Wearing contact lenses 0.059 ± 0.054 169 
(healthy eye) 
0.079 ± 0.060 169 
(presence of bacteria on CL) 
 
0.54 (0.33-1.24) 57 
(wearing Ortho-K CL 
overnight)  
 
Data from three studies are presented for each condition 
 
Lundh and coworkers fitted 50 eyes with contact lenses and investigated IgG 
and HSA concentrations in the tear film. The concentration of both serum proteins 
increased in 20 eyes, indicating a higher permeability of the blood-tear barrier.171 
The impact of etafilcon A lenses worn on an extended wear schedule on protein 
levels in the tear film was investigated by Carny et al..172 Lactoferrin, lysozyme and 
HSA levels in collected tears were measured on 10 neophytes before lens wearing 
and after a period of six months. There was a trend for increasing HSA 
concentration in the tear film over the six months of extended wear, but this 
increase was not statistically significant. In an orthokeratology study, Choy et al. 
found increasing amounts of HSA, while other tear film proteins (lysozyme, 
lactoferrin and lipocalin) remained in an unchanged concentration.57 The ratio 
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between HSA and lactoferrin has also been reported as an indicator for diagnosing 
primary Sjogren’s Syndrome (SS).173 Bjerrum measured the protein concentration in 
patients with connective tissue diseases, SS and controls and concluded that an 
albumin:lactoferrin ratio above 2:1 is commonly found in patients diagnosed with 
SS. These findings are of potential significance, since higher protein concentrations 
in the tear film also appear to lead to increased deposition levels on contact 
lenses.132,174-176 
1.5.4 Albumin adhesion to various substrates 
The process of protein adsorption from an aqueous solution onto a solid 
surface is typically described in three steps. Firstly, transportation of the protein 
from the solution towards the solid surface occurs. This is followed by attachment 
of the protein to the surface, and finally the protein structure undergoes a 
conformational change after adsorption.177 Carter and Ho investigated the 
physicochemical properties of HSA and described it as a flexible protein that easily 
changes its molecular structure.178 Fluorescent X-ray techniques revealed that the 
BSA molecules flattened when bound on a gold substrate and the heart-shaped 
protein, with an initial side length of 3 x 80 Å, increased to a side length of 127 Å, 
with a simultaneous reduction in depth from 30 Å to 11.6 Å, with this short axis 
being perpendicular to the solid surface.153,179 The amount of HSA that forms a 
monomolecular layer on most surfaces is approximately 0.15μg/cm2.180 
Ishiguro and colleagues investigated how lysozyme and BSA deposited and 
underwent conformational changes on poly tris(trimethylsiloxy)silylstyrene (pTTS), a 
highly hydrophobic polymer.181 They reported very different adsorption behaviour 
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for the two proteins. Conformational changes of BSA derived strongly from the 
amount adsorbed to the surface, regardless of soaking time or BSA concentration in 
the aqueous solution. This was different to lysozyme, where the adsorption time 
was the leading factor that influenced changes in lysozyme conformation, 
regardless of the concentration in the solution or the adsorption amount. During 
the first 15 minutes, BSA adsorption was nearly complete, with only a minor 
increase occurring over the following 10 hours, while lysozyme build-up rose 
significantly over the 10 hour time period. After adsorption on pTTS, both BSA and 
lysozyme exhibited smaller α-helix contents and larger contents of β-structure, turn 
and random coil.181 Similar findings of conformational changes occurring after short 
periods of time have been noted for contact lens materials. Garret et al. looked at a 
variety of contact lens materials and reported changes in the HSA structure when 
adsorbed to vifilcon A, after as little as one hour of exposure.182 
1.5.5 Albumin adsorption at biomaterial interfaces 
It is clear that albumin is found extensively throughout the body and in the 
tear film. An understanding of the interaction of this protein with biomaterials is of 
great importance to understanding biocompatibility. Implanted biomaterials are 
expected to perform a specific task, without being affected by the biological host 
and without causing side effects such as toxic, carcinogenic, immunogenic or 
inflammatory responses. Biomaterials are used for contact lenses and a variety of 
medical applications, including artificial blood vessels, catheters or drug delivery 
devices.4,5,183 
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Albumin adsorption is the initial event that occurs after the implant comes 
into contact with blood serum. The protein is then replaced by immunoglobulin-G, 
which in turn is replaced by fibrinogen and high molecular weight kininogen. This 
adsorption and desorption process of blood plasma proteins on artificial surfaces is 
known as the Vroman effect.184 It has been shown that platelets can adhere to 
fibrinogen, which significantly increases the risk of thrombogenesis.185-187 It is 
desirable to have a minimum amount of adsorbed protein onto the biomaterial and, 
ideally, this uptake should be reversible, with minimal conformational change 
occurring to the irreversibly adsorbed protein.188-190 To improve biocompatibility and 
minimize the adsorption of fibrinogen and platelets some artificial organs undergo 
HSA treatment prior to surgery.191  
Within the eye, the aqueous humour of the interior eye has no cellular 
components and therefore the response to intraocular lenses (IOL) after cataract 
surgery is mainly affected by the adsorption of various proteins, such as HSA and 
various globulins.192 
On the ocular surface, deposition of albumin may play a significant role in 
healthy contact lens wear. Taylor and coworkers demonstrated that increased HSA 
deposition on etafilcon A lenses resulted in increased adherence of bacteria such as 
Pseudomonas aeruginosa and Staphylococcus epidermidis.174 However, the opposite 
was true for polymacon lenses, with higher HSA deposition being associated with 
lower bacterial adherence. Other studies have confirmed that some tear-coated 
contact lens materials enhance adhesion of Pseudomonas aeruginosa, but high 
individual variation is always reported.141,193 
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1.5.6 Albumin adsorption on contact lens materials 
Contact lenses represent a very specific type of biomaterial interface, in 
which the material is exposed to both the tear film and various environmental 
factors. While the level of protein deposition on contact lenses is strongly 
influenced by the tear composition, it is also modified by the chemical 
characteristics of the lens material.122,182,194,195 It has been shown that material 
composition 121 and properties like water content 123 and pore size 120,196 roughness of 
the surface,128 hydrophobicity 121,122 and charge,140,176,195 all play a role, in addition to 
tear film pH and ionic strength.132,175 Finally, protein characteristics such as size,120 
charge 132 and time of material exposure to the protein 15,119,122-126,129,132,133,137,181,182,194 are 
all important factors to consider. When patients present with extensively deposited 
lenses, this deposition will frequently include albumin as a component 
43,123,137,139,142,151,152 (Figure 1-3). However, visual inspection by the clinician will be 
unable to determine the exact composition of the deposition seen, with various 
laboratory-based assays being required to identify individual components.  
In vitro, in vivo and ex vivo studies have all been extensively used to 
describe protein deposition on contact lens materials. During these studies a 
number of key variables relating to the material under consideration have all proven 




Figure 1-3: Slit lamp appearance of a heavily deposited hydrogel contact lens 
 
1.5.7 Water content  
Soft contact lenses based on pHEMA are often combined with other 
monomers and polymers to enhance surface wettability, strength, flexibility and 
oxygen permeability.197 In pHEMA-based hydrogels, increasing water content results 
in increased oxygen permeability,197 and it has been shown previously that water 
content can influence the level of protein deposition.  
Garrett and coworkers synthesized a variety of carboxymethylated pHEMA 
hydrogels with varying degrees of carboxymethylation, with higher levels of 
carboxymethylation resulting in lenses with a higher ionic charge and water 
content.120 Using a radiolabel-tracer technique they found a clear trend, with 
increasing water content resulting in decreased amounts of albumin deposition.120 
This is in agreement with the results from Keith et al.123 who found significant 
differences in albumin deposition between commercially available contact lenses 
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with low and high water content. All lenses were soaked in an artificial tear solution 
and two low water content soft lens materials (pHEMA at 38% water content) 
exhibited albumin deposition, while no detectable levels of albumin were found on 
four materials with water contents >55%.123  
Bohnert et al. investigated a variety of commercially available lens materials, 
in conjunction with a number of pHEMA materials synthesized with N-vinyl 
pyrrolidone (NVP), acrylamide (AAM) and methacrylic acid (MAA).122 They found that 
the deposition of radiolabeled albumin was similar in materials of varying water 
content, suggesting that water content alone is not the driving force for albumin 
deposition.122 This issue of protein deposition and water content is somewhat 
complicated, as the deposition is driven by both the charge and water content of 
the material under consideration, in addition to the size and charge of the 
depositing protein. In general, lower water content materials tend to deposit 
proteins such as albumin, in comparison with higher water content materials, which 
tend to deposit proteins such as lysozyme. This trend is exemplified in the study of 
Bohnert et al., where lysozyme deposition was greatest on an ionic composition of 
HEMA-MAA with water contents of 35% and 42%, followed by high water content 
hydrogels, suggesting that both charge and water content are important.122  
Subbaraman et al. incubated five commercially available pHEMA-based 
hydrogel materials over 28 days in lysozyme.97 He found increasing lysozyme 
uptake with increasing water content, with the exception of etafilcon A (58% water), 
which adsorbed multiple times more lysozyme than all other materials. He also 
reported on five silicone hydrogel (SH) lenses. These materials all deposited 
significantly less lysozyme than the pHEMA-based conventional hydrogels and a 
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trend for lower water content SH materials to deposit less lysozyme was also 
apparent.97 
While some studies indicate that albumin deposition is inversely proportional 
to water content, others suggest that this is not the case, indicating that water 
content alone is not the sole driving force for albumin deposition.121-123,133,176,182 
1.5.8 Hydrophobicity 
Hydrogel materials have both hydrophilic and hydrophobic domains, which 
are influenced by the various monomers used to produce the contact lens material. 
Factors such as surface wettability and tear film deposition are both markedly 
affected by the hydrophilicity and hydrophobicity of the lens material. When the 
surface is covered in a fluid then the surface is orientated such that more 
hydrophilic components are present at the material interface. In situations where 
the surface becomes dehydrated (such as that which occurs when the tear film 
breaks), then chain rotation forces come into play, whereby the hydrophobic 
polymeric components become reorientated such that they are preferentially 
expressed on the biomaterial surface. This results in the surface becoming less 
wettable. 
The relatively hydrophobic cross-linking agent ethylene glycol dimethacrylate 
(EGDMA) is frequently used in the polymerization of pHEMA. Bajpai and Mishra used 
a spectrophotometric procedure and reported that increasing concentrations of 
EGDMA increased albumin deposition.176 Bohnert et al. synthesized lens materials 
with various concentrations of relatively hydrophobic MMA and hydrophilic HEMA 
components and reported that increasing levels of HEMA decreased albumin 
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deposition.122 In contrast, a study from Pokidysheva et al. investigated four 
intraocular lenses and they found no significant correlation between hydrophobicity 
of the material and the level of albumin deposition.192 However, their results clearly 
show that hydrophobic PMMA adsorbed the highest level of albumin, and 
significantly more than pHEMA, which is in agreement with the other studies 
described above.198 However, Barbucci and coworkers synthesized hydrogels with 
different cross-linking agents to increase the hydrophobic component of the 
material, and investigated adsorption kinetics and potential denaturing of HSA and 
fibrinogen using infrared spectroscopy coupled with the attenuated total reflection 
technique (ATR–FTIR).198 They reported a decreasing HSA uptake with increasing 
hydrophobicity of the material, but the opposite trend was found for fibrinogen 
with increasing adsorption at increasing hydrophobicity. Furthermore, the 
hydrophobic character of the material resulted in significantly stronger 
conformational changes for HSA compared to fibrionogen. It is worthwhile pointing 
out that the use of different types of cross-linkers might also affect other chemical 
properties such as strength and pore size of the polymer and not just the 
hydrophobic nature of the material.  
Studies have shown that with higher concentrations of cross-linking agents 
the material modulus increases and the pore sizes decrease making it more difficult 
for larger proteins to penetrate into the matrix.199,200 
In conclusion, the majority of studies report that albumin deposits in higher 
concentrations on hydrophobic surfaces,128,134,182,195,198,201,202 as compared to relatively 
hydrophilic surfaces.  
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1.5.9 Charge  
Many studies have investigated the pH of the tear film and a range from 5.2 
to 8.6 has been reported,203,204 with a mean pH value of 7.0 to 7.5. Therefore, 
albumin with an isoionic point (IOP of 5.16) has a negative charge in the tear film, 
as compared with lysozyme (with an IOP of 11.4) which has a net positive charge. In 
general, proteins absorb in maximum amounts on solid surfaces if the solution 
containing the protein has approximately the same isoionic pH as the protein. This 
is true for albumin interactions with hydrogels, with the highest albumin uptake 
occurring at a pH around 5.0 133,175,176 or slightly below.121 
In addition to the pH of the tear film and the polarity of the protein, the 
relative charge of the material substrate is also highly relevant for the level of 
deposition. Contact lens materials are categorized in one of four FDA groups, with 
FDA groups III and IV being considered ionic or negatively charged.197 PolyHEMA 
itself is non-ionic, but the addition of monomers such as methacrylic acid (MAA), 
which are commonly used to enhance wettability and/or increase the water content, 
produces a polymer with an overall net negative charge compared with the tear 
film.  Garrett and coworkers investigated the effect of ionic charge on the uptake of 
radiolabeled HSA and lysozyme.120 Their results showed that increasing the negative 
charge of the material increased the deposition of positively charged lysozyme and 
reduced the deposition of negatively charged HSA.120 In a later study,121 Garrett 
investigated the deposition on materials containing negatively charged MAA and 
relatively neutral NVP. Once again, increasing MAA resulted in greater deposition of 
lysozyme and reduced deposition of albumin. Both radiolabeled proteins adsorbed 
in higher amounts with increasing NVP concentrations; however the amount of 
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lysozyme detected on the lens was always multiple times higher compared to the 
albumin uptake.121 This is in agreement with a study from Moradi et al., where they 
investigated the same proteins and their interactions with pHEMA and acrylic acid 
(AA).132 As before, the negative AA adsorbed less albumin and more lysozyme than 
the neutral pHEMA, which showed higher albumin uptake.132  
Contrary to these findings for lysozyme is the study of Lord et al..195 They 
investigated HSA uptake on pHEMA, pHEMA-MAA, pHEMA–MAA-NVP and PMMA 
materials using the quartz crystal microbalance with dissipation (QCM-D) technique. 
They did not find increased lysozyme uptake on the negatively charged pHEMA-
MAA: however, they found the same adsorption pattern for HSA as described in 
other studies, confirming that HSA adsorbed in highest concentrations to PMMA, 
followed by pHEMA-MAA-NVP and pHEMA, with the lowest albumin uptake reported 
for the most negatively charged substrate (pHEMA-MAA).132 A further study 
comparing nonionic to anionic (negatively charged) and cationic (positively charged) 
materials was conducted by Soltys-Robitaille.140 They used matrix assisted laser 
desorption ionization mass spectrometry (MALDI-ToF MS) and detected albumin on 
the cationic lens material but not on the pure pHEMA material. Likewise, lysozyme 
was detected on the anionic material only.140 
In conclusion, these studies all reveal that electrostatic attraction has a 
strong impact on albumin deposition. The negatively charged albumin is more 
likely to deposit on neutral or positively charged substrates than on materials with 
a net negative charge.  
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1.5.10   Pore size and surface roughness 
Protein penetration into hydrogel materials depends on the pore size and the 
density of the polymer chains in the material, as well as the structure and size of 
the protein under consideration. Albumin is known to be a flexible protein which 
can easily change its original heart-shaped structure (diameter of approximately 55 
Å) when binding to other molecules such as fatty acids or depositing onto a solid 
surface.178,205,206 Wood and coworkers determined the pore size of HEMA with 
different concentrations of the cross-linker EDGMA.207 They reported pore diameters 
of 11.82 Å for pure pHEMA, and even at a maximum concentration of EDGMA of 
1.59/104 mol cm-3 the average pore size only decreased minimally to 11.02 Å. 
Significantly larger pore dimensions were found by Gatin and coworkers.208 They 
used different experimental and simulation techniques to determine the pore size 
of a pHEMA-based contact lens and reported an average pore diameter of 428 Å. 
However, most researchers have reported pore sizes < 100 Å for the surface of 
various contact lens materials.  
Gachon et al. reported pore diameters between 56 and 70.6 Å for poly(MMA-
VP) lenses, by measuring with a two-dimensional electrophoretic system which 
protein can penetrate into hydrogels and which ones are blocked due to the 
proteins being too large.196 The two hydrogels examined had identical water 
contents (70%) and monomer composition, but were sourced from different 
companies. Albumin was detected in both hydrogels, but the larger protein 
ceruloplasmin (diameter of 66.2 Å) was only found in one of them, indicating the 
impact of manufacturing on average pore diameter and surface structure. Garrett 
and coworkers created two different models to calculate the actual average pore 
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size, based on the water content of the hydrogel material.120 They added different 
concentrations of MAA to pHEMA to increase the water content in the material and 
calculated the changing pore sizes. For a maximum concentration of 5% MAA they 
calculated an average pore diameter of 34.7 and 29.3 Å for their two models, and 
therefore predicted that HSA should not penetrate into their material, which they 
confirmed experimentally.120  
However, a recent study conducted by Luensmann et al. investigated BSA 
penetration into a conventional pHEMA-MAA and a plasma-treated SH contact lens 
using confocal laser scanning microscopy.209 They labeled BSA with a fluorescent 
dye and found increasing BSA uptake into the lens matrix for the pHEMA material 
over time, with the SH lens only detecting the fluorescent signal from the labeled 
protein on the lens surface. This might suggest that the polymer chains were more 
dense for the SH lens and the pore size on the surface was < 55 Å, while the surface 
structure of the pHEMA lens was looser and/or the average pore size was > 55 Å. 
The impact of different techniques for manufacturing pHEMA contact lenses and 
albumin adsorption was investigated by Castillo et al..128,175 After an incubation 
period of 72 hours they reported a 1.5 times higher HSA uptake on lathe-cut lenses, 
which provide a rougher surface compared to the spin cast lenses with a smoother 
surface. 
In summary, pore sizes for contact lens materials vary significantly between 
the polymer composition, manufacturing procedure and the applied measurement 
technique. It would appear that the average pore size of pHEMA-based contact 
lenses is between 20 to 70 Å and that albumin uptake can be mediated by this 
factor, with larger pore sizes exhibiting greater – and faster - penetration.  
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1.5.11   Temperature and ionic strength 
Albumin deposition decreases with increasing temperature of the solution. 
Demirel et al. measured the albumin uptake onto hydrogels between 5ºC and 40ºC 
and found more than double the amount of albumin deposited at 5 ºC, as 
compared to 40 ºC.175They suggested that interactions between the hydrogel and 
the protein were based on hydrogen bonds, which are weakened with increasing 
temperature.  
Ionic strength of the surrounding media also has an impact on the amount of 
albumin depositing on the biomaterial. Bajpai and Mishra found decreasing BSA 
adsorption on pHEMA with increasing ionic strength of the solution, measured at 
pH 7.4.176 However, no such strong tendency was observed by Moradi et al., who 
investigated the uptake of lysozyme and chicken egg albumin onto pHEMA and 
acrylic acid materials by measuring the UV absorbance of the proteins.132 
1.5.12 Conclusions 
Within seconds of insertion, contact lenses are coated with tears, which form 
a biofilm over the lens surface. This coating, which contains all the components of 
the tear film, starts to adhere to the lens and progressively increases over time. 
Increasing levels of HSA in the tear film are found during contact lens wear, 
especially during overnight wear, and the deposition of HSA is driven by many 
factors, including the concentration in the tears and the underlying chemical 
composition of the material being worn. Thus far, most published data have 
focused on the amount of deposited HSA, and only little is known about its degree 
of denaturation.181,182 Future work should examine the potential impact of 
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denaturation of HSA on immunological responses and clinical consequence of HSA 
accumulation on contact lenses, as the latest generation of silicone hydrogel 
materials appears to be deposit only small amounts of protein, but this protein is 
often denatured.97,100  
From this review, it can be concluded that many factors impact the 
adsorption of albumin onto hydrogel and PMMA lens materials. The higher the 
concentration of albumin in the tear film the greater the degree of deposition that 
can be expected on the lens material, particularly if the lens is worn overnight, or 
the patient exhibits dry eye or ocular surface disease. In addition, a larger pore size 
of the lens polymer will also increase albumin absorption. However, albumin 
deposition can be minimized if the material exhibits a net negative charge, is 
relatively hydrophilic and exhibits a high water content. Given these characteristics, 
deposition on silicone hydrogels, which now comprise a significant proportion of 
the lens materials fitted worldwide,29,34 is to be expected and the deposition of 
albumin and its structural conformation on silicone hydrogels should be a focus of 
future work . 
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1.6 Protein evaluation on contact lenses 
A number of qualitative and quantitative techniques have been applied to 
analyze protein deposition on contact lens materials. They can be categorized into 
three groups: Clinical assessment, assays and imaging techniques. While none of 
these methods can exactly describe the protein structure, quantity and distribution 
at the same time, each technique has the advantage of being able to provide very 
specific information about the deposition. 
1.6.1 Clinical assessment 
Subjective grading provides a fast, non-destructive method to assess 
deposition on contact lenses. Rudko and Proby categorized the degree of visible 
deposition on soft contact lenses using a slit lamp, as described in Table 1-5.210 
 
Table 1-5: Rudko classification 
Type I No deposits or films detectable under 7x magnification 
Type II Deposition only visible under 7x magnification 
Type III Deposition visible on dry lens under normal lighting conditions without the aid 
of magnification; deposition not visible on the wet lens 
Type IV Deposition visible on either dry or wet lens under normal lighting conditions 
without the aid of magnification 
 
Despite some modifications of this classification, the lack of correlation 
between Rudko scores and the total amount of protein deposited on lenses remains 
and differentiation between deposition types are difficult to determine.138,211 
Nevertheless, the assessment of the overall contact lens performance in situ 
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requires an evaluation of a number of aspects, including ocular health, comfort, 
surface wettability, lens movement, lens centration and also lens deposition. 
1.6.2 Assays 
Biochemical assays provide detailed information on the type of deposition. 
Assays typically require the extraction of the deposit from the contact lens before it 
can be analyzed and often focus on the identification of the protein content. 
Chemical reagents that are typically used to undertake the extraction include urea, 
guanidine hydrochloride, potassium thiocyanate, potassium perchlorate, 
hydroxylamine, ethylene dithretyl acetamide, sodium dodecyl suphate (SDS), 
dithiolthreitol, and trifluoroacetic acid/acetonitrile.39,123 The efficiency of these 
reagents depends on the type of deposition and lens material and may remove as 
little as 25% of the deposited substances.145,212 
General protein assays, amino acid analysis, gel electrophoresis and high 
performance liquid chromatography (HPLC) have been used to quantify and identify 
the deposited proteins. Other analytical assays, such as the micrococcyl activity 
assay, can furthermore determine the conformational state of the protein.98,100,102 
Although most assays have a high specificity, they experience difficulties 
identifying the few hundred different proteins found in the tears.106,213 In addition, in 
many cases the extraction efficiency is unspecified, the location of the deposited 
protein is unknown, it is uncertain, if denatured proteins can be extracted from the 
lens material as efficiently as native proteins, and finally it is unstated whether or 
not the reagent denatures the protein during the extraction process.43 
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1.6.3 Imaging techniques 
Microscopic and spectroscopic techniques provide primarily qualitative 
results, with some techniques providing some level of quantitative information.214 A 
number of microscopy techniques have been used to examine gross and fine 
morphological aspects of the deposition, including light-and dark field microscopy, 
phase contrast and interference microscopy.214,215 For higher resolution imaging and 
elemental analysis, scanning electron (SEM) and transmission electron microscopy 
(TEM) have successfully been adopted.151,216,217 Atomic force microscopy (AFM) 
provides details at the nanometer range and is therefore even more advanced 
compared to scanning microscopy techniques.218 In contact lens research, AFM has 
been used to image surface roughness and tear film deposition.219-222 
Spectroscopic methods typically measure the energy that is either absorbed 
or emitted by the deposited species and can, for example, identify proteins, 
carbohydrates or lipids by analyzing specific absorption bands. Ultraviolet (UV) and 
fluorescence spectroscopy,223 attenuated total reflectance (ATR),129 electron 
spectroscopy for chemical analysis (ESCA),224 surface matrix assisted laser 
desorption/ionisation (MALDI) mass spectrometry 136,213 and radiolabeling 121,225 are 
just some examples of previously used spectroscopic techniques.  
With resolutions of a few nanometers,215,218 both spectroscopy and AFM 
microscopy techniques are very powerful for surface analysis. However, all of these 
techniques can only measure the outermost surface region, with a maximum depth 
of a few microns.214 
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1.6.3.1 Confocal microscopy 
A confocal microscope provides higher transverse (XY) and axial (Z) 
resolutions as compared to conventional light microscopes, but is inferior when 
compared to electron or atomic force microscopes.215,218,226 The resolution of a 
confocal microscope depends on the sample reflectivity, the numerical aperture of 
the objective lens, illumination wavelength and intensity. The principle design of a 
confocal microscope requires two pinholes: The first pinhole focuses the light on 
the specimen and the second pinhole allows only those light rays to pass through 
to the detector that are directly returning from the focal plane. Figure 1-4 
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The adjustment of the pinhole provides good observation of the specimen, 
and allows focusing on different levels of depth. The collection of multiple XY 
images throughout a transparent sample can finally be used to reconstruct a 3-
dimensional image. Marvin Minsky invented the first confocal microscope in 1955 
227 and although modern instruments use more advanced optics and electronics, the 
key elements are still based on Minsky’s design.228 Most confocal microscopes 
collect either the reflected light from the specimen or (when using fluorescence) 
collect the light emitted from the fluorophore applied to the specimen. 
1.6.3.1.1  Types of confocal microscopes 
The first tandem confocal microscope was developed in 1968 and used 
rotating Nipkow disks to image living cells and tissue.229 Two Nipkow disks were 
built into the system, with each disk being constituted of >100 pinholes, with 
diameters between 40 and 60 μm. Each pinhole in the illumination path had a 
conjugated pinhole for the reflected light returning from the sample. However, 
since the area of holes on the disk covered only 1-2%, only low levels of light 
reached the sample and made it difficult to image low reflecting tissue.230 In a 
similar design, only a single Nipkow disk was used, in which illuminating and 
reflecting light followed the same optical path. Although it had the advantage of a 
simpler optical arrangement when compared to a tandem scanning Nipkow disk, 
the disadvantage of low light transmission remained.230 Modern clinical tandem 
confocal microscopes are equipped with discs of 64000 pinholes and bright Xenon 
or Mercury arc illumination sources, for improved imaging of ocular tissue.226 
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Approximately at the same time that early tandem scanning confocal 
microscopes became available, slit scanning confocal microscopes were 
introduced.231 These microscopes use conjugated slits for illumination and 
detection, with the distinct advantage of increased light transmittance and reduced 
scanning time.226,232 Although true confocal imaging is only possible in the axis 
perpendicular to the slit height, the image quality is acceptable and slit scanning is 
successfully implemented in current clinical instruments to image, for example, 
corneal cell layers.226,230,233,234 Images can be acquired at a rate of 25 frames/sec, 
scanning up to 350 images in one session.228 
Confocal laser scanning microscopy (CLSM) has further been introduced for 
in vivo and in vitro purposes. The use of a 670nm Helium Neon diode provides 
better contrast compared to slit scanning microscopes, particularly towards the 
edges of an image. The beam spot of less than 1 μm in diameter scans over the 
object and de-scanning of the deflected light gets digitized to form the image. 
Today, clinical laser scanning confocal microscopes are used for both retinal and 
corneal imaging.228 
The main difference between clinical and laboratory-based CLSM is the 
choice of the illumination source. Clinical instruments are required to use Class 1 
lasers, to prevent any ocular damage. The laser intensity in these microscopes is 
typically limited to <1mW. Laboratory research CLSM devices commonly use 3B 
lasers, which are limited to a maximum of 500mW. Direct eye exposure to this laser 
beam is hazardous and may lead to permanent ocular damage.235 
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1.6.3.1.2  Zeiss LSM 510 Meta, Axiovert 200 
This CLSM is used in laboratory applications and can perform a number of 
different microscopy techniques, for transmitted and reflected light imaging. 
Transmitted light applications include brightfield, differential interference contrast 
(DIC), phase or Varel contrast. The reflected light application allows fluorescence 
contrast microscopy (Figure 1-5). 
This CLSM is primarily used for fluorescence contrast applications, including 
single or multi fluorescence imaging, fluorescence resonance energy transfer 
(FRET), fluorescence recovery after photobleaching (FRAP), fluorescent loss in 
photobleaching (FLIP), time lapse experiments etc. These techniques have 
successfully been applied to study cell dynamics, including diffusion and transport 
of fluorescently conjugated molecules such as proteins, and in materials 
research.236-242 
 
Figure 1-5: Zeiss LSM 510 Meta, Axiovert 200 
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The Zeiss 510 Meta is equipped with the following lasers: Diode laser – 
405nm (25 mW), Argon multi-line gas laser – 458, 477, 488, 514nm (30 mW), 
Helium Neon gas laser – 543nm (1 mW), Helium Neon gas laser – 633nm (5 mW) 
Available objectives provide a magnification range from 10x to 63x for air, 
water and oil immersion. Predefined main dichroic beam splitters (HFT) have 
windows for either a single or up to three different excitation wavelengths, 
depending on the application and the number of fluorophores. An additional 
secondary dichroic beam splitter (NFT) cut wavelengths below the excitation 
wavelength for improved image quality. A number of different long pass (LP), band 
pass (BP), or individual adjustable emission filters can be selected. The object plane 
is scanned in a point-by-point, line-by-line raster with an XY light deflection system. 
The detector is a photomultiplier that converts the optical information into 
electrical signals. Fluorescence imaging can achieve lateral (XY) resolutions of 
0.2μm and axial resolutions up to 0.65 μm.242 
1.6.3.2  Fluorescence 
Photoluminescence occurs if a molecule absorbs photons from the UV or 
visible light spectrum, which raises the molecule into a high-energy electronic state 
within femtoseconds (10-15 sec). If this excited state remains stable for only a few 
nanoseconds (10-9 sec) and is followed by an energy release in form of light, it is 
called fluorescence. If light emission occurs with a delay between 10-4 and 10 sec 
after excitation has been stopped, it is called phosphorescence.243 Figure 1-6 shows 




Figure 1-6: Schematic fluorescence and phosphorescence energy states 
Light absorption raises the electron from the ground state (S
0





). The electron within this singlet state loses energy rapidly due to micro-environmental collisions, 
and drops from a higher vibrational level down, until it reaches the lowest vibrational level within the 
same singlet state. If the electron was first raised to S
2
 it now drops down to the highest vibrational 
level of S
1
. If it was first raised to S
1
 it relaxes to S
0
 while emitting light in the form of fluorescence, or 
if the remaining energy dissipated by further collisions the molecule returns to S
0 
without light 
emission. The final relaxation path can also lead from S
1 
to the triplet state (T
1
). The energy drops 
down to the lowest vibrational level of T
1
 and returns to S
0
 either in form of phosphorescence or 
radiationless, due to collisional deactivation. 
 
The intensity of the emitted light depends on the quantum yield of the 
fluorophore. The quantum yield describes the ratio between the amount of emitted 
and absorbed light, with a maximum value of 1 (total amount of absorbed light is 
emitted = bright light emission) and a minimum of 0 (none of the absorbed light is 
emitted). The quantum yield is primarily dependent on the molecular absorbance 
but is further impacted by a number of factors that can either increase or decrease 
(quench) the emission intensity. Factors that influence the emission signal strength 
are described in more detail in Chapter 4. 
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The excitation wavelength is generally different from the emission 
wavelength for both fluorescence and phosphorescence. In Stokes fluorescence, the 
emitted light is typically at a longer wavelength, which is explained by the energy 
loss before emission occurs. However, if thermal energy is added during the 
excitation process the emitted light may occur at a shorter wavelength, which is 
known as anti-Stokes fluorescence. The excitation spectrum for a specific molecule 
is identical to its absorbance spectrum, and depending on the substrate, it is 
possible to have more than one specific wavelength for excitation. As an example, 
Lucifer yellow’s maximum excitation is at 280nm and 430nm, but maximum 
emission is always at 525nm.244,245 
Molecules with no fluorescent or phosphorescent properties absorb light 
without energy transition of the electrons and the light is reemitted at the same 
wavelength. This is known as Raleigh scattering and can occur at all wavelengths.  
1.6.3.3  Radiolabeling 
The use of radioactive iodine isotopes to detect proteins was introduced over 
50 years ago.246 Although 37 iodine isotopes are characterized today, most of them 
are unsuitable because of their poor availability, stability specific activity, energy 
spectrum and short half-life of <1 hour.247 The majority of these isotopes are 
gamma emitters, except for 137I, 138I and 139I which emit beta rays. Popular isotopes 
for protein conjugation are 125I and 131I. The attachment of isotopes to proteins 
necessitates the addition of a reagent, therefore a number of techniques have been 
applied including iodine monochloride (ICL), peroxidase, electrolytic iodination or 
oxidizing techniques based on chloro-compounds.248  
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The ICL method was initially used as a halogenating agent in 1840 and 
became adapted for protein conjugation by McFarlane in 1958.248,249 A 4-fold molar 
excess of ICL over protein has been suggested by Helmkamp, providing optimal 
labeling efficiency and a low impact on protein function.250 The isotope 125I binds to 
the aromatic ring of tyrosine, and thus for albumin - which has 21 tyrosine amino 
acids - approximately half of them may be available for conjugation.251 The impact 
of iodine on protein properties has been debated, but the majority of studies seem 
to agree that radiolabeling causes only minor protein modification.252-254 Studies 
investigating the quantity of protein sorption to various materials typically use low 
contents of radiolabeled protein, which are mixed with native protein to reach the 
required concentration. Horbett showed that the majority of plasma proteins 
deposited in similar quantities to pHEMA-based materials regardless of the 
percentage of radiolabeled protein content in the solution.253 For the protein 






Tear film deposition on contact lenses became a major focus of attention for 
clinicians and researchers almost as soon as the first hydrogel lenses were 
developed. Tear film components adhere to the lens and can reduce vision and 
wearer comfort and increase ocular health complications, particularly as the lens 
ages. The advent of frequent replacement systems resulted in a reduction in 
interest in tear film contamination of lenses, as lenses were thrown away before the 
deposits produced a clinical problem. However, although new silicone hydrogel 
materials are highly oxygen permeable and deposit less protein compared to 
pHEMA-based lenses, the occurrence rate of some contact lens complications - such 
as CLAPC that may be associated with deposition - appears higher with these new 
materials. 
Protein adherence to any biomaterial - including contact lenses - is the initial 
response of the immune system to isolate the “foreign body” from the human 
system, and occurs within a few minutes after exposure. Although this interaction 
is a well known phenomenon in biomaterials research, to date no blood contacting 
material prevents protein adsorption, and the risk of further cell adherence and 
blood coagulation remains. Albumin is the most abundant protein in blood serum 
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and is therefore of particular interest when investigating blood-contacting 
biomaterials. 
A number of investigative techniques can either image or quantify the 
protein accumulation on biomaterials, but it remains unclear whether or not the 
protein sorbs exclusively on the surface or can also penetrate the material matrix. 
This might be of interest, as proteins that are tightly bound to a surface are more 
likely to denature and cause undesirable complications. In contact lens wear, 
denatured proteins are closely related to the immunological response known as 
giant papillary conjunctivitis. Therefore the purpose of this research work focuses 
on the detection of proteins on the surface and throughout contact lenses and 
intraocular lenses to gain a better understanding of interactions between proteins 
and hydrogel biomaterials. 
In the first study (Chapter 3) confocal laser scanning microscopy (CLSM) 
technique is introduced to locate proteins throughout contact lens materials. A 
fluorescein-based dye was conjugated to albumin and sorption profiles to pHEMA-
based contact lenses and a surface coated silicone hydrogel (SH) lens were 
determined.  
Chapter 4 evaluated the use of three different organic fluorescent probes on 
their impact on protein sorption behaviour. Four different contact lens materials 
were investigated, with some lenses being incubated in conjugated albumin and 
others incubated in dye solutions containing no protein. Comparisons between 
sorption patterns caused by the dye only and conjugated proteins are discussed. 
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Lysozyme is the most abundant protein in human tears and is known to 
adhere in high amounts to negatively charged surfaces. Chapter 5 applied the 
confocal technique previously developed to investigate nine different contact lens 
materials, including SH, neutral and charged pHEMA-lenses. A fluorescein-based 
dye and lucifer yellow were used for lysozyme conjugation. CLSM detected the 
fluorescent signal from the conjugated protein and sorption profiles of these two 
conjugates to the different material types were determined. 
Contact lens cleaning solutions are required to disinfect, clean, store and 
rinse worn contact lenses. Previous studies have shown that their efficiency at 
removing proteins from a contact lens depends on the care regimen as well as the 
lens material investigated. However, it remained unclear if manual lens rubbing is 
more efficient for the removal of surface-deposited proteins, as compared with lens 
soaking alone. The aim of Chapter 6 was to investigate the efficiency of hydrogen 
peroxide and a multipurpose cleaning solution to remove lysozyme and albumin 
from three types of contact lenses. CLSM was used to determine the sorption profile 
and incubation in radiolabeled protein determined the total amount of protein 
deposited. 
The application of this CLSM method for materials other than contact lenses 
was demonstrated in Chapter 7. Intraocular lenses (IOL) are frequently implanted 
into the eye to replace the opaque crystalline lens after cataract surgery. Following 
the surgery, inflammatory cell responses and cell proliferations are often observed, 
which is impacted by the surgical technique, the IOL material and design and the 
surrounding medium. The IOL is typically placed in the remaining capsular bag, 
which is surrounded by aqueous humour. Because albumin is the primary protein in 
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the aqueous humour, its interactions between silicone, polymethyl methacrylate 
and a hydrophilic acrylic materials was investigated. Albumin sorption profiles were 




In the following chapter of this thesis, the principle of CLSM will be described 
to detect fluorescently conjugated albumin throughout a pHEMA-based and a 
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3.1 Overview 
Purpose: To develop a novel in vitro method to detect the depth of 
penetration of the tear film protein albumin into contact lens materials using 
confocal laser scanning microscopy (CLSM). 
Methods: A poly-HEMA-based hydrogel (etafilcon A) and a silicone hydrogel 
material (lotrafilcon B) were examined. In vitro, bovine serum albumin (BSA) was 
labeled with 5-(4,6-dichloro-s-triazin-2-ylamino) fluorescein hydrochloride (DTAF). 
The lenses were incubated in this protein solution (0.5 mg/ml) at 37°C. After 1 and 
7 days incubation, the lenses were examined using CLSM (Zeiss 510, config. META 
18) and the location of the fluorescently labeled BSA was identified. 
Results: BSA adsorption on the surface and penetration into the lens matrix 
occurred at a higher concentration for etafilcon compared to lotrafilcon (p<0.001). 
For both materials, BSA was detected on the surface after 1 day of incubation. 
Significant levels of BSA were detected within the matrix of etafilcon after as little as 
1 day (p<0.001), but no BSA was detected in the matrix of lotrafilcon at any time 
(p>0.05). 
Conclusions: CLSM can be successfully used to examine the depth of 
penetration of fluorescently labeled proteins into various hydrogel polymers. Our 
results show that etafilcon lenses both adsorb BSA on the surface and absorb BSA 





Deposition of tear film components such as proteins, mucins and lipids on 
contact lenses can cause discomfort and inflammatory complications such as giant 
papillary conjunctivitis (GPC) 1-6 and these problems can appear with any type of 
daily or extended wear lenses.7 The recently introduced silicone hydrogel (SH) 
materials have different deposition profiles to that seen with conventional hydrogel 
lenses (CH) based on pHEMA, with lower levels of protein deposition and higher 
levels of lipid deposition being measured.8-12  
Of the tear film proteins that deposit on contact lenses, most of the 
literature to-date has concentrated on the deposition of the positively charged 
protein lysozyme, which is the most abundant protein in the tear film, with a 
concentration of approximately 3 mg/ml,13-15 and a molecular weight of 14.4 kDa. 
Another protein of interest is the larger protein serum albumin, with a molecular 
weight of 66 kDa, which is negatively charged and has a lower concentration in the 
tear film of approximately 0.04 mg/ml during the daytime. This amount increases 
to approximately 0.2 mg/ml during sleep and may rise as high as 0.5 mg/ml 
following wear of orthokeratology lenses.14,15  
Work to-date on conventional pHEMA-based lens materials has shown that 
the deposition of lysozyme and albumin depends upon the polymer composition,16 
charge 17-19 and water content,20 with lysozyme being mainly deposited on negatively 
charged substrates and albumin being deposited on neutral and/or positively 
charged materials. Thus far, while the deposition of lysozyme on SH materials has 
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been determined,9-12 less information is available describing the deposition of 
albumin on these new materials.21 
A variety of methods can be used to examine deposition on contact lenses, 
including visible clinical grading, surface imaging and analytical methods that 
require the deposits of interest be removed.8,22-25 Major disadvantages for clinical 
grading include substantial inter-subject variability and a lack of biochemical 
analysis of the deposits. Imaging techniques such as microscopy do not allow for 
quantification of the species of interest. Methods requiring removal lack certainty 
both in terms of the removal process and the exact location of the deposited 
substance on or within the lens material. 
The purpose of this study was to develop a novel method to investigate the 
spatial and temporal penetration profile of serum albumin labelled with a 
fluorescent marker on and into various hydrogel contact lens materials and to 




Bovine serum albumin (BSA) with a purity of 99% (agarose gel 
electrophoresis) and a molecular weight of 66 kDa was purchased from Sigma-
Aldrich (St. Louis, MO, USA). BSA was chosen for this study, since it has very similar 
properties to albumin from human serum (HSA).26 BSA was labelled with the 
fluorescent dye DTAF (5-[4,6-Dichloro-s-triazin-2-ylamino] fluorescein 
hydrochloride) from Sigma-Aldrich (St. Louis, MO, USA). This dye was chosen as it 
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does not significantly change the molecular weight and size of BSA.27,28 For the 
labeling procedure, BSA (180 mg) was dissolved in 0.05M borate buffer (pH = 8.5) 
containing 0.04M NaCl (18 ml). DTAF (10 mg) was dissolved in dimethylsulfoxide 
(DMSO; 1 ml; Sigma-Aldrich, St. Louis, MO, USA) and was added drop wise, while 
stirring the solution. The BSA-DTAF was stirred for two hours at room temperature 
before separating the conjugate from unreacted labeling agent using PD10 
desalting columns (Amersham Biosciences, Piscataway, NJ, USA). Further elimination 
of unreacted DTAF was done by dialysis against phosphate buffered saline (PBS, pH 
7.4) (5x4 litre). The dialysis cassettes were purchased from Pierce, Rockford, IL, USA 
and the membrane, with pore sizes of 7000 MW, filtered all particles out of the 
protein solution that were small enough to diffuse through the pores, including free 
dye and small protein fractions. Subsequent measurements with a fluorescence 
spectrophotometer (Hitachi F-4500, Tokyo, Japan) verified a continuous decrease of 
the unbound dye. The calculated labeling ratio was 2 molecules of dye per molecule 
of BSA, and this solution was diluted with PBS to obtain a final BSA concentration of 
0.5 mg/ml. To verify the purity and molecular size of the BSA before and after the 
labeling process a sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) was performed. A prestained standard with molecular markers from 10 kDa 
to 250 kDa was used on a PhastGel Gradient 10-15 (Amersham Bioscience, Uppsala, 
Sweden) 
The lens materials examined were etafilcon A (Acuvue 2; Johnson & Johnson, 
Jacksonville, FL, USA) and lotrafilcon B (O
2
Optix; CIBA Vision, Duluth, GA, USA), 
details of which can be seen in Table 3-1. 
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Table 3-1: Hydrogel lens materials 
Proprietary name O
2
 Optix Acuvue 2 
United States adopted name lotrafilcon B etafilcon A 
Manufacturer CIBA Vision Johnson & Johnson 
Center thickness (@ –3.00 D) mm 0.08 0.084 
Water content (%) 33 58 
Oxygen permeability (× 10–11) 110 17 
Oxygen transmissibility (× 10–9) 138 21 
Surface treatment 
25nm plasma coating with 
high refractive index 
No surface treatment 
FDA group I IV 
Principal monomers 
DMA + TRIS + siloxane 
macromer 
HEMA + MAA 
 
DMA (N,N-dimethylacrylamide); HEMA (poly-2-hydroxyethyl methacrylate); MA (methacrylic acid); TRIS 
(trimethylsiloxy silane) 
 
All lenses examined had powers of -3.00D. They were individually soaked for 
30 minutes in 10 ml sterilised PBS, before they were incubated in the protein 
solution for 1 and 7 days, with four replicates for each condition. The labelled BSA 
solution was sterilised with syringe filters (Pall Corporation, Ann Arbor MI, USA) and 
in total 8 lenses of each type were incubated in individual amber vials, which were 
filled with 1 ml of the protein solutions and kept in an oven at 37 degrees on a 
gently rotating plate. Negative controls consisted of 8 further lenses for each lens 
type, incubated for equivalent periods of time in PBS. Thus, 32 lenses in total were 
examined (2 lens types, 2 doping solutions, 2 incubation times and 4 replicates of 
each). After the defined incubation time, lenses were rinsed for five seconds with 
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PBS and a punch press was used to remove a circle of 4 mm diameter from the 
middle of the lens, which was then placed on a microscope slide (Fisher Scientific, 
Pittsburgh, PA, USA) using PBS as mounting solution. Samples were covered with 
cover-slides (VWR, Bridgeport NJ, USA), sealed with nail polish. 
Samples were analyzed using a confocal laser scanning microscope (CLSM) 
Zeiss 510, config. META 18 equipped with an inverted motorized microscope 
Axiovert 200M, (Zeiss Inc. Toronto, Canada). The Argon laser was set to an output 
of 50% to obtain a stable laser beam. The beam pathway was assigned to channel 3, 
and the main (HFT 488nm) and secondary (NFT 490nm) dichroic mirrors were 
chosen according to the dye specific excitation wavelength. The long pass filter LP 
505nm was used to detect the emission wavelength. The water-immersion C-
Apochromat objective (numeric aperture 1.2) was chosen to achieve an optimised 
image quality, and the pinhole size was set to 1 Airy unit to eliminate out of focus 
rays. Settings for the scan control were: 625 for the detector gain, -0.025 for the 
amplifier offset and 1 for the amplifier gain. A laser transmission of 5% at 488nm 
was chosen to minimise photobleaching of the fluorescent dye. For the image 
settings a frame size of 512x512 pixels, maximum scan speed, a pixel depth of 8 
bit and the returning scan direction was used for collection of all images. All 
described microscope settings remained the same for the duration of the study. 
To detect the contact lens surface of the sample under the microscope, a 
small area on the lens was marked with a pen that was visible using 2% transmitted 
light. A suitable position on the lens surface was chosen and using the z-stack, 
which is the module to measure through the sample, the first and last positions on 
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the sample were determined. With a constant step size of 1 μm, continuous images 
were captured from the front to the back surface of the sample.  
Six scans of each sample were obtained. To investigate the influence of any 
potential photobleaching effects, two measurements at identical central locations 
were taken (scan numbers 1 and 6), with a scan size of 190x190 μm. After scan 1 
and before scan 6 four other readings (scans 2-5) were obtained in the four corners 
of the sample (115x65 μm) in a randomised fashion to investigate differences in 
penetration profiles over the lens. Scans 1 and 6 were measured using 400x 
resolution and the other locations were measured using 800x resolution. ImageJ 
(Bethesda, MD, USA) was used to calculate the fluorescence signal of DTAF for each 
single image along the vertical axis.  
The cross-section through the lens material was divided into three regions of 
interest (Figure 3-1). The “front surface region” was defined as the average of the 
front fluorescence peak ± 2 μm, the “back surface region” was defined as the 
average of the rearmost peak ± 2 μm and a “central region” or “bulk” was defined as 
the average of the 30 central images, using the front and back peaks as borders.  
One factor to consider when conducting studies using dye-tagged proteins is 
whether the data obtained could be due to the absorption of unbound dye and that 
the results obtained are more indicative of dye-binding rather than protein uptake. 
To reduce this, the labelled protein solution was extensively dialysed until only very 
minor amounts of fluorescent signal were detectable in the protein solution. In 
addition, lenses were incubated in a control PBS-DTAF solution without the addition 
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of BSA, at a dye concentration approximately 200 times lower than the study 
solution. 
 
Figure 3-1: Definition of front, back and “bulk” regions for etafilcon A 
incubated in labeled BSA 
The “front surface region” was defined as the average of the front fluorescence 
peak ±2 μm, the “back surface region” was defined as the average of the rearmost 
peak ±2 μm and a “central region” or “bulk” was defined as the average of the 30 
central images, using the front and back peaks as borders. The x-axis shows the 
measurement through the thickness of the central lens material (μm) and the y-axis 
shows the relative fluorescence intensity. 
 
For analysis of the protein uptake on the front, back and “bulk” regions, a 
repeated measures ANOVA (analysis of equal variance) was applied (significance 
level p<0.05), with the factors being solution (labelled BSA and PBS solution), 
contact lens type (lotrafilcon B and etafilcon A), incubation time (1 and 7 days) and 
location (the 4 corner scans). To determine if any photobleaching had occurred 
during the exposure to the confocal laser beam, the Limits of Agreement (LOA) 
between scans 1 and 6 were examined, where LOA = d ± 1.96 x sd on the three 
























two central locations (1 and 6) and ‘sd’ is the calculated standard deviation. 
Additionally, the Correlation Coefficient of Concordance (CCC) was calculated to 
describe the concordance between the repeated scans (1 and 6).29 CCC describes 
the deviation between the scans from a perfect 45º line and therefore the 
repeatability. (CCC=1 = perfect correlation and perfect repeatability; CCC=0 = no 
correlation and no repeatability). 
 
3.4 Results 
SDS-Page was used to verify purity and final molecular weight (approximately 66 
kDa) for the unlabelled, labelled and sterilized BSA solutions, as seen in Figure 3-2. 
The gel also shows that no smaller BSA fractions appear below the standard of 
50MW but some proteins aggregated and therefore weaker bands with higher 
molecular weights were found. These results are of importance, as it may be 
expected that smaller proteins or protein fractions would penetrate more easily into 






Figure 3-2: SDS-PAGE for different BSA-PBS solutions 
SDS-Page was used to verify no proteins are smaller than the expected MW of 66 
kDa. Column 1: Molecular marker; Column 2: 1.5 mg/ml BSA; Column 3: 1.5 mg/ml 
labeled BSA; Column 4: 0.5 mg/ml labeled BSA; Column 5: Molecular marker; 
Column 6: 0.25 mg/ml BSA; Column 7: 0.25 mg/ml labeled BSA; Column 8: 0.25 
mg/ml labeled and sterilized BSA. 
 
The fluorescent signals of the labelled BSA on the lens surfaces and inside 
the matrix were different for the two contact lens materials (p<0.001). Figures 3-3A 
and 3-3B demonstrate the typical pattern of the fluorescent signal on both surfaces 
and inside the matrix of etafilcon and lotrafilcon B materials after 7 days incubation 
with labelled BSA. The image galleries were plotted in a step size of 1 μm through 
the thickness of the lens materials. The brighter the image, the more fluorescent 
signal was detected, representing a greater degree of albumin deposition. For the 
etafilcon material (Figure 3-3A), an almost equally distributed fluorescent intensity 
was found on the surface regions and inside the matrix, indicating that the surface 
of the etafilcon lens was not a barrier for penetration of the BSA molecules. This 
was contrary to the results seen with the plasma-coated lotrafilcon B material 
(Figure 3-3B), where a weak fluorescence signal was detected on the surfaces and 






Figure 3-3: Image galleries of typical x-y-confocal scans for etafilcon A (A) and 
lotrafilcon B (B) 
Images show examples after 7 days of incubation in labeled BSA. Brighter colors 




















































































































con A (A) 
shows the 
 and the y-
n fluoresc
ck surface
















significant difference between the control (PBS only) and BSA solution at all times 
(p<0.001), indicating that BSA adsorbed in significant quantities even after one day 
of incubation. The amount of adsorbed BSA increased significantly between days 1 
and 7 (p<0.001), with no such change being seen for the PBS control group 
(p>0.05). There was no significant difference in the degree of albumin deposition 
between the front and back surfaces (p>0.05).  
Figure 3-5B illustrates the average fluorescence intensity for all four 
replicates for the lotrafilcon B material, for lenses incubated in both the test and 
control solutions, for the surface regions only, for both time periods. There was a 
significant difference between the lenses incubated in the control and labelled BSA 
solution at all times (p<0.001), indicating that BSA adsorbed in significant 
quantities even after one day of exposure. Examination of figure 3-5B indicates that 
the amount of adsorbed BSA apparently decreased over time on both the front and 
back surfaces (p=0.05), but at both points in time the fluorescence intensity was 
greater than that seen in the PBS-doped control lenses (p<0.001). A significant 
difference between the front and back surfaces were found for day 1 (p<0.001), but 
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than the control sample, indicating that only a small amount of BSA adsorbed on 
the surface of lotrafilcon B. In contrast etafilcon showed no such surface peak 
(Figure 3-3A), regardless of the incubation solution. 
To investigate the potential loss of fluorescence intensity due to light 
exposure (fluorescence loss in photobleaching - FLIP), two scans of the same 
location were taken on each lens and the discrepancies between these two 
measurements (from scans 1 and 6) were calculated and the Limits of Agreement 
plotted in Figures 3-7(A+B). Exposure to the laser beam was between 60 and 80 
seconds for each location. The average intensity loss for the lenses incubated with 
labelled BSA was 0.8 ± 2.1 units for etafilcon and 0.2 ± 0.8 units for lotrafilcon B. 
Generally, a slightly lower intensity for the second scan was also found for both 
control groups (etafilcon 0.01 ± 0.01units; lotrafilcon B 0.39 ± 0.42 units). CCC 
results were 0.98 for etafilcon and 0.99 for lotrafilcon B both calculated for the 
incubation in labelled BSA, confirming high concordance for repeated 
measurements and therefore consistent results for the different lenses. These 
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Hydrogels have been shown to be highly biocompatible and as a result they 
find application in various biomedical and pharmaceutical areas and are frequently 
used for implanted materials, including artificial blood vessels, catheters or as drug 
delivery devices.30,31 Albumin is the most abundant protein in human serum and its 
adsorption on biomaterials is of major importance, since it is the initial event 
happening before cell attachments occur. The protein layer works as an interface 
between the biomaterial and the cellular tissue. However, this biochemical 
adsorption process can induce a higher risk of thrombogenicity due to 
conformational changes and irreversible adsorption of the protein on the 
surface.32,33 
Contact lens complications due to protein deposition have been reported by 
many researchers.1-6 The impact of albumin adhesion alone to contact lenses was 
studied by Taylor and et al.34 They demonstrated that increased albumin deposition 
to etafilcon A lenses resulted in increased adherence of Pseudomonas aeruginosa 
and Staphylococcus epidermidis, with the opposite result occurring for polymacon 
lenses.34 Other studies confirmed that tear-coated contact lens materials are more 
likely to adsorb Pseudomonas aeruginosa compared to unworn lenses, but high 
individual variation was always reported.35,36 
To determine protein adsorption on and/or absorption into hydrogel contact 
lenses, a variety of different imaging, immunological and microscopic techniques 
have been successfully used,8,22-25 but none of these methods adequately describe 
the locations of proteins within the lens matrix or on the lens surface. A number of 
70 
researchers have previously attempted to investigate protein penetration into 
hydrogel polymers, using both microscopic techniques and, more recently, CLSM. 
Refojo and Leong 37 used light microscopy and FITC- labelled lysozyme, BSA and 
dextrans to look at the penetration of these substances into hydrogel polymer films 
of varying water contents and charge. The authors found that BSA penetrated into 
high water content gels but not into lower water content pHEMA gels and that 
lysozyme, with its lower molecular weight, penetrated further than BSA. 
Subsequently, Bohnert et al. used an “ultraviolet lamp” to investigate protein 
penetration,16 but they could not detect any significant penetration of fluorescently-
labelled lysozyme or BSA into the bulk of a variety of hydrogel membranes. The 
most recent microscopy study investigating protein penetration into hydrogels used 
a staining technique (Coomassie brilliant blue) to investigate lysozyme and BSA 
penetration into all four FDA groups.38 It is unclear whether the lenses investigated 
included silicone hydrogels, but their data showed that BSA was only located on the 
surfaces of the lens materials, with no visible penetration being observed, as 
compared to lysozyme, which showed penetration into FDA group IV materials.38 
One of the most recent advances in microscopy relates to the development 
of confocal microscopy, which was patented by Minsky in 1961 and became even 
more popular with the addition of a laser in the late 1980’s. Since then various 
confocal microscopy techniques have been used extensively in ocular research to 
image cells and tissue, both in vivo and in vitro.39-44 This form of microscopy has the 
significant advantage of being able to obtain images through thick samples using 
small step sizes. It has been previously used in deposition research to provide 
information about both the contact lens surface and matrix, without the need to 
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remove the protein of interest. Meadows and Paugh 45 used CLSM to study protein 
penetration in worn lenses and showed that protein penetrates through both 
etafilcon and pHEMA lens materials. To-date, they are the only researchers to have 
used CLSM to study ex vivo lenses, and they were able to show that protein 
deposition increased in both materials over time. The most recent reports on 
protein penetration using CLSM are the studies by Garrett et al.17,18,20 Their study 
examined both lysozyme and human serum albumin (HSA) penetration, using both 
commercially available conventional hydrogel materials and fabricated polymeric 
films of varying water content and charge. The result of this study showed that 
lysozyme penetrates in significantly greater quantities than HSA and that porosity 
and surface charge has a significant effect on lysozyme penetration, with ionic 
materials exhibiting greater penetration than neutral materials. Surface charge had 
no influence on HSA penetration, with very little penetration being seen after 1 day 
of exposure.  
This study is unique in that we are the first to report on the use of CLSM to 
study the penetration of BSA with a molecular mass of 66kDa into silicone hydrogel 
lens materials and one of the first to report that BSA can penetrate into 
conventional hydrogel materials. We found higher BSA uptake on an FDA group IV 
pHEMA-based conventional contact lens material (etafilcon A) compared to an FDA 
group I silicone hydrogel material (lotrafilcon B). Our results confirm previous 
studies, reporting that silicone hydrogel lenses adsorb very low levels of proteins 
compared to conventional pHEMA-based materials,9-12 however, the advantage of 
this technique is that it does not only indicate differences in the amount of 
deposited protein, but can also locate the protein in terms of whether it is 
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predominantly found on the surface or within the bulk providing the spatial and 
temporal distribution profile.  
Figures 3-3A and 3-3B show clearly that the location and degree of BSA 
deposited differ markedly between lotrafilcon B and etafilcon A. Figures 3-4 to 3-7 
demonstrate that a significant amount of BSA penetrated into the matrix of 
etafilcon A after only one day of exposure, with no detectable labelled BSA being 
found inside lotrafilcon B and that a greater amount of BSA also accumulated on the 
surface of etafilcon. Within the matrix of the lens, even after 7 days of incubation 
no detectable levels of BSA could be seen within lotrafilcon B. Over time, the 
amount of BSA on and within the matrix of etafilcon A increased and the amount of 
absorbed BSA became similar to that adsorbed on the surface.  
Albumin absorption is influenced by many factors, including pH and ionic 
strength of the solution, water content and charge of the material, and, 
importantly, pore size.46 Garrett et al. estimated two different models to calculate 
the actual pore size based on the water content of the hydrogel material.17 They 
added different concentrations of methacrylic acid (MA) to pHEMA to increase the 
water content in the material and calculated the changing pore sizes. For a 
maximum concentration of 5% MA they calculated an average diameter of 34.7 and 
29.3 Å for their two models, and therefore predicted that HSA, which has a 
diameter of approximately 55 Å, should not penetrate into their material, which 
they confirmed experimentally. However other researchers estimated bigger 
average pore sizes for various HEMA compositions: Gachon et al. reported pore 
sizes between 56 and 70.6 Å for poly(MMA-VP) lenses 47 and even bigger pores were 
found by Gatin et al. who investigated pHEMA-based lenses and measured pore 
73 
sizes of 428 Å.48 Based on these studies it would be possible for BSA to penetrate 
into HEMA-based materials and our data support the conclusion that BSA with a 
molecular weight of 66kDa can indeed penetrate into etafilcon A.  
One final point to discuss is the surprising finding that the apparent degree 
of BSA deposition reduced on the lotrafilcon B material between days 1 and 7. This 
could be due to photobleaching or due to the dye intensity reducing over time. A 
previous study 49 showed that DTAF has comparably high fluorescence intensity to 
other dyes, but does tend to bleach faster. In our study we adjusted the argon laser 
to a very low intensity of 5% to prevent extensive light exposure, which could lead 
to bleaching effects. Figures 3-7(A+B) demonstrate that for both materials only 
minor intensity losses were seen in the second scan at the same location, ruling out 
the possibility of photobleaching being significantly involved. This result confirms 
that the DTAF had good short time stability for the confocal laser, but it was not 
stable enough under long incubation conditions at 37 degrees. Fading in the 
intensity of the dye was confirmed in a separate free-dye study (see Appendix B), 
confirming that the reason for the relatively small, but statistically significant, 
reduction in fluorescence intensity after 7 days for the lotrafilcon B material was 
due to weakening of the DTAF and not BSA desorption. The increased amount of 
BSA adsorbed onto the etafilcon material prevented this small reduction in intensity 
being detectable. Further work is underway to locate a dye that remains stable over 




CLSM is a useful technique to examine the penetration profile of the protein 
albumin into different contact lens materials. After incubating etafilcon A in         
0.5 mg/ml fluorescently labelled BSA, significant uptake on the surface and within 
the matrix was seen, which increased over time. The lotrafilcon B material adsorbed 
very little BSA on the surface and no significant BSA was found in the matrix after 7 
days of exposure. This confocal technique is applicable to any study in which 









The next chapter will evaluate the use of different fluorescent probes to label 
albumin. CLSM will monitor the sorption pattern throughout the lens materials, and 
comparisons will be made between conjugates.   
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Purpose: To investigate the impact of fluorescent probes on the sorption 
behaviour of proteins. 
Methods: Bovine serum albumin (BSA) was conjugated to three organic 
fluorescent probes, 5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein hydrochloride 
(DTAF), Rhodamine B isothiocyanate (RITC) and Lucifer yellow (LY). The protein 
sorption profile to one pHEMA-based (etafilcon A) and three silicone hydrogel (SH) 
contact lens materials (lotrafilcon B, balafilcon A and senofilcon A) was determined 
using confocal laser scanning microscopy. In addition, all materials were incubated 
in dye solutions containing the fluorescent probe alone; and finally BSA 
accumulation was quantified using radiolabeling.  
Results: The different conjugates showed similar sorption profiles for the 
pHEMA-based material, but marked differences for all SH materials. Lotrafilcon B 
accumulated more protein on the surface as compared to the matrix, independent 
of the fluorescent probe used for conjugation. Protein sorption varied for senofilcon 
A, with DTAF-BSA sorbing primarily to the surface region, while the other 
conjugates penetrated in equal amounts into the matrix. Balafilcon A exhibited 
smaller differences between conjugates, with LY-BSA allowing the protein to fully 
penetrate the matrix, while the other conjugates showed minor surface adsorption. 
Sorption curves of unbound dyes were often similar compared to the conjugated 
results. 
Conclusions: BSA profiles to pHEMA-based and silicone hydrogel materials 
were highly dependent on the fluorescent probe used and none of the probes 
accurately reflected quantitative protein levels for the materials investigated. 
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4.2 Introduction 
Fluorescent probes are frequently used as analytical tools in biochemistry 
and biotechnology 1,2 as well as for clinical and diagnostic applications.3 The 
fluorescence quantum yield, which is described as the total energy emitted relative 
to the energy absorbed, is 1000 times higher compared to most 
spectrophotometric methods, with detectable quantities of one in a billion.2,4 
However, a number of factors are known to either increase or decrease the 
emission signal or lead to de-excitation of the fluorescent molecule. Firstly, the 
fluorophore itself, with molar absorptivity, concentration, luminescence lifetime, 
phototoxicity, absorption and emission spectra all playing relevant roles. Secondly, 
the microenvironment, in which the type of solvent, pH, temperature, oxygen level, 
solvation, ionic strength, viscosity, and molecular collisions- resulting in energy or 
charge transfer- are known to impact emission intensities. Finally, instrument-
specific effects such as the availability of the optimal wavelength for excitation, lack 
of control over radiation intensity, aging of the light source, and variations in 
detector sensitivity during measurements are all significant factors. 
Fluorescent spectroscopy techniques find a variety of applications in protein 
characterization,5 because most proteins exhibit a weak intrinsic fluorescence due 
to their aromatic amino acids. The molar extinction coefficient of these amino acids 
is highest for tryptophan > tyrosine > phenylalanine, with maximum absorbance 
peaks at 279nm, 275nm, 257nm respectively.6 However, not all analytical 
techniques allow measurements within the ultraviolet spectrum and frequently 
require the attachment of an extrinsic fluorescent probe to the protein. Extrinsic 
fluorescent probes can either non-covalently attach to proteins using electrostatic 
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and hydrophobic interactions or bind covalently to specific residues with the help of 
additional reactive derivatives. Examples for covalent conjugations are amine-or 
thiol-reactive probes. Amine-reactive dyes typically bind to the aliphatic ε-amine of 
the amino acid lysine and the N-terminal amino acid of the protein under conditions 
above pH 8.0, while thiol-reactive probes attach to sulfhydryl groups of cysteine 
and methionine under neutral pH conditions.4,7,8 
Fluorescent probes have a molecular weight between 300 and 1500 Dalton 
(Da),8 and are therefore multiple times smaller compared to most proteins (e.g 
serum albumin at 66,000 Da). Nevertheless, a number of studies have 
demonstrated significant changes in charge,9,10 isoelectric point,9,11 size,9,12 binding 
characteristics,13-15 and kinetics 16,17 between native and fluorescently conjugated 
proteins. 
Confocal laser scanning microscopy (CLSM) is often used for 
chromatographic materials research to study their interaction with proteins.18 
However, conjugation effects and material-based factors need to be considered 
when evaluating fluorescence emission intensities.19 
The purpose of this work was to determine the sorption profile of albumin to 
poly-2-hydroxyethyl methacrylate (pHEMA) and silicone hydrogel contact lens 
materials. In separate experiments, three organic fluorescent probes were 
covalently conjugated to albumin and using CLSM the protein was located 
throughout the lenses. Furthermore, all investigated material types were incubated 
in a dye solution containing no protein and the resulting dye-sorption pattern were 
compared to the pattern found with conjugated albumin. 
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4.3 Methods 
The protein bovine serum albumin (BSA, 99% agarose gel electrophoresis, 
Sigma-Aldrich, St. Louis, MO) was selected as a model protein, which is commonly 
used for research purposes, due to its stability, water solubility, versatile binding 
capacity and availability.20 Three organic fluorescent probes, 5-(4,6-Dichloro-s-
triazin-2-ylamino)fluorescein hydrochloride (DTAF), rhodamine B isothiocyanate 
(RITC) and lucifer yellow VS dilithium salt (LY) (all Sigma-Aldrich, St. Louis, MO) were 
selected due to their differences in molecular composition, spectra for excitation 
and emission, and protein coupling affinities (Table 4-1).  
 
Table 4-1: Fluorescent probes investigated 
 
Da Dalton; EM emission wavelength; EXC excitation wavelength, nm nanometer; MW molecular weight 
 
Four contact lens materials were specifically chosen due to their distinct 
differences in polymeric composition and surface modification. All lenses had a 
power of -3.0 D (dioptres), with the material properties listed in Table 4-2. Prior to 
the experiment, lenses were removed from the blister pack and presoaked in sterile 
phosphate buffered saline (PBS) (pH 7.4) for 30 minutes. Presoaking of the lenses 
was performed to minimize the potential impact caused by components of the 































































packaging solution on subsequent protein sorption behaviour and fluorescence 
quenching.  
 
Table 4-2: Contact lens materials investigated 
 
DMA N,N-dimethylacrylamide; HEMA 2-hydroxyethyl methacrylate; MAA methacrylic acid; mPDMS 
monofunctional polydimethylsiloxane; NVA N-vinyl aminobutyric acid; NVP N-vinyl pyrrolidone; PBVC 
poly[dimethylsiloxyl] di [silylbutanol] bis[vinyl carbamate]; PVP polyvinyl pyrrolidone; TEGDMA 
tetraethyleneglycol dimethacrylae; TPVC tris-(trimethylsiloxysilyl) propylvinyl carbamate; TRIS trimethyl 
siloxy silane.  
 
4.3.1 Protein conjugation 
For solution 1, the individual fluorescent probes were conjugated to BSA 
using optimized protocols for each dye, to achieve a degree of labeling (DOL) ≤ 3 to 
reduce the risk of protein modification seen with overlabeling.9 The conjugation 
with DTAF 21 and LY 22 have been described previously. Briefly, 180 mg BSA was 
dissolved in 0.05M borate buffer (pH = 8.5) containing 0.04M NaCl (18 ml). The 






































OASYSTM senofilcon A I 
Johnson & 
Johnson 70 38 
PVP is 
incorporate










dimethylsulfoxide (DMSO; 1 ml; Sigma-Aldrich, St. Louis, MO, USA) and the 
hydrophilic probe (LY – 7 mg) in borate buffer. The dissolved dye was added drop 
wise to the protein solution, while stirring. Following the reaction time of two hours 
at room temperature, unconjugated dye was separated using PD10 desalting 
columns (Amersham Biosciences, Piscataway, NJ, USA) and dialysis against PBS 
(pH=7.4). The continuous decrease of the unbound dye was monitored using a 
fluorescence spectrophotometer (Hitachi F-4500, Tokyo, Japan). The labeling 
efficiency was calculated by determining the BSA concentration in the solution 
using the DC Protein Assay (Bio-Rad, Hercules, CA, USA) and measuring the 
absorbance at 492, 543 and 415nm for DTAF, RITC and LY respectively. The 
resulting degree of labeling was 1.9 for DTAF, 2.3 for RITC and 2.2 for LY 
(Appendix A). The solutions were further diluted with PBS to obtain final BSA 
concentrations of 0.5 mg/ml, to mimic the albumin concentration in the tear 
film.23,24  
For solution 2, containing free dye only, approximately 1 mg of the 
fluorescent probe was dissolved in either DMSO or PBS and further diluted with PBS 
to reach a peak fluorescence intensity which was approximately 4 times lower as 
compared to the BSA-conjugate. (Dye uptake/intensity in the materials is multiple 
times higher as compared to the protein conjugate). 
4.3.2 Sample incubation 
Both the dye and the conjugated BSA were sterilized using 0.2 μm 
polyethersulfone syringe filtration (VWR, Mississauga, ON, Canada) and 1 ml of the 
solution was filled in sterile amber glass vials. The contact lenses were individually 
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incubated for one and seven days at 37ºC under constant rotation of 72 rpm. Three 
replicates were used for each lens material, solution and time point, resulting in 
144 lenses being examined using CLSM. 
4.3.3 Localization of the protein  
After the incubation, lenses were rinsed in PBS and gently dabbed on lens 
paper. The central 4 mm section was cut out of the lens using a mechanical punch 
press and mounted on a microscope slide. The CLSM Zeiss LSM 510 Meta (Zeiss Inc. 
Toronto, Canada) was utilized to scan each sample, according to the specific 
excitation wavelength of the individual fluorescent probe: 488nm Argon Laser for 
DTAF, 543nm Helium Neon Laser for RITC and 405nm Laser diode for LY. Emission 
filters of >505nm, >560nm and >515nm were chosen for DTAF, RITC and LY 
respectively. Appropriate settings for detector gain and laser intensity were 
determined for each solution via a number of preliminary tests. These settings 
remained constant for all lens types incubated in the same solution throughout the 
experiment to allow comparisons over time and between materials.  
Each sample was scanned on four random locations in a size of 230x230 μm 
(512x512 pixel) using a step width of 1 μm. A representative scan was selected to 
show the typical sorption profile for each material for both time points after the 
incubation in free dye solution and conjugated BSA. Arbitrary fluorescence units 
were converted into a 1-100 scale. 
4.3.4 Protein quantification 
Radiolabeled BSA was used to determine the total amount of protein sorbed 
to each of the four contact lens materials over time. BSA was radiolabeled with 125I 
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using the iodine monochloride method.25-27 Three replicates of each material were 
incubated in a 0.5 mg/ml BSA solution, containing a mixture of 2% labeled and 98% 
unlabeled BSA. After incubating the lenses for one and seven days, lenses were 
rinsed with PBS to remove loosely adsorbed protein and the amount of accumulated 
BSA was determined using a gamma counter (1470 Wallac Wizard PerkinElmer, 
Woodbridge, ON). For comparisons between the protein accumulation to the 
different materials over time, repeated measures ANOVA (analysis of equal 
variance) was applied followed by post-hoc comparisons using Tukey's HSD 
(honestly significant difference) test. 
4.3.5 Confirmation of unbound dye uptake 
Unbound LY was further investigated to determine the reduction of 
fluorescence intensity from the solution after the incubation. After seven days, 
lenses were removed from the LY dye solution and fluorescence spectrophotometer 




4.4.1 Comparisons between conjugated and unconjugated dyes 
Sorption profiles for etafilcon A incubated in free dye and conjugated BSA are 
plotted in Figures 4-1A-F. This pHEMA-based material has no surface treatment and 
allows all three dyes (Figures 4-1A, 4-1C and 4-1E) and conjugated BSA (Figures 4-
1B, 4-1D and 4-1F) to fully penetrate the matrix.28 All three unconjugated 
84 
fluorescent probes (Figures 4-1A, 4-1C and 4-1E) were almost evenly distributed 
throughout the material after one day of incubation, with only marginally lower 
signals detected in the lens center for RITC (Figure 4-1C). Furthermore, no major 
increase in fluorescence intensity was observed between the two time points, 
indicating a saturation uptake after 24 hours incubation for all free dye solutions. 
The conjugated BSA showed higher intensity levels on the lens surface region as 
compared to the matrix for DTAF-BSA (Figure 4-1B) and RITC-BSA (Figure 4-1D) on 
Day 1. This was followed by an overall intensity increase on Day 7 with both 
conjugates, showing an almost even distribution throughout the material. Etafilcon 
A incubated in LY-BSA (Figure 4-1F) exhibited an even protein distribution on Day 1, 
with no increase over time. Thus, for etafilcon A, the three fluorescent probes alone 
and the conjugated BSA showed similar profile curves with different intensity levels 
after one week of incubation, independent of the fluorophore used. 
Conjugated BSA and free dye sorption profiles for lotrafilcon B are seen in 
Figures 4-2A-F. The surface of this silicone hydrogel material is plasma modified 
with a 25nm high refractive index coating 28,29 and accumulated higher levels of 
unbound DTAF and RITC on the surface as compared to the central matrix (Figures 
4-2A and 4-2C). A minor increase in dye penetration into the lens matrix was seen 
for DTAF on Day 7 (Figure 4-2A). No such surface sorption was observed with LY 
(Figure 4-2E), which allowed the dye to penetrate the full lens on Day 1, with no 
noticeable increase to Day 7. BSA, when conjugated to any of the fluorescent 
probes, showed higher uptake levels on the material surfaces as compared to the 
matrix at both time points (Figures 4-2B, 4-2D and 4-2F). Furthermore, a minor 
increase within the matrix could be seen for all solutions over time, which was most 
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apparent for DTAF-BSA (Figure 4-2B). Overall, the three unbound fluorescent probes 
deposited in different profile pattern to lotrafilcon B. However, conjugated BSA 
showed increased deposition rates at the surface region compared to the central 
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Sorption profiles for balafilcon A incubated in free dye and conjugated BSA are 
plotted in Figures 4-3A-F. The surface of this silicone hydrogel material is modified 
using a plasma treatment, which transforms the hydrophobic silicone components 
into hydrophilic silicate (‘glassy-islands’), which is inhomogeneous in appearance.28,30,31 
Unbound DTAF and LY distributed evenly throughout the lens after one day of 
incubation, with a strong increase in fluorescence intensity seen for LY on Day 7 
(Figures 4-3A and 4-3E). RITC was detected primarily at the surface region of the 
material, with lower intensities being observed within the central matrix (Figure 4-3C). 
This distribution profile was still apparent after seven days of incubation. After 
balafilcon A was incubated in DTAF-BSA and RITC-BSA, most protein accumulated on 
the outer surface region of the lens on Day 1 and allowed only little penetration into 
the material (Figures 4-3B and 4-3D). After seven days of incubation, the fluorescent 
intensity within the matrix increased, but remained lower compared to the surface 
regions for DTAF-BSA. The conjugate LY-BSA penetrated evenly throughout the 
material on Day 1 and showed an overall intensity increase on Day 7 (Figure 4-3F). 
Overall, for balafilcon A, free DTAF and LY showed even distributions throughout the 
materials (Figures 4-3A and 4-3E), while RITC bound stronger to the surface region 
(Figure 4-3C). The conjugates were likewise not in agreement, with DTAF-BSA showing 
an increased surface build-up (Figure 4-3B), LY-BSA demonstrating an even sorption 
profile (Figure 4-3F) and RITC-BSA in-between these two extremes (Figure 4-3D). 
Conjugated BSA and free dye sorption profiles for senofilcon A are seen in 
Figures 4-4A-F. This silicone hydrogel material has no specific surface coating but 
incorporates polyvinyl pyrrolidone (PVP) as an internal wetting agent.28,32 The unbound 
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fluorescent probe DTAF was detected in high amounts at the surface region of the 
material, with only little penetrating into the central region (Figure 4-4A). This profile 
did not change markedly over time (Figure 4-4A). RITC and LY distributed evenly 
throughout the material on Day 1, with a minor increase for LY and a slight decrease 
for RITC over time (Figures 4-4C and 4-4E). The incubation of senofilcon A in BSA 
conjugated with DTAF showed protein sorption primarily to the surface of the 
material on Day 1, which remained surface dominated over time, with only minor 
penetration into the central matrix of the material (Figure 4-4B). This was in stark 
contrast to RITC-BSA, which accumulated only slightly less protein in the central 
matrix as compared to the surface on Day 1 (Figure 4-4D). RITC-BSA amounts 
increased marginally over time and allowed an even protein distribution on Day 7 
(Figure 4-4D). LY-BSA penetrated into the material after one day, with small intensity 
peaks seen on the lens surface (Figure 4-4F). A minor intensity increase was seen on 
Day 7, with no change in sorption profile (Figure 4-4F). Thus, for senofilcon A, marked 
differences in sorption profile were found between unbound fluorescent probes and 
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4.4.2 Comparisons between materials 
In general, free DTAF bound to all four materials at a similar intensity (Figures 
4-1A, 4-2A, 4-3A and 4-4A). Lotrafilcon B bound DTAF more strongly on the surface 
and allowed less dye to penetrate the matrix (Figure 4-2A), which was similar to that 
seen with senofilcon A (Figure 4-4A), but to a lesser extent. DTAF conjugated to BSA 
showed higher uptake levels for both senofilcon A and balafilcon A (Figures 4-3B and 
4-4B), as compared to etafilcon A and lotrafilcon B (Figures 4-1B and 4-2B). An even 
distribution profile throughout the lens material was seen for both free DTAF (Figure 
4-1A) and DTAF-BSA (Figure 4-1B) when sorbed to etafilcon A; likewise a comparable 
sorption trend for the bound and unbound DTAF was observed for lotrafilcon B 
(Figures 4-2A and 4-2B) and senofilcon A (Figures 4-4A and 4-4B), which exhibited 
higher sorption rates on the surface compared to the matrix. For balafilcon A, free 
DTAF was distributed throughout the lens material (Figure 4-3A), but DTAF-BSA 
deposited in higher rates to the surface region and allowed less protein to enter the 
central matrix (Figure 4-3B). 
Fluorescence intensities for free RITC were highest on the surface of lotrafilcon 
B (Figure 4-2C) and within the matrix of etafilcon A (Figure 4-1C), moderate for 
balafilcon A (Figure 4-3C) and lowest for senofilcon A lenses (Figure 4-4C). As seen 
with free DTAF, all lens materials exhibited different sorption patterns (intensity and 
shape). However, the sorption curves were not necessarily identical between these two 
dyes, with some materials exhibiting markedly different profiles (e.g. Figures 4-3A 
and 4-3C). The RITC-conjugated BSA accumulated highest on etafilcon A (Figure 4-1D), 
followed by balafilcon A (Figure 4-3D) and much smaller amounts could be seen for 
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both senofilcon A (Figure 4-4D) and lotrafilcon B (Figure 4-2D). Comparisons between 
the shape of free RITC vs RITC-BSA for all four materials (Figures 4-1C, 4-1D, 4-2C, 4-
2D, 4-3C, 4-3D, 4-4C and 4-4D) show a strong agreement for the overall intensity 
levels and sorption curves, suggesting that this fluorescent probe impacts the BSA 
sorption profile determined with these hydrogel materials.   
Free LY was distributed evenly throughout all lens materials at both time 
points, with no increase in surface sorption (Figures 4-1E, 4-2E, 4-3E and 4-4E), which 
was different to the other two unbound probes. For unbound LY, the highest intensity 
levels were observed with balafilcon A (Figure 4-3E), which also increased to the 
greatest extent over time. Moderate signal strength was seen for senofilcon A (Figure 
4-4E) and the weakest intensities were found for both etafilcon A (Figure 4-1E) and 
lotrafilcon B (Figure 4-2E). Sorption patterns for conjugated LY-BSA also showed the 
highest intensity for balafilcon A (Figure 4-3F), followed by a similar level for 
senofilcon A (Figure 4-4F) and lotrafilcon B (Figure 4-2F) and slightly less for etafilcon 
A (Figure 4-1F). Comparisons between the sorption pattern for free and conjugated LY 
show similar results, with even distributions of free LY or LY-BSA throughout etafilcon 
A and balafilcon A materials (Figures 4-1E, 4-1F, 4-3E and 4-3F). In contrast, small 
surface increases for lotrafilcon B (Figure 4-2F) and senofilcon A (Figure 4-4F) could 
be detected with the LY-BSA conjugate. These differences between sorption patterns 
for unbound LY and LY-BSA suggest that the protein sorption pattern observed were 
more likely determined by the BSA rather than the dye.  
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4.4.3 BSA quantification 
Protein sorption to all four materials was quantified using radiolabeled BSA. 
Results for both time points are shown in Table 4-3. 
Overall, BSA uptake was highest for senofilcon A, followed by similar uptake for 
lotrafilcon A and balafilcon A (p=0.17), with the lowest amounts being detected on 
etafilcon A. An increase over the 7 day time period was seen for lotrafilcon B, 
balafilcon A and senofilcon A, but no statistically significant change was seen for 
etafilcon A (Table 4-3) 
 
Table 4-3: BSA accumulation to contact lens materials determined by 125I 
radiolabeling 
 




4.4.4 Confirmation of unbound dye uptake 
To confirm free dye uptake into the materials, the LY solution was investigated 
after lenses were removed out of the solution. Fluorescence spectrophotometer 
measurements determined an intensity of 278 (arbitrary units) at 525nm for free LY 
prior to lens exposure. Following placement of the lenses into the free dye solution 
for seven days, a reduction to 236 units for etafilcon A, 244 for lotrafilcon B, 187 for 
senofilcon A, and 73 for balafilcon A were measured, confirming that dye was taken 
up into all the lens materials, but to differing extents.  
 etafilcon A lotrafilcon B balafilcon A senofilcon A 
Day 1 0.15  ±  0.03 μg 0.84  ±  0.09 μg 0.63  ±  0.07 μg 1.19  ±  0.10 μg 
Day 7 0.19  ±  0.04 μg 1.39  ±  0.05 μg 1.28  ±  0.18 μg 1.78  ±  0.18 μg 
p value 1.0 0.006 0.002 0.004 
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4.5 Discussion 
Fluorescent imaging technologies such as CLSM are used for various 
applications in cell imaging 33 and material research.18 CLSM provides higher 
resolution than conventional light microscopes due to the adjustment of the pinhole, 
which rejects out of focus rays.34 The focal plane can be moved a few hundred 
microns deep into the species under investigation, with step sizes of <1 micron, and 
XY images can be collected without destroying the sample. Images from the XY image 
gallery finally allow 3D reconstruction of the sample.34 
In protein research, fluorescent tracers are used successfully in many 
applications, for example to determine the process of protein refolding and 
unfolding,35 protein surface hydrophobicity,36 aggregation and fibrillation,37 
conformational changes induced by chemical degradation,38 protein–surfactant 
interactions 39 and protein kinetics.1 However, due to the number of factors impacting 
fluorescence intensity levels, studies primarily report qualitative results.40-43 
In this study, BSA was conjugated with three different fluorescent probes and 
the sorption profile of both free and conjugated dye to four contact lens materials, 
with thicknesses of 70-100 μm, were investigated. The fluorescein-based probe DTAF 
was chosen over fluorescein isothiocyanate (FITC) for its stability, purity, labeling 
efficiency at lower pH and minor impact on BSA in respect of molecular weight and 
size.9,44,45 In DTAF, the binding derivative cyanuric chloride is constituted of three 
highly reactive chloro groups, of which the first is replaced by the attachment of the 
fluorescein molecule, the second reacts with amino groups and the third group either 
hydrolyzes or remains unbound.44 The more chloro groups that are substituted, the 
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less reactive the remaining chloro group becomes, which means that a single DTAF 
molecule is unlikely to bind to more than a single protein.44 Under almost neutral 
conditions (pH 7.0-8.0), DTAF binds primarily to ε-amino groups of lysine and N-
terminal amino groups. However, conjugations to sulfhydryl groups, tyrosine or 
histidine occur at pH >8.0.44,46  
The chemical reactive group for RITC is isothiocyanate, which is a commonly 
used derivative for fluorescent probes, due to its high reactivity under basic 
conditions.47 Conjugations with RITC provide superior photostability and have been 
shown to modify BSA to a smaller extent compared to FITC, for dye/protein ratios less 
than 5.11,48 The carbon atom of the isothiocyanate is the reactive component, which 
binds in a similar manner, primarily to lysine and the N-terminal group, as seen with 
cyanuric chloride.47,49 
LY is, in contrast to RITC and DTAF, a hydrophilic probe, which can readily be 
dissolved in water-based solutions.50 The reactive vinyl sulfone derivative binds 
primarily to sulfhydryl groups of cysteine, but also to lysine and imino groups of the 
imidazole ring of histidine.51-53 Covalent conjugation of LY to human serum albumin 
does not require a basic environment, but can be performed under neutral pH.54 LY 
exhibits a low quantum yield of 0.2,51,55 compared to 0.92 for DTAF 2,44 and 0.7 for 
RITC.2,55 However, LY has a large Stokes shift of approximately 100nm, which allows 
signal detection over the full emission spectrum, without the concerns that arise from 
the collection of data from the excitation “tail” that overlaps the emission 
spectrum.2,50,55 This also prevents reabsorption of emitted light.  
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In this current study, the conjugation with all fluorescent probes was 
performed at pH 8.5, to allow an optimal reactivity of the highly alkali ε-amine of 
lysine.56 Although BSA consists of 60 lysines, only a few of them are located on the 
protein surface and these are only reactive when exposed within a suitable 
environment. The lysines (Lys) in BSA that are most likely to react are Lys 220, Lys 
474 and potentially Lys 350 and Lys 116.57 The native structure of both human and 
bovine serum albumin has 35 cysteines, of which 34 are typically paired with disulfide 
bonds to cystines and the sulphydryl group of the single Cys-34 remains mainly 
unbound.57,58 Cys-34 is highly reactive and can possibly be coupled with thiol-reactive 
probes such as LY.  
In this study, we determined both the amount and location of BSA deposition, 
using two differing techniques. The total amount of BSA accumulation on these four 
hydrogel contact lens materials was determined using 125I-conjugated BSA. The highest 
BSA amounts per lens were found for senofilcon A > lotrafilcon B = balafilcon A > 
etafilcon A (p< 0.01 for all comparisons, except for lotrafilcon B and balafilcon A with 
p=0.16). Over time, only lotrafilcon B, balafilcon A and senofilcon A increased in BSA 
sorption (p<0.01). Examination of these quantitative data (Table 4-3) shows that there 
is an apparent mismatch between some of the quantification data compared with the 
relative intensities of the fluorescently conjugated BSA. For example, with only 0.19 
μg of BSA per lens (Table 4-3), etafilcon A deposited the lowest amount of BSA. 
However, the RITC-BSA profile for etafilcon A (Figure 4-1D) showed a higher intensity 
profile throughout this material compared to the other materials incubated in RITC-
BSA (Figures 4-2D, 4-3D and 4-4D). Another example is seen for DTAF-conjugations. 
Table 4-3 shows that senofilcon A deposited the highest amount of BSA, compared 
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with the other materials. However, this apparently high level of BSA was only reflected 
by the BSA-DTAF combination (Figure 4-4B), with the other conjugates showing 
relatively low protein uptakes (Figures 4-4D and 4-4F). To further complicate this 
issue, the DTAF conjugate showed only minor fluorescent intensities for lotrafilcon B 
(Figure 4-2B) and high levels for balafilcon A (Figure 4-3B), although similar quantities 
of BSA were determined on these materials (Table 4-3). In addition, conjugations with 
LY showed the strongest fluorescent signal for balafilcon A (Figure 4-3F), which was 
not confirmed by the radioactive uptake (Table 4-3).  
These comparisons suggest that none of the fluorescent probes investigated in 
this study provided “true” levels of fluorescence intensities relative to the total 
amount of protein sorbed to the material. Due to this fact, it was necessary to clarify 
whether low fluorescence intensities within samples were observed primarily due to 
fluorescent quenching within certain materials or due to lower sorption rates of the 
individual fluorescent probe. To address this query, we determined the remaining 
fluorescent intensity of the free LY solution after lens removal on Day 7 using 
fluorescent spectrophotometry. The relative starting intensity of the free dye solution 
was 278 fluorescent units and the remaining intensities in the solution following 
exposure of the dye solution to the materials were: 236 for etafilcon A, 244 for 
lotrafilcon B, 187 for senofilcon A, and 73 for balafilcon A. These numbers can be 
compared to our intensity values found in the CLSM scans, which confirmed highest 
fluorescence levels on balafilcon A (Figure 4-3E), moderate intensities for senofilcon A 
(Figure 4-4E) and lower levels for lotrafilcon B and etafilcon A (Figures 4-2E and 4-1E 
respectively). These findings confirmed that all materials deposited different amounts 
of this fluorescent probe, resulting in different fluorescence levels. However, 
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quenching factors within samples may still partially contribute to the overall emission 
intensity. Other material-based factors, such as the refractive index, autofluorescence 
or light absorbance at the specific wavelength may also contribute to the final 
emission strength. To correct for these light attenuation effects, a number of 
mathematical models have been proposed.19  
An important factor to consider relates to which of the conjugate-binding 
results is most reflective of the location of BSA deposited. This must be considered in 
light of the binding of unbound dye (which will impact on the apparent protein 
location) and what is known about the structure of the materials investigated: In this 
study, only unbound LY showed an even distribution throughout all the materials, 
with no surface peaks being observed (Figures 4-1E, 4-2E, 4-3E and 4-4E). Senofilcon 
A and lotrafilcon B appear to adsorb LY-BSA in higher levels on the surface compared 
to the matrix alone (Figures 4-2F and 4-4F). This result can be accepted with a high 
level of confidence, as it can only be achieved if the BSA is truly adsorbing on the 
surface, as the “bigger” protein-dye conjugate is less likely to penetrate as easily as 
the dye alone into the material matrix, giving rise to the peak at the surface. If this is 
compared to the results for lotrafilcon B when exposed to unbound RITC (Figure 4-2C) 
or RITC-BSA (Figure 4-2D), it is possible that the dye will impact the result seen with 
the conjugated BSA. Thus, it is our opinion that of the three conjugates that it is the 
LY results that are most likely to be reflective of the protein uptake. (LY sorption 
profiles to contact lens materials not presented in this chapter can be found in 
Appendix C.) 
Some previous studies have examined the bulk and surface properties of both 
hydrogel and silicone hydrogel materials,28,31,59,60 and these data must be considered. 
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The high water content of etafilcon A (58%) and lack of surface coating results in a 
porous polymer structure and allows protein penetration into the matrix, as 
demonstrated with all three conjugates (Figures 4-1B, 4-1D and 4-1F). Scanning 
electron microscopy confirmed a macroporous structure for balafilcon A but not for 
lotrafilcon B,31 which helps to explain our results for balafilcon A, which allowed LY-
BSA to fully penetrate the material after only one day of incubation (Figure 4-3F), in 
comparison to that for lotrafilcon B, which accumulated only small amounts of protein 
(Figure 4-2F).  
The impact of fluorescent dyes on protein-sorption behaviour to ion exchange 
adsorbents have been investigated by Linden et al.61 They conjugated human 
immunoglobulin G and BSA with two fluorescent probes, Cy5 and Oregon Green. 
Similar protein sorption profiles were found for the conjugates when sorbing to SP 
Sepharose Fast Flow and Source 30S, regardless of the dye used for conjugation.61 
This provides further support that materials with a homogenous bulk structure and 
no surface modification allow an equal distribution of the fluorescent probe through 
the entire sample (as seen for the pHEMA material etafilcon A), while surface 
modification may exhibit minor differences in charge and hydrophobicity and 
therefore attract certain dyes to a greater extent.  
A final factor to discuss relates to the degree of protein modification due to the 
attachment of the different dyes, which was not investigated in this study. However, 
the specific dye-binding location on the protein may impact both the emission 
intensity of the fluorophore 49 as well as the protein sorption behaviour.13,14 Although 
desalting and extensive dialysis were applied to remove unbound dye molecules and 
small protein fractions from the solutions, it cannot be excluded that weakly bound 
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dye molecules may release over time and potentially impact the fluorescent pattern of 
the conjugated BSA uptake. 
 
4.6 Conclusions 
When investigating protein sorption to biomaterials using fluorescent probes, 
preliminary tests must be undertaken to detect specific dye affinities towards the 
material surface. This will avoid potential misinterpretations of protein sorption 
patterns when using fluorescently conjugated proteins. From the three probes 
investigated in this study, only unbound LY distributed evenly throughout the 
materials, and then subsequently showed varying sorption curves when conjugated 
with BSA.  
However, despite the fact that the location of the sorbed protein could be 
determined using CLSM, a simultaneous quantitative method remains necessary to 
provide information on the total amount of protein sorbed to the biomaterial.  
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In the next chapter, lysozyme was conjugated to a hydrophobic fluorescein-
based dye (FITC) and a hydrophilic dye (lucifer yellow). Sorption profiles for both 
conjugates to nine different contact lens materials were imaged using CLSM and 
quantified using radiolabeled protein. Both results were combined to describe the 
lysozyme content on the surface and inside the lens matrix.   
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5. LOCALIZATION OF LYSOZYME SORPTION TO 
CONVENTIONAL AND SILICONE HYDROGEL CONTACT 
LENSES USING CONFOCAL MICROSCOPY 
This chapter is published as follows: 
Doerte Luensmann1, Feng Zhang1,2, Lakshman Subbaraman1, Heather Sheardown1,2, 
Lyndon Jones1,2 
1Centre for Contact Lens Research, School of Optometry, University of Waterloo, 
Waterloo, ON, N2L 3G1 
2Department of Chemical Engineering, McMaster University, Hamilton, ON, L8S 4L7 
Curr Eye Res 2009;34(8):683–697 - Reprinted with permission 
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Zhang Y n/a Y Y - 
Subbaraman - n/a Y - - 
Sheardown Y n/a - - - 
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5.1 Overview 
Purpose: To investigate the distribution profile of hen egg lysozyme (HEL) 
through poly-2-hydroxyethyl methacrylate (pHEMA)-based lens materials and silicone 
hydrogel (SH) lens materials using confocal laser scanning microscopy (CLSM).  
Methods: Five silicone SH materials (balafilcon A, lotrafilcon A, lotrafilcon B, 
galyfilcon A, senofilcon A) and four pHEMA-based materials (alphafilcon A, etafilcon A; 
omafilcon A, vifilcon A) were incubated in 1.9 mg/ml protein solution for 24 hours. 
The protein solution consisted of HEL which was conjugated with either Fluorescein 
isothiocyanate (FITC) or Lucifer Yellow VS dilithium salt (LY). CLSM (Zeiss LSM 510 
META) identified the location of the fluorescently-labeled protein by using 1μm depth 
scans through the lens. In a second experiment, lenses were incubated with 2% 125I 
labeled HEL to determine the amount of deposited protein on each lens. Both 
techniques were combined to describe the individual HEL profiles. 
Results: After the incubation in fluorescently-labeled HEL, all pHEMA-based 
materials and the SH material balafilcon A accumulated protein throughout the entire 
lens material, while, for the SH lenses lotrafilcon A and lotrafilcon B, HEL was primarily 
detected on the lens surface alone. Differences in protein uptake pattern due solely to 
the two conjugated dyes were most apparent for the SH materials galyfilcon A and 
senofilcon A; HEL was detected throughout these lenses when conjugated with LY but 
accumulated primarily on the surface when conjugated with FITC.  
Conclusions: CLSM in combination with a radiolabel technique can describe 




Hydrogel contact lens materials rapidly deposit proteins from the tear film,1-3 
which negatively impact on lens comfort 4,5 and visual performance.6 Frequent 
replacement systems, in which the lenses are replaced on a pre-determined basis, 
limit deposit build-up 4,7-9 and improve both clinical performance and overall success 
rates.3,5 Contact lens cleaning and disinfecting systems aim to remove proteins and 
other tear film contaminants from contact lenses, to reduce the risk of bacterial 
adhesion 10,11 and other adverse responses such as contact lens associated giant 
papillary conjunctivitis (CLAPC).12-14  
Protein deposition profiles on contact lenses have been extensively studied 
both ex vivo and in vitro.15-25 In most cases, the focus has been on the identification 
and quantification of the adsorbed/absorbed components, with minimal interest in 
the location of the deposited species. In other cases, microscopy techniques have 
been used to qualitatively describe surface-located deposition.2,3,26-29 However, none of 
these methods can adequately describe the distribution of a specific protein 
throughout the entire contact lens material. The development of confocal laser 
scanning microscopy (CLSM) 30,31 allows optical slicing through thick samples and 
provides high resolution images through sections up to a few hundred microns in 
depth.31 CLSM has been used in pharmaceutical and cell imaging studies,32,33 material 
science 31 and in vivo imaging of the human cornea.34 Furthermore, this technique has 
been adapted, using fluorescently-tagged proteins, to describe the depth of 
penetration and location of protein on both ex- vivo and in- vitro deposited contact 
lenses.35-37 
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Among tear proteins, lysozyme has been a major focus, since it is the most 
abundant protein in the tear film 38,39 and can play a dominant role in lens spoliation.3 
Studies have demonstrated that the overall net positive charge, in addition to its 
relatively small size (14.4 kDa), contributes to its high levels of uptake, particularly in 
materials with a net negative charge such as those based on combinations of poly-2-
hydroxyethyl methacrylate (pHEMA) and methacrylic acid (MAA).20,40,41  
While pHEMA-based soft lens materials have dominated the market since their 
introduction in the early 1970’s,42 their relatively poor oxygen transmissibility has 
resulted in a variety of hypoxic complications.43-45 The commercialization of siloxane-
based, highly oxygen permeable hydrogel materials in 1999 resulted in significant 
adoption of these so-called “silicone hydrogels” (SH), due to their exceptional oxygen 
transmissibility 42,46 and lack of hypoxic complications.47 However, the siloxane 
component results in materials that are relatively hydrophobic and modification of 
either the surface or incorporation of wetting agents is necessary to obtain adequate 
in-eye wettability.42 Studies investigating tear film deposition with hydrogel lenses 
indicate, not surprisingly, that pHEMA lenses tend to absorb higher amounts of 
protein but lower quantities of lipid, when compared to SH lenses.23,48-50 Despite the 
reduced protein accumulation, recent observations have shown that SH lenses do not 
eliminate the risk of CLAPC.51-53 It would appear that denaturation of proteins on the 
lens surface and the higher modulus of SH lenses may be involved in the stimulation 
of palpebral conjunctival responses,54 independent of the total amount of 
accumulated protein on the lens.17,53 
The biocompatibility of contact lenses on the ocular surface is still not fully 
understood, particularly when lenses are worn on a continuous wear basis for up to 
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30 nights. While the amount of deposition is fairly well characterized, the location of 
proteins on the lens surface or within the lens matrix remains unknown. This 
information may prove useful in understanding the inflammatory processes seen with 
soft lens materials and could provide valuable information for enhancing current 
contact lens materials and designs, as well as during the development of more 
efficient cleaning regimes.  
This in vitro study uses CLSM, combined with protein radiolabeling, to locate 
and quantify protein distribution throughout nine hydrogel lens materials, in an 
attempt to describe the role of contact lens materials on protein spoilation.  
 
5.3 Methods  
The key properties of the soft contact lens materials investigated in this study 
are summarized in Table 5-1. All lenses examined were unworn lenses with a power 










Table 5-1: Contact lens materials examined 
 
DMA N,N-dimethylacrylamide; EGDMA ethyleneglycol dimethacrylate; HEMA 2-hydroxyethyl methacrylate; 
MAA methacrylic acid; MMA methyl methacrylate; mPDMS monofunctional polydimethylsiloxane; NVA N-
vinyl aminobutyric acid; NVP N-vinyl pyrrolidone; PBVC poly[dimethylsiloxyl] di [silylbutanol] bis[vinyl 
carbamate]; PC phosphorylcholine; PVP polyvinyl pyrrolidone; TEGDMA tetraethyleneglycol dimethacrylae; 
TPVC tris-(trimethylsiloxysilyl) propylvinyl carbamate; TRIS trimethyl siloxy silane.  
 
 
5.3.1 Fluorescent labeling of lysozyme 
Figures 5-1 and 5-2 show the two fluorescent probes that were conjugated with 
hen egg lysozyme (HEL, Sigma-Aldrich, St. Louis, MO). Fluorescein isothiocyanate 
(FITC, Molecular Probes, Eugene, OR) and Lucifer Yellow VS dilithium salt (LY, Sigma 
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    monomers 
Silicone Hydrogel Lens Materials 
ACUVUE® 
ADVANCE® Galyfilcon A I 
Johnson & 






OASYSTM Senofilcon A I 
Johnson & 















PureVision® Balafilcon A III Bausch & Lomb 90 36 
NVP, TPVC, NVA, 
PBVC 
Conventional (pHEMA-based) Lens Materials 
ACUVUE®2TM Etafilcon A IV 
Johnson & 
Johnson 80 58 HEMA, MAA 
Focus® 
Monthly Vifilcon A IV CIBA Vision 100 55 HEMA, PVP, MAA 
Proclear® 
Compatibles Omafilcon A II 
Cooper 
Vision 65 62 HEMA, PC 
SofLens® 66 Alphafilcon A II Bausch & Lomb 90 66 HEMA, NVP 
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Aldrich, St. Louis, MO) were conjugated in two separate experiments, using methods 
optimized for each dye. 
 
 























, MW: 550 
 
FITC-HEL conjugation: A mass ratio of 20:1: FITC:HEL was used. Briefly, HEL in 
0.1 M sodium bicarbonate (10 mg/ml) was prepared. FITC (10 mg) was dissolved in 
1mL dimethyl sulfoxide (DMSO, Sigma-Aldrich, St. Louis, MO) and then added to the 























conjugated protein may occur during the reaction (since FITC-HEL is usually less 
soluble than native protein), the mixture was centrifuged at 12,000g for 1 minute. 
Free FITC was removed using a Sephadex G25 column (Amersham Biosciences, Baie 
d’Urfe, QC, Canada). Elution was performed using PBS, at pH 7.4. A portable UV light 
was used to monitor the separation process by observing fluorescence in the column. 
Following this, dialysis against PBS using a 7 kDa molecular weight cutoff dialysis 
cassette (Pierce, Rockford, IL) was performed, until only a small amount of free FITC 
was detected with a fluorescence spectrophotometer (Hitachi F-4500, Tokyo, Japan). 
The efficiency of binding of the fluorescent dye to the protein was determined 
spectroscopically (Multiscan Spectrum, Thermo Electron, Waltham, MA) by measuring 
the absorbance at 280nm (to determine the protein concentration) and at 494nm 
(which is the maximum absorbance for FITC). The resulting degree of labeling (DOL) 
was 0.94 (0.94 molecules dye per molecule of protein) (Appendix A).  
LY-HEL conjugation: Preliminary experiments showed that a mass ratio of 1:1 
LY:HEL provided sufficient fluorescence intensity for the conjugated protein to be 
easily detected. Briefly, HEL in 0.05 M borate buffer (pH = 8.5) and 0.04 M NaCl (10 
mg/ml) was prepared. LY is water soluble and 7mg could be dissolved in 1mL of 
borate buffer (pH 8.5). The LY solution was added to the HEL solution followed by 
gentle stirring for one hour in the dark. Since no precipitation of the conjugated 
protein occurred, no subsequent centrifugation step was necessary. Free LY was 
removed using a Sephadex G25 column. Following this, dialysis against PBS using a 7 
kDa molecular weight cutoff dialysis cassette was performed, until only minor free LY 
was detected with a fluorescence spectrophotometer. The labeling efficiency was 
calculated by determining the HEL concentration in the solution using the DC Protein 
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Assay (Bio-Rad, Hercules, CA) and measuring the absorbance at 415nm (which is the 
maximum absorbance for LY). It was necessary to use the DC Protein assay to 
quantify the protein in this case as LY has substantial absorption between 250 and 
300nm and would therefore interact with the protein absorption measured at 280nm. 
The resulting DOL was 0.27 (0.27 molecules dye per molecule of protein). 
5.3.2 Lysozyme sorption to contact lens materials 
The conjugated HEL solutions were sterilized with 0.2 μm syringe filters to 
prevent microbial contamination of the samples during the incubation phase. 
Unlabeled HEL was added to the conjugated HEL to give a physiologic tear 
concentration of 1.9 mg/ml.55,56 Since lower amounts of labeled protein result in less 
photobleaching during subsequent confocal analysis, the lowest possible amount of 
conjugated HEL was used for the experiments. Contact lens materials that were 
known to accumulate large amounts of lysozyme from previous studies 22,24 were 
incubated with low levels (2%) labeled and 98% unlabeled HEL, while other materials 
known to accumulate only small amounts of protein were incubated in 100% labeled 
HEL.  
Prior to protein incubation, all lenses were removed from their blister packs 
and presoaked for 30 minutes in sterile PBS (phosphate buffered saline) at pH 7.4, to 
minimize the influence of the lens packaging solution components on protein uptake. 
Many companies now include a variety of surface-active agents into these packaging 
solutions, whose influence on protein sorption remains unknown. Following this 
presoaking phase, lenses were transferred into brown Eppendorf vials using sterile 
metal forceps and placed in a face up position. 1 ml of the prepared protein solution 
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was added, and lenses were incubated for 24 hours under constant rotation at 72 
RPM at a temperature of 37°C to mimic the approximate human body temperature. 
5.3.3 CLSM examination technique 
After incubation for 24 hours, the contact lenses were removed from the vials 
and prepared for confocal microscopy. Following rinsing with PBS, the lens was placed 
onto the mantel of a mechanical punch press and a round button of 4 mm diameter 
was cut out of the center of the lens. The punch press was carefully cleaned prior to 
each use to ensure a clean, dust and protein free surface. Using plastic tweezers, the 
lens button was gently dabbed dry using lens paper and mounted onto a glass 
microscope slide. Approximately 40 μL of mounting media containing PBS was placed 
onto the microscope slide. A glass coverslip was then carefully applied and sealed 
with nail polish to prevent evaporation and to stabilize the coverslip for use with the 
immersion objectives of the confocal microscope. 
The lens materials were subsequently examined for protein uptake using 
confocal laser scanning microscopy (CLSM) (Zeiss Inc. Toronto, Canada). The Zeiss 
510, configuration Meta 18 was equipped with an inverted motorized microscope 
Axiovert 200M. Each lens was scanned at a central location using an excitation 
wavelength of 488nm (Argon Laser) for FITC-HEL and 405nm (Laser Diode) for LY-HEL. 
The selected emission filters were BP 505-530nm and LP 505nm for FITC and LY 
respectively. Each section of z stacks was set at 1 μm intervals with image sizes of 
512 x 512 μm. Lenses were scanned with a 40x water immersion C-Apochromat 
objective. Using the software provided with the microscope and ImageJ (Bethesda, 
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MD),57 the means of the fluorescence intensity were plotted as a function of the 
scanning depth.  
5.3.4 Protein uptake measured by 125I radiolabeling 
For quantification purposes, the intensity values over the 24 hour doping 
period were converted into microgram amounts per lens based on previous 24 hour 
data obtained in our laboratory, using a radioactive HEL uptake method.22 Briefly, HEL 
was radiolabeled with 125I using the iodine monochloride method, as previously 
described.58-60 Lenses were subsequently incubated in a 1.9 mg/ml HEL solution, 
containing a mixture of 2% labeled and 98% unlabeled HEL. Following incubation for 
24 hours, the lenses were rinsed with PBS to remove loosely adsorbed protein and the 
amount of firmly sorbed HEL was determined using a gamma counter (1470 Wallac 
Wizard PerkinElmer, Woodbridge, ON).  
5.3.5 Determination of lens thickness  
As described above, the CLSM measurements were taken at the center of each 
lens. However, this z-scan does not represent the average thickness across the lens, 
as contact lenses with a power of -3.0 D (dioptres) increase in thickness from the 
center towards the lens edge, resulting in an increase in average thickness over any 
specific chosen diameter.61 Therefore, an adjustment for thickness over the entire lens 
was required prior to converting the total amount of protein found with the 
radiolabeled HEL technique 22 to the CLSM scans.  
To measure lens thickness, each contact lens type under examination was slit 
from the mid-periphery to the edge of the lens using a razor blade, allowing them to 
be flat mounted on a clear plastic slide with pre-printed concentric rings. Lens 
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thickness was determined at 20 different points, using an electronic thickness gauge 
(Rehder Development Company, Castro Valley, CA), which measured to 1 μm steps. 
Lens thickness was determined in a room with a fixed humidity of 60%, in order to 
control lens dehydration. Thickness values were obtained centrally and at 1.5, 3.1, 
4.8 and 6.9 mm away from the center, which represented on-eye distances of 1.5, 
3.0, 4.5, 6.0 mm from the centre of the lens. Measurements were taken at 3, 6, 9 and 
12 o’clock locations using two replicates for each lens type (resulting in eight values 
for each location).  
5.3.6 Combining CLSM and radiolabeling results 
As described above, our CLSM technique provides an excellent method for 
determining the location of protein on these hydrogel membranes. However, it cannot 
be used to accurately quantify the amount of deposited protein. Our previously 
reported radioactive data 22 is quantitative in nature, but it cannot be used to 
determine the location of the protein deposition. By combining data from both 
methods it is possible to accurately quantify the amount and describe the location of 
the deposited protein of interest associated with the lens or other biomaterial. One 
problem that arises in trying to reconcile these data is that the previously obtained 
radiolabeling results used a lens of the commercially available diameter, but our CLSM 
method only uses a central section of 4 mm diameter. A further confounding factor, 
as described above, is that the thickness of the hydrogel sample examined is not 
constant across the entire diameter of the lens, being thicker at the periphery for the  
-3.00D lenses examined in this study.  
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In order to address these issues, a method was developed that enabled us to 
determine the approximate protein accumulation throughout the lens section scanned 
with the CLSM, independent of the scan thickness. To achieve this, a formula was 
derived that adjusted the protein amount per CLSM scan for the average thickness of 
the lens. As an example, if a CLSM scan obtained centrally showed a lens thickness of 
80 μm and the average thickness of the lens determined via the Rehder gauge 
showed an average thickness of 120 μm, then the fluorescence intensity determined 
via the CLSM needed to be converted into a fluorescence intensity over a lens section 
that was 40 μm thicker, to compensate for this increase in thickness over the lens 
diameter. The fluorescence intensity per scan step was converted into the respective 
HEL amount using the radiolabeled HEL data in Table 5-3. Modifications of the inner 
matrix of the scan were applied to address for the difference between average lens 




where HELi is the amount of HEL on an individual scan image (μg), FLi is the 
fluorescence intensity of this individual scan image, ∑HEL is the total amount of HEL 
per lens (μg), FLm is the fluorescence intensity of the average inner matrix scan, aveT 
is the average lens thickness (μm), scanT is the individual scan thickness (μm) and 
∑FL is the sum of the fluorescent intensity for the entire scan. 
This calculation method was applied solely to approximate the average lens 
thickness of each lens type investigated in this study. 
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5.4 Results  
5.4.1 Lens thickness 
The lens thickness at each of the five points described above and the average 
thickness over the entire lens, as determined by the Rehder gauge, for all lenses are 
shown in Table 5-2.  
 
Table 5-2: Contact lens thickness (-3.00D) determined by Rehder gauge 
Silicone Hydrogel Lens Materials (Mean ± SD (μm)) 
Distance 
from center Senofilcon A Galyfilcon A Lotrafilcon A Lotrafilcon B Balafilcon A 
Central 67.0±1.1 70.5±1.5 84.5±2.1 79.6±1.7 81.6±1.8 
1.5mm 75.8±1.5 79.8±2.1 91.9±5.3 85.5±10.7 90.3±3.5 
3.0mm 101.1±4.1 106.9±3.9 109.1±8.8 110.6±17.8 117.5±4.9 
4.5mm 149.8±4.4 166.5±9.4 131.3±14.9 154.9±30.8 172.3±4.2 
6.0mm 185.4±3.0 213.3±7.6 132.4±23.6 196.8±40.7 172.4±6.6 
Average 
thickness 115.8 ± 50.5 127.4 ± 60.9 109.8 ± 22.0 125.5 ± 49.7 126.8 ± 43.6 
Conventional (pHEMA-based) Lens Materials (Mean ± SD (μm)) 
Distance 
from center Etafilcon A Vifilcon A Omafilcon A Alphafilcon A 
Central 78.9±1.0 83.5±0.5 79.5±0.5 90.5±3.0 
1.5mm 85.9±3.1 91.8±3.2 87.5±1.3 98.1±3.7 
3.0mm 111.8±5.1 117.5±4.8 114.6±3.3 122.0±4.9 
4.5mm 170.8±11.1 143.6±7.2 154.3±4.2 160.6±4.3 
6.0mm 211.8±3.4 169.3±11.8 174.0±5.6 186.8±3.5 
Average 
thickness 131.8 ± 57.5 121.1 ± 35.8 122.0 ± 41.2 131.6 ± 41.2 
 
As expected, the lens thickness values for all materials were lowest centrally, 
ranging from 67 to 91 μm, and increased towards the edge (132.4 to 213 μm). The 
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majority of the measured centre thickness of the lenses was within 5 μm of the 
manufacturer stated values. The average thickness of the 5 locations across the 
lenses was between 110 and 132 μm.  
5.4.2 Radiolabeling results  
The amount of HEL deposited on the various lens materials after 24 hours of 
incubation, as determined by the radiolabel method, is reported in Table 5-3. 
 
Table 5-3: Radiolabeled HEL sorption after 24 hours of incubation 22 
Silicone Hydrogel Lens Materials (Mean ± SD (μg)) 
HEL per lens 
Senofilcon A Galyfilcon A Lotrafilcon A Lotrafilcon B Balafilcon A 
0.53±0.10 0.75±0.10 0.20±0.08 0.33±0.08 1.40±0.09 
Conventional (pHEMA-based) Lens Materials (Mean ± SD (μg)) 
HEL per lens 
Etafilcon A Vifilcon A Omafilcon A Alphafilcon A 
620.5±93.0 144.3±36.0 11.0±5.6 16.0±5.8 
 
5.4.3 CLSM data 
Typical CLSM intensity scans for lotrafilcon A and balafilcon A are shown in 
Figures 5-3A and 5-3B. For the lotrafilcon A lens, fluorescence intensity bands were 
only detected on the surface of the lens, indicating that the HEL does not penetrate 
into the lens matrix (Figure 5-3A). This is very different from the balafilcon A material, 
which shows an even distribution of the labeled HEL throughout the lens, with the 
surface being no barrier to protein penetration (Figure 5-3B). 
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Figure 5-3: Typical CSLM profile scans for LY-HEL sorption to lotrafilcon A (A) and 
balafilcon A (B) materials after 24 hours of incubation 
 
5.4.4 Combined radiolabel and CLSM data 
The HEL sorption for the two FDA group II (high water content, neutral charge) 
materials, omafilcon A and alphafilcon A, are plotted in Figures 5-4 and 5-5. Both 
materials absorb similar amounts of HEL (approximately 11 μg/lens for omafilcon A 
and 16 μg/lens for alphafilcon A), with relatively rapid penetration occurring after 24 
hours throughout the entire lens material. Only minor differences can be seen 
between HEL conjugated with the two dyes for omafilcon A (Figure 5-4). Omafilcon A 
incubated in FITC-HEL showed small “peaks” at the lens surface, suggesting an 




This was not confirmed with the HEL-LY conjugation, suggesting that the apparent 
protein deposition at the lens surface may be due to uptake of the specific fluorescent 
dye, rather than uptake of protein per se. HEL sorption for the alphafilcon A material 
(Figure 5-5) was evenly distributed throughout the entire thickness of the lens, 
regardless of the fluorescent dye used. 
 
 
Figure 5-4: FITC-HEL and LY-HEL sorption profiles to omafilcon A 
Figure 5-5: FITC-HEL and LY-HEL sorption profiles to alphafilcon A 
The x-axis shows the confocal scan through the lens (μm) and the y-axis shows the relative 
HEL accumulation (μg). 
 
Protein levels associated with both FDA group IV (high water content, ionic 
charge) materials were significantly greater than all other materials. Figures 5-6 and 
5-7 show the deposition curves for etafilcon A and vifilcon A, and these clearly 
demonstrate that greater HEL deposition occurred with the etafilcon A material. After 
24 hours of incubation, etafilcon A accumulated more HEL on the surface compared 
to the matrix, when conjugated with FITC. However, an even distribution of the 
protein throughout the material was found when conjugated with LY. Other lenses 
(see Appendix D) that were incubated for a shorter incubation period of 3 hours 
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showed that LY-HEL was primary found on the surface, mimicking the pattern shown 
in Figure 5-6 with the FITC-HEL. However, a longer incubation time of 3 days with 
FITC-HEL showed an even distribution of HEL between the surface region and the 
matrix, similar to that shown in Figure 5-6 for LY-HEL. These data suggest that the 
dyes used for conjugation of the proteins impact the kinetics of HEL uptake for 
etafilcon A lenses. 
Figure 5-7 shows that vifilcon A accumulated slightly more HEL on the lens 
surface compared to the central region, regardless of the fluorescent dye used. 
Overall, this lens deposited only approximately half the amount of HEL compared to 
the etafilcon A lens. 
 
 
Figure 5-6: FITC-HEL and LY-HEL sorption profiles to etafilcon A 
Figure 5-7: FITC-HEL and LY-HEL sorption profiles to vifilcon A 
The x-axis shows the confocal scan through the lens (μm) and the y-axis shows the relative 
HEL accumulation (μg). 
 
The HEL sorption for the two FDA group I (low water content, neutral charge) 
materials, lotrafilcon A and lotrafilcon B, are plotted in Figures 5-8 and 5-9. These two 
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silicone hydrogel lenses show HEL sorption almost exclusively on the surface of the 
lenses, with both materials absorbing the smallest amounts of HEL compared to all 
other materials investigated, at approximately 0.20 μg/lens for lotrafilcon A and 0.33 
μg/lens for lotrafilcon B. Minor penetration of the conjugated HEL into the matrix 




Figure 5-8: FITC-HEL and LY-HEL sorption profiles to lotrafilcon A 
Figure 5-9: FITC-HEL and LY-HEL sorption profiles to lotrafilcon B 
The x-axis shows the confocal scan through the lens (μm) and the y-axis shows the relative 
HEL accumulation (μg). 
 
The HEL sorption for the three remaining silicone hydrogel lenses (balafilcon A, 
galyfilcon A and senofilcon A), are plotted in Figures 5-10 to 5-12. After 24 hours of 
incubation, HEL could be detected throughout the balafilcon A material in an evenly 
distributed pattern, which was independent of the fluorescent dye used (Figure 5-10). 
With approximately 1.4 μg/lens, balafilcon A attracted the highest amount of HEL of 
the SH materials investigated.  
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For galyfilcon A, the HEL distribution was strongly dependent on the 
conjugated dye used (Figure 5-11). When conjugated with FITC, HEL was primarily 
detected on the surface, with some HEL penetrating a few microns into the matrix. 
However, no signal could be detected in the central matrix of the material. In 
contrast, HEL conjugated with LY showed penetration through the entire galyfilcon A 
material, with only little higher uptake on the surface region. 
The discrepancies between the two fluorescent dyes were even more apparent 
for senofilcon A (Figure 5-12). FITC-HEL was almost exclusively located on the surface 
of the lens, while the distribution of LY-HEL was throughout the entire lens. The 
unequal distribution profiles suggest a strong impact of the individual dye used, when 
investigating galyfilcon A and senofilcon A-type materials. The total amount of HEL 




Figure 5-10: FITC-HEL and LY-HEL sorption profiles to balafilcon A 
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Figure 5-12: FITC-HEL and LY-HEL sorption profiles to senofilcon A 




5.5.1 Conventional pHEMA materials 
The sorption behaviour of tear-film proteins is critical in understanding and 
investigating mechanisms involved in contact lens spoilation and material 
biocompatibility. Protein sorption at a liquid-solid interface includes adsorption of the 
protein at the surface and protein diffusion into the polymer matrix. Previous studies 
have demonstrated that proteins, particularly lysozyme, rapidly penetrates into 
commercially available and model pHEMA/MAA copolymers.35,62 Since commercial 
contact lens materials are classified by the Food and Drug Administration (FDA) 
according to their water content and charge, it is of interest to determine how these 
two properties affect the lysozyme uptake profile. Two previous in vitro studies have 
used CLSM to determine protein location within hydrogel materials. Garrett and 
colleagues 20 demonstrated that increased amounts of MAA within hydrogel substrates 
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resulted in significantly increased lysozyme sorption and penetration, but reduced 
levels of albumin adsorption. They surmised that this was due to differences in 
electrostatic attractions between the material and the two proteins studied. Our group 
36 used CLSM to locate the deposition profile of albumin on a FDA group IV material 
(etafilcon A) and a SH material (lotrafilcon B). Different uptake patterns were shown 
for the overall negatively charged albumin, with the albumin being located only on the 
surface of lotrafilcon B, but throughout the matrix for etafilcon A. 
Our current results show that the location of deposited HEL in this in vitro 
model is significantly impacted by both bulk and surface material properties. The FDA 
group II (high water content, neutral charge) material omafilcon A incorporates 
phosphorylcholine (PC), a synthetic analogue that simulates natural phospholipids, 
into pHEMA. PC possesses both a positive charge on the nitrogen and a negative 
charge on the carbonyl groups. It is found in the outer lipid layers of red blood cell 
membrane and is responsible for cell membrane biocompatibility.63 Omafilcon A has 
previously been shown to be deposit resistant to both tear proteins and lipids 64 and 
exhibited a low dehydration rate compared to other hydrogel contact lens 
materials.64,65 Figure 5-4 shows that omafilcon A exhibits a small peak of HEL at the 
lens surface region, which may be related to the lack of PC present at the lens 
interface since the presence of PC is widely accepted to reduce protein fouling. The 
concentration and distribution of PC in omafilcon A is not stated by the manufacturer, 
but studies investigating the polymer structure of omafilcon A confirmed that PC is 
found throughout the lens 66 but not in the outermost 100 Å.67 The other group II 
material, alphafilcon A, is a pHEMA-based lens that incorporates N-vinyl pyrrolidone 
(NVP), a non-ionic and water-soluble monomer to increase water content. NVP-
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containing contact lenses have been shown to deposit high levels of lipid from the 
tear film but only small amounts of protein.7,16 Figure 5-5 shows an equal distribution 
of HEL throughout the alphafilcon A material, indicating that the high water content of 
66% and presumably high porosity allows rapid penetration of the protein into the 
lens matrix.  
In FDA group IV materials (high water content, negative charge), the ionic 
monomer methacrylic acid (MAA) is incorporated with HEMA to generate a polymer 
with increased water content. Figures 5-6 and 5-7 show the deposition profiles of 
etafilcon A (pHEMA/MAA) and vifilcon A (pHEMA/MAA/PVP) after 24 hours incubation 
in HEL. Etafilcon A incorporates an increased quantity of MAA than vifilcon A, 
imparting an increased negative charge to the material.42 Figure 5-6 shows that the 
HEL in etafilcon A is located relatively uniformly throughout the lens when conjugated 
with LY, but that the protein is seen in higher concentrations at the surface when 
conjugated to FITC. Incubation for longer than 24 hours 99 reveals that this difference 
between the two dyes disappears over time, which suggests that LY-HEL penetrates 
more quickly into the lens matrix than FITC-HEL, presumably due to size and 
chemistry differences between the two dyes. Specifically the more hydrophobic 
character of FITC 68 compared to the hydrophilic LY 69 or a potential change in the 
overall charge of the conjugated HEL 70,71 may alter the uptake kinetics. Vifilcon A 
lenses (Figure 5-7) show a similar uptake pattern for both dyes examined. HEL can be 
detected throughout the material, with slightly higher concentrations within the 
outermost 20 μm depth. Even with longer incubation times 99 (see Appendix D) HEL 
remains more abundant on the surface region, with less HEL detected inside the 
central matrix, regardless of the dye used. As a result of this negative charge, 
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etafilcon A and vifilcon A attract high levels of positively charged lysozyme, which is 
in agreement with previous ex- vivo and in- vitro studies.8,22,23,41,72 While the protein 
uptake patterns were similar between etafilcon A and vifilcon A, the addition of the 
PVP to the vifilcon A and possible differences in MAA concentrations for both 
materials clearly resulted in decreased levels of protein sorption to vifilcon A.  
The role of MAA on the bulk absorption of lysozyme to pHEMA/MAA containing 
materials has been studied extensively by Garrett and coworkers, who reported that 
lysozyme amounts increased as a function of increasing percentage of MAA in 
hydrogels.73 They suggest that this increase in lysozyme penetration with higher MAA 
content is due to increased water content, porosity and electrostatic force. The results 
of the current work are in agreement with these conclusions. In contrast, studies 
investigating the relatively hydrophilic PVP reported reduced lysozyme attraction for 
PVP-coated surfaces.74,75 
Our study confirms that the levels of protein associated with both group II lens 
materials were similar, and significantly lower, compared to those observed in the 
group IV materials (Figures 5-4,-5-7 and Table 5-3). 
5.5.2 Silicone hydrogel materials 
Silicone hydrogel lenses have more complex monomer compositions compared 
to pHEMA-based materials. Commercially available materials contain multiple polymer 
components such as Tris, PDMS, TPVC, DMA or siloxane macromers (Table 5-1). 
However, regardless of the polymer makeup, the hydrophobic nature of the silicone 
component necessitates additional modification or surface treatment. Currently 
available SH lenses can therefore be divided into two categories, depending upon 
127 
their surface characteristics used to overcome their hydrophobic nature.42 Balafilcon 
A, lotrafilcon A and lotrafilcon B are modified using a plasma treatment. The 
balafilcon A material is surface treated using a reactive gas plasma, which transforms 
the siloxane components on the surface of the lenses into hydrophilic silicate 
compounds,46,76,77 whereas lotrafilcon A and lotrafilcon B are permanently modified by 
gas plasma using a mixture of trimethylsilane oxygen and methane to create a thin 
(25nm), continuous hydrophilic surface.42,78,79 Galyfilcon A and senofilcon A utilise a 
different methodology, in which the wetting agent PVP is incorporated during the 
polymerization process.80-82 This non-ionic high molecular chain is very hydrophilic 
and shields the tear film from the hydrophobic siloxane component in the material, 
which may enhance comfort during lens wear.83,84 
Results of this study strongly suggest that within the FDA group I (low water 
content, neutral charge) SH materials HEL sorption is closely linked to material water 
content, with higher water content values resulting in higher levels of HEL sorption 
(Tables 5-1 and 5-3), although there are clearly a number of other factors which can 
also impact on protein sorption. The highest level of HEL sorption was seen in the 
FDA group III (low water content, negative charge) SH material (balafilcon A), in which 
the predominant factor driving deposition was likely to be the negatively charged 
aminobutyric acid monomer NVA. 
The similar material composition and surface coating of lotrafilcon A and 
lotrafilcon B clearly results in a similar protein uptake pattern (Figures 5-8 and 5-9). 
Sharp peaks of HEL deposition at or near the lens surface can be detected for both 
lenses. The plasma coating on lotrafilcon A appears to be a strong barrier to protein 
entry, as it allows no HEL to penetrate into the inner matrix, however minor but 
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significant amounts of HEL could be detected throughout the matrix of lotrafilcon B 
(Figure 5-9). Given that the two lotrafilcon materials undergo identical surface 
treatment processes, we propose that the higher water content of lotrafilcon B might 
be responsible for a reduced polymer density, resulting in an increase in pore size 
within the material, which results in the differences in protein sorption patterns 
observed.  
Examination of Figure 5-9 shows that more HEL was detected inside the matrix 
of lotrafilcon B when conjugated with LY compared to FITC. It is possible that 
unbound dye, which is 25-30 times smaller than HEL, could penetrate into the lens 
material and therefore cause a systematic error. To determine if the binding between 
the two dyes and HEL were equally stable over time it was necessary to investigate the 
amount of unbound dye in the solution. This was determined by dialysing the 
conjugated HEL over 24 hours. This experiment revealed that the LY-HEL conjugation 
was much stronger than that obtained with FITC-HEL, with the latter showing more 
dye release over time (data not presented). This enables us to conclude that the result 
shown in Figure 5-9 is not due to dissociation between the LY-HEL conjugation, but is 
a true result. This could be due to increased surface attraction for FITC-HEL compared 
with bulk attraction, as compared with the LY-HEL, which also migrates into the 
material. 
For balafilcon A, the penetration of HEL into the interior of these matrices is 
likely due to the macroporous nature of this lens, as shown by both scanning electron 
microscopy and atomic force microscopy.79,85,86 Under conditions of dehydration and 
hydration, it was found that the diameter of macropores in the balafilcon A could be 
as high as 0.5 μm, which is significantly larger than the pore size of conventional 
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pHEMA-based materials, which have a reported pore size of <0.05 μm.87-89 Our results 
(Figure 5-10) confirmed that these macropores are sufficiently large to permit the 
diffusion of HEL from the bulk solution, without significant pore fouling. After 24 
hours of incubation balafilcon A accumulated more FITC-HEL in the surface region 
compared to the central matrix, while LY-HEL was already distributed evenly 
throughout the material. Incubation over seven days (see Appendix D) proved that 
both conjugates are uniformly distributed inside the material. This indicates that 
FITC-HEL travels slower into the lens matrix, compared to LY-HEL. 
Senofilcon A and galyfilcon A (FDA group I, low water content, neutral charge) 
have similar material compositions, with both materials incorporating the wetting 
agent PVP, which can act as a protein repellent interfacial layer.22,74,75 Examination of 
Figures 5-11 and 5-12 show that there were significant differences between the 
different conjugates when investigating senofilcon A and galyfilcon A. FITC-HEL was 
mainly located in the surface region of galyfilcon A and senofilcon A, as compared to 
LY-HEL which was almost evenly distributed throughout the lens materials. Even with 
longer incubation times99 no major changes in the distribution profiles were observed. 
A comparison between the two materials when incubated in FITC-HEL showed that the 
protein traveled about 20 μm into galyfilcon A but only 10 μm into senofilcon A. One 
potential reason for these differences between the two different fluorescent dyes 
might be an increased electrostatic attraction between FITC-HEL and monomers such 
as PVP that are located in different concentrations at the surface of the lens. These 
substantial differences between the two dyes, which drives FITC-HEL to almost 
exclusively accumulate at the surface of these PVP-containing SH materials, but LY-
HEL to be almost evenly distributed between the surface and bulk warrants further 
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investigation and calls into question the actual distribution of HEL throughout both 
galyfilcon A and senofilcon A.  
5.5.3 Impact of the conjugate on the native protein 
Fluorescence analysis of proteins is an extremely useful technique and the 
majority of proteins exhibit an intrinsic fluorescence in the ultraviolet spectrum due 
to the aromatic amino acids tryptophan, tyrosine and phenylalanine. However, many 
analytical techniques do not permit measurements in the UV spectrum or necessitate 
that proteins are differentiated, which then requires the protein to be tagged with an 
extrinsic fluorescent dye. Most fluorescent dyes do not bind to a protein unless they 
are modified with an additional reactive group. This reactive group is covalently 
attached to the dye and binds under specific conditions with reactive residues of the 
protein, such as the ε-amino group of lysine.90 Although fluorescent dyes are multiple 
times smaller than the protein, many studies report differences in charge, seize and 
mobility between labeled and unlabeled proteins.70,91 Bingaman et al.70 conjugated 
albumin and α-lactalbumin with five different fluorescent dyes, including FITC. Most 
apparent physiochemical changes were found for the conjugation with FITC. Molecular 
size and weight, relative molecular charge, and isoelectric point were different 
compared to the native protein, which became even more significant with higher DOL. 
A study by Crandall et al. investigated the properties of albumin, when labeled to I125 
and FITC.92 They reported significant changes in chromatographic and electrophoretic 
behaviour when conjugated with FITC, but only minor changes for radioiodine-labeled 
albumin. 
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To investigate the conjugation-bond stability, L-lysine and myoglobin have 
been conjugated to FITC, dichlorotriazine (DTAF) and succinimidyl ester (CFSE).93 All 
three reactive probes achieved similar DOL but the conjugation stability at 37ºC was 
inferior for FITC compared to DTAF and CFSE.93  
The high quantum yield for FITC of 0.92 provides higher emission intensities 
compared to LY, which has a quantum yield of only 0.27.69,94,95 However, FITC is highly 
phototoxic compared to other dyes and requires careful consideration for 
fluorochrome concentration, excitation light intensity and duration of light 
exposure.96-98 Furthermore, FITC has a smaller Stokes shift of only 30nm, compared to 
LY with 110nm, which makes it more difficult for FITC to differentiate between 
overlapping excitation and emission spectra.  
The attachment of a fluorescent dye to a protein inevitably changes the 
absorption ability of the protein to solid surfaces. A study conducted by Teske et al. 
compared the competitive adsorption of labeled vs. native lysozyme and observed a 
displacement of weaker binding labeled lysozyme by stronger binding unlabeled 
lysozyme.71,91 Finally, because of its popularity, investigational studies focus more on 
applications with FITC compared to LY, which makes a direct comparison between the 
performances of these two dyes impossible and leaves potential downsides of LY 
unrecognized.  
Using fluorescent techniques to quantify protein deposition on a solid surface 
is very complex, as various factors impact the quantum efficiencies of the dye. These 
include concentration quenching, pH of the surface and differences between the 
dipole moments of the surrounding media that affect the energy between ground and 
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electronically excited states of the dye.94 As an example, contact lens materials are 
composed of different principal monomers and with the addition of a surface coating, 
such as for lotrafilcon A and B, a solid protein layer accumulates on the surface. In 
contrast, pHEMA-based materials, such as alphafilcon A, have a more sponge-like 
porous structure, which allows the protein to be carried from the water phase 
throughout the entire lens and prevents a tightly bound protein layer on the surface. 
To overcome these challenges, which all impact on the fluorescence intensity 
determined for each material investigated, we chose to use this technique with one 
employing radioiodine-labeled HEL to quantify the protein uptake. 
 
5.6 Conclusions  
The interaction of tear proteins with hydrogel lens materials is clearly very 
complex, and is governed by the nature of the materials and the size and charge of 
the protein in question. In this study, CLSM was used to examine the location of FITC 
and LY labeled HEL in hydrogel contact lenses. By combining this with a radiolabeling 
technique, the amount of HEL throughout the lens structure could be quantified. A 
total of nine different commercially available contact lenses were examined, including 
conventional pHEMA-based and silicone hydrogel lenses. Different sorption profiles 
were found, with a variety of factors influencing the HEL uptake, including porosity of 
the polymer network, charge of the polymer components and choice of the 
fluorescent probe. Understanding these differences may lead to the development of 
improved lens materials and will enhance our knowledge of the mechanisms by which 
protein sorption affects comfort. 
133 
5.7 Acknowledgements 
The authors would like to acknowledge at this point the work of Feng Zhang (a 
co-author of the published manuscript), who provided the data in this thesis chapter 
on the lysozyme conjugated with FITC. This work was published in his Masters thesis 














In the next chapter, the location and quantity of deposited albumin and 
lysozyme was determined before and after lenses were incubated in contact lens 
cleaning solutions. Furthermore, the effect of manual lens rubbing on the removal of 
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6.1 Overview 
Purpose: To investigate the efficiency of lysozyme and albumin removal from 
silicone hydrogel and conventional contact lenses, using a polyhexamethylene 
biguanide multipurpose solution (MPS) in a soaking or rubbing/soaking application, 





Methods: Etafilcon A, lotrafilcon B and balafilcon A materials were incubated in 
protein solutions for up to 14 days. Lenses were either placed in radiolabeled protein 
to quantify the amount deposited or in fluorescently conjugated protein to identify its 
location, using confocal laser scanning microscopy (CLSM). Lenses were either rinsed 




or MPS with and without lens rubbing. 
Results: After 14 days, lysozyme was highest on etafilcon A (2200μg) > 
balafilcon A (50μg) > lotrafilcon B (9.7μg) and albumin was highest on balafilcon A 
(1.9μg) = lotrafilcon B (1.8μg) > etafilcon A (0.2μg). Lysozyme removal was greatest 
for balafilcon A > etafilcon A > lotrafilcon B, with etafilcon A showing the most change 





 exhibited greater lysozyme removal from etafilcon A compared to 
both MPS procedures (p<0.001), but performed similarly for lotrafilcon B and 
balafilcon A lenses (p>0.62). Albumin removal was solely material specific, while all 
care regimens performed to a similar degree (p>0.69). 
Conclusions: Protein removal efficiency for the regimens evaluated depended 
on the lens material and protein type. Overall, lens rubbing with MPS prior to soaking 




The initial response of the immune system to isolate an implanted material 
from the body prior to fibrous or granulous tissue growths is the development of a 
coating consisting of a variety of proteins and lipids.1-3 A similar response is found 
after a new contact lens is inserted onto the ocular surface, with organic (proteins, 
mucins and lipids) and inorganic (calcium, potassium and chloride ions) tear film 
elements, in addition to exogenous components such as cosmetics, forming a coating 
over the lens within minutes of exposure to the tear film.4-10 A variety of ocular 
complications during lens wear can be directly related to such deposition, particularly 
on soft contact lenses.11-16 One particularly relevant complication is giant papillary 
conjunctivitis (GPC), which has been observed with a variety of materials and wearing 
schedules 14,15,17,18 and has been closely linked with deposition of denatured proteins 
on the lens surface, potentially through a mechanical lens interaction with the under-
surface of the lids.11 
More than 100 different proteins have been identified in the human tear      
film 19,20 with a total concentration of 6.5-9.6 mg/ml.21 This concentration may change 
over the day,22 during sleep 23 and under specific conditions, including stimulated 
tearing,24,25 increasing age,26 contact lens wear 27 and in various eye diseases such as 
Sjögren’s syndrome.28 Lysozyme is of particular interest due to its high abundance 
and antimicrobial activity in the tear film.24,25,29 It exhibits an overall positive charge, 
with an IEP pH =11.1 and is constituted of 129 amino acids, which results in a 
molecular weight of 14.5 kDa.30 Lysozyme has a concentration in the tear film of     
1.9 mg/ml.23,25 Albumin is the most abundant protein in blood serum and is involved 
in the initial response to implanted biomaterials.2 Albumin has a size of 66kDa 
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(585amino acids) and the concentration in the tear film ranges from 0.02 to          
0.04 mg/ml during the day 22,24 and rises to approximately 0.5 mg/ml after sleep. 23 31 32 
Its overall negative charge (IEP pH= 4.7) results in a different sorption behavior 
compared to lysozyme.31,33-35  





are the most commonly used care regimens to clean and disinfect soft contact 
lenses.36 Due to their convenience, MPS systems have become increasingly popular 





being used by <10% of patients.36-38 The majority of MPS systems 
were initially developed for use with conventional pHEMA (poly-2-hydroxyethylene 
methacrylate)-based materials and were prescribed using a manual rub and rinse-step 
prior to overnight soaking of the lenses.39,40 To improve convenience, a number of 
care systems were developed that were approved as “NO-RUB” products, with a brief 
rinse and long overnight soak only being required.  
Silicone hydrogel (SH) contact lens materials provide high levels of oxygen to 
the cornea 41,42 and result in fewer hypoxic complications compared with conventional 
polyHEMA (pHEMA)-based materials.43,44 The majority of SH materials are worn on a 
daily wear basis 45 and 90% of the patients wearing these materials on an overnight or 
continuous wear basis will remove the lenses at some point during the wearing 
cycle.46 Once removed, the lenses require cleaning and disinfection prior to 
reinsertion.  
Previous studies have reported that the deposition profile of SH and 
conventional pHEMA-based materials differ markedly, with SH materials depositing 
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lower amounts of tear proteins, which are primarily denatured. On hydrogel 
biomaterials, denatured proteins are more tightly bound than native proteins,2,47 which 
raises the question of whether proteins bound to contact lens materials can be 
removed from the lens by rinsing and/or soaking alone. 
 
6.3 Methods 
This in vitro study was conducted to investigate the efficiency of protein 
removal from pHEMA-based and SH contact lens materials using commonly prescribed 
care regimens. The location and amount of two tear film proteins (lysozyme and 
albumin) was determined prior to and after soaking the lenses using either a 






Two SH materials (lotrafilcon B, balafilcon A) and one pHEMA-based lens 
(etafilcon A) were investigated (Table 6-1). All lenses had a power of -3.0 D (dioptres) 
and were presoaked in sterile phosphate buffered saline (PBS) 24 hours prior to 








 Table 6-1: List of contact lenses investigated in this study 
 
DMA N,N-dimethylacrylamide; HEMA 2-hydroxyethyl methacrylate; MAA methacrylic acid; NVA N-vinyl 
aminobutyric acid; NVP N-vinyl pyrrolidone; PBVC poly[dimethylsiloxyl] di [silylbutanol] bis[vinyl carbamate]; TPVC 
tris-(trimethylsiloxysilyl) propylvinyl carbamate; TRIS trimethyl siloxy silane. 
 
Two techniques were used in this study to quantify and locate the protein of 
interest on the contact lens. In Experiment 1, a radiolabeling technique was used to 
quantify the overall amount of bound protein per lens and in Experiment 2, confocal 
laser scanning microscopy (CLSM) identified the location of fluorescently-labeled 
protein on the surface and inside the lens matrix (for conjugation methods, see 
below). Hen egg lysozyme (HEL, Sigma-Aldrich, St. Louis, MO) and bovine serum 
albumin (BSA, Sigma-Aldrich St. Louis, MO) were investigated in separate experiments, 
applying both the radiolabeling and CLSM method. BSA and HEL were substituted for 
human albumin and lysozyme primarily due to cost considerations; however, the 
shape and physicochemical properties between the proteins are very similar and they 
are expected to behave in an analogous manner.48-53 
In both experiments lenses were incubated in amber glass vials filled with 
protein solution, with physiological concentrations of 1.9 mg/ml HEL 23, 25 or            
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0.5 mg/ml BSA.31 Etafilcon A is known to accumulate high levels of lysozyme 54,55 and 
was therefore incubated in 3 ml of HEL solution, to ensure sufficient protein was 
available over the incubation period of 14 days. All other lens/protein combinations 
were soaked in 1 ml of solution. Three replicates were used for each condition and 
the incubation was performed at 37ºC under constant rotation of 72 rpm for time 
periods of 1 and 14 days. For an overview of the experimental procedures, please 




Figure 6-1: Schematic diagram for contact lens incubation in HEL and BSA 
solution, followed by overnight soaking and the methods to locate and quantify 
the protein on the lens  
HEL (1.9mg/ml) BSA (0.5mg/ml) 
Conjugated with a radioisotope 
(125I) – Exp 1 
Conjugated with a fluorescent 
dye (LY) – Exp 2 
Incubation for 1 day and 14 days @37°C 
(a) RINSE Overnight soaking:      (b) MPS-NO-RUB       (c) MPS-RUB        (d) H
2
O





An automated gamma counter quantifies the 
radiolabeled protein content sorbed to the 
lens 
Protein location: 
CLSM identifies the location of the 
fluorescently labeled protein on and inside 
the lens 
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After protein incubation, lenses underwent one of four treatments, described 
below. The contact lens care regimens used in this study are listed in Table 6-2. 
• (a) “RINSE” - all lenses were held with plastic-tipped tweezers and gently swirled in 
100ml PBS for 3 seconds (repeated twice) and either processed immediately for 
protein localization or quantification or further prepared for overnight soaking 
using one of three differing treatments (b), (c), or (d).  
• (b) “MPS-NO-RUB” - lenses were individually placed in COMPLETE® Easy Rub contact 
lens cases (Advanced Medical Optics, Santa Ana, CA), which were filled with 3ml of 
COMPLETE® Easy Rub (Advanced Medical Optics, Santa Ana, CA) solution.  
• (c) “MPS-RUB” - lenses were placed in a nitrile-gloved hand, 200μl of COMPLETE® 
Easy Rub was added and using the index finger alone, five circular rotations on 
each side of the lens were performed (10 sec total). The lenses were then briefly 





” - lenses were individually placed in ClearCare® lens cases (CIBA Vision, 
Duluth, GA), which were then filled with 9ml of ClearCare® (CIBA Vision, Duluth, 
GA).  
 
Lenses processed in treatments b, c and d remained in the respective care 
solution for 12 hours, followed by immersing and swirling for 3 seconds in fresh PBS 




Table 6-2: List of care regimens used in this study  
 
Three replicates for each of the three lens types (etafilcon A, lotrafilcon B, 
balafilcon A) were incubated in two proteins (HEL, BSA) at two time points (D1, D14) 




) and two 
techniques to either quantify or locate the protein on the lens. This resulted in 288 
lenses being examined. 
 
6.3.1 Experiment 1: Protein quantification using 125I  
In separate experiments, HEL and BSA were conjugated to 125I using the iodine 
monochloride method as previously described.56,57 Lenses were incubated in single 
protein solutions containing 1.9 mg/ml HEL or 0.5 mg/ml BSA, using a mixture of 2% 
labeled and 98% unlabeled protein (pH 7.4). Following the four treatments a, b, c or d 
the remaining protein content on the lens was determined using an automated 
gamma counter (1470 Wallac Wizard PerkinElmer, Woodbridge, ON). For 
quantification purposes, the radioactivity on each lens was converted into micrograms 
of protein.58,59 
 
Trade Name Manufacturer Disinfectant Other constituents Buffer 







Poloxamer 237, Edetate 




6.3.2 Experiment 2: Protein conjugation for CLSM 
In separate labeling procedures, 180 mg HEL and BSA were dissolved in 0.05 M 
borate buffer (pH 8.5) and 0.04 M NaCl (HEL 5 mg/ml; BSA 10 mg/ml). The water 
soluble fluorescent dye Lucifer Yellow VS dilithium salt (LY, Sigma Aldrich, St. Louis, 
MO) was dissolved in 1mL of borate buffer (pH 8.5) (7mg for BSA, 10mg for HEL). The 
dye was added to the protein solution followed by gentle stirring for one hour in the 
dark. Free LY was separated from the conjugated proteins using Sephadex G25 PD10 
desalting columns (Amersham Biosciences, Piscataway, NJ, USA). Following this, 
dialysis against PBS using a 7 kDa molecular weight cutoff dialysis cassette was 
performed, until only negligible amounts of free LY were detected with a fluorescence 
spectrophotometer. The labeling efficiency was calculated by determining the protein 
concentration in the solution using the DC Protein Assay (Bio-Rad, Hercules, CA) and 
measuring the absorbance at 415nm (which is the maximum absorbance for LY). The 
resulting degree of labeling (DOL) was 0.26 for HEL and 2.94 for BSA (DOL = 
molecules dye per molecule of protein) (Appendix A). 
6.3.3 Contact lens incubation in fluorescently labeled protein 
The conjugated protein solutions were sterilized with 0.2 μm syringe filters to 
prevent microbial contamination of the samples during the incubation phase. Since 
lower amounts of labeled protein result in less photobleaching during subsequent 
laser scans and to allow consistent settings on the microscope throughout the 
experiment, the lowest possible amount of conjugated HEL was used. Contact lens 
materials that were known to accumulate large amounts of lysozyme from previous 
studies58,60 were incubated with 2% labeled and 98% unlabeled HEL, while other 
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materials known to accumulate only small amounts of protein were incubated in 100% 
labeled HEL. The final concentration of HEL was 1.9 mg/ml (pH 7.4). Due to the lower 
BSA sorption rate to contact lens materials,54 all lens types were incubated in 100% 
conjugated BSA. 
6.3.4 CLSM examination technique 
The center 4 mm of the lens was cut out using a mechanical punch-press and 
the sample was gently dabbed dry on lens paper before it was mounted onto a glass 
microscope slide. Approximately 40 μL of PBS was used as the mounting media. A 
glass coverslip was then carefully applied and sealed with nail polish to prevent 
evaporation and to stabilize the coverslip for use with the immersion objectives of the 
microscope. 
The lens materials were subsequently examined for protein uptake using CLSM 
(Zeiss Inc. Toronto, Canada). The Zeiss 510, configuration Meta 18 was equipped with 
an inverted motorized microscope Axiovert 200M. Each lens was scanned at four 
random locations using an excitation wavelength of 405nm (Laser Diode) and an 
emission filter LP >505nm. Each section of z stacks was set at 1 μm intervals with 
image sizes of 512 x 512 μm. Lenses were scanned with a 40x water immersion C-
Apochromat objective. Using the software provided with the microscope and ImageJ 
(Bethesda, MD), the means of the fluorescence intensity were plotted as a function of 
the scanning depth. 
For statistical analysis of the quantitative protein uptake and protein location, 
repeated measures ANOVA (analysis of equal variance) was applied followed by post-
hoc comparisons using Tukey's HSD (honestly significant difference) test. P<0.05 was 
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considered significant. To determine the significance of differences between the 
amount of protein sorbed to the investigated materials, a comparison between the 
RINSE data was tested using the factors “Protein” (HEL, BSA), “Material” (etafilcon A, 
lotrafilcon B, balafilcon A) and “Time” (Day 1, Day 14). The cleaning efficiency was 
analyzed individually for each lens-protein combination due to the wide range of 
protein uptake between lens materials. Differences between the amounts of protein 
were determined separately for each lens material (etafilcon A, lotrafilcon B, balafilcon 





), including interactions.  
To determine differences in protein location, each CLSM lens scan was sectioned 
into front- and back-surface and ‘bulk’ regions as previously described.61 Briefly, the 
fluorescence intensity on the front and back surface was calculated by averaging the 
five micron scan steps around the front and back ‘surface peak’ and the ‘bulk’ 
intensity was calculated by averaging the innermost 30 micron of the lens scan.61 As 
noted in our previous study,61 the relative fluorescence signal on the back surface 
typically showed a minor decrease as compared to the front surface. This is due to 
increased absorbance of the laser light when measuring deeper into the lens material, 
and could be seen in the majority of cases. Therefore, comparisons between protein 
location on and within the lens will focus only on differences in front surface versus 
the bulk (central) region, with the assumption that both surfaces accumulate similar 
amounts of protein. The scaling of the CLSM results is based on arbitrary units and 
solely allows comparisons between a single protein type on one specific material. 
Using repeated measures ANOVA, significant differences in fluorescence intensity 
were determined separately for each lens material (etafilcon A, lotrafilcon B, balafilcon 
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) and “Location” (front surface, back surface, ‘bulk’), including 
interactions. The fluorescence signal does not provide quantitative results and the 
units cannot be compared directly between materials, therefore radiolabeled protein 
was used for quantitative comparisons. 
 
6.4 Results 
Etafilcon A, lotrafilcon B and balafilcon A incubated in 125I labeled protein showed 
significantly more HEL on all lens types compared to BSA at all time points (p<0.001). 
An increase in HEL and BSA sorption was found on all three lens materials over time 
(p<0.05), except for BSA in combination with etafilcon A (p=0.48). 
Following incubation of the three contact lens materials in either 1.9 mg/ml HEL 
or 0.5 mg/ml BSA, the total amount and location of protein on these materials was 
determined prior to and after overnight soaking in MPS with and without manual lens 






Etafilcon A accumulated the highest amounts of HEL (mean 2200 μg/lens) and 
the lowest amounts of BSA (mean 0.2 μg/lens) compared to the other materials 
(p<0.001) (Table 6-3). After overnight soaking, both care regimens removed 





 removed 24.3% of the HEL from etafilcon A, which was significantly 
more (p<0.001) compared to both MPS-RUB (15.8%) and MPS-NO-RUB (16.3%), which 
were not different to each other (p=0.88). The very low amounts of BSA were 




, MPS-RUB and 
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MPS-NO-RUB respectively, with all cleaning procedures performing similarly (p>0.98) 
(Table 6-3). 
 
Table 6-3: Total amount of HEL and BSA sorbed to etafilcon A after 1 and 14  





 (Mean (μg) ± 95% confidence interval)  
 










RINSE (a) 1139.8±7.14 2200.3±15.64 (b), (c), (d) 0.16±0.037 0.20±0.037 (b), (c), (d) 
MPS-NO-RUB (b) 909.3±5.52 1852.1±19.16 (a), (c), (d) 0.03±0.006 0.09±0.005 (a) 





(d) 783.4±11.13 1666.1±15.83 (a), (b) 0.02±0.004 0.08±0.041 (a) 
 
*Overall differences between treatments (p<0.05), using the combined time points. 
 
The CLSM results for the different cleaning treatments show the distribution of 
the fluorescently conjugated protein on the front surface, within the central lens 
matrix (bulk) and at the back surface of etafilcon A (Figures 6-2A-D). Following the 
RINSE procedure alone, HEL sorption to etafilcon A showed a slightly higher protein 
density on the surface compared to the matrix region on Day 1 (p<0.001), but this 
leveled out over time, with no difference being seen on Day 14 (p=1.0). For both time-




removed significantly higher amounts of HEL from the surface 
of etafilcon A compared to all the other procedures (p<0.001), and significantly more 
HEL was measured in the central region than on the surface (p<0.001). This 
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phenomenon was seen to this extent only with this specific lens-protein-care regimen 
combination. For the MPS on Day 1, both techniques removed significant amounts of 
protein from both the surface and matrix compared with RINSE alone (p<0.001). No 
differences between the surface and bulk regions were measured for either RUB or 
NO-RUB methods, but there was a reduction in both regions on Day 1 when the lens 
was rubbed (p<0.001). Both techniques, RUB and NO-RUB, removed more HEL from 
the surface than from the bulk region on Day 14, but there was no significant 
difference between the two techniques (p=0.64). 
The overall BSA sorption to etafilcon A with the RINSE procedure was similar at 
both time points (p=1.00), showing an almost even distribution of the protein at the 





showed a successful removal of BSA from both the surface and the bulk regions 
(p<0.001), with a slightly reduced efficiency on Day 14. There were no significant 











Figure 6-2: CLSM scans were analyzed to locate the fluorescently-conjugated 
proteins on the front surface, within the bulk region and on the back surface of 
etafilcon A - HEL (A+B); BSA (C+D) 
                     Etafilcon A - HEL
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Lotrafilcon B accumulated higher quantities of HEL (mean 9.65 μg/lens) as 
compared to BSA (mean 1.82 μg/lens) after 14 days of incubation in radiolabeled HEL 
solution (p<0.001) (Table 6-4). Following overnight soaking, none of the care 
regimens removed appreciable amounts of HEL from this lens type (p>0.46), while a 









 removed 7.2% HEL from lotrafilcon B, 
which was similar to both MPS-RUB (3.6%) and MPS-NO-RUB (2.9%) (p>0.90). The 





MPS-RUB and MPS-NO-RUB respectively, with all cleaning procedures performing 
similarly (p>0.89) (Table 6-4). 
 
Table 6-4: Total amount of HEL and BSA sorbed to lotrafilcon B after 1 and 14 





 (Mean (μg) ± 95% confidence interval)  
 










RINSE (a) 5.14±0.64 9.65±1.54 - 0.84±0.10 1.82±0.19 (d) 
MPS-NO-RUB (b) 3.28±0.85 9.37±1.72 - 0.54±0.07 1.62±0.08 - 





(d) 4.41±0.84 8.96±1.28 - 0.45±0.05 1.57±0.13 (a) 
 
*Overall differences between treatments (p<0.05), using the combined time points. 
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The location of fluorescently conjugated HEL on the surface and within the 
matrix of lotrafilcon B is shown in Figures 6-3A+B. Significantly higher amounts of HEL 
were detectable on the surface of lotrafilcon B following the RINSE procedure as 
compared to the bulk region on Day 1, which became even more distinct on Day 14 




 or MPS with or without rubbing removed protein 
solely from the central lens region on Day 1 (p<0.04); however the front surface on 
Day 1 and both locations on Day 14 did not show a significant decrease in protein 
accumulation using any of the three procedures (p>0.3), with the exception of the 





BSA sorption to lotrafilcon B showed a trend similar to HEL, with more BSA 
detected on the surface compared to the bulk region after the RINSE procedure, as 
seen in Figures 3C+D (p<0.001). All cleaning techniques removed BSA from the 
central location at both time points (p<0.001). For the surface, only MPS-RUB removed 
significant amounts of BSA on Day 1 and only MPS-NO-RUB reduced the BSA content 
on Day 14 (p<0.001). On Day 14, both MPS applications removed more protein from 




care solution (p<0.01), but no differences could be 
detected for the bulk region (p>0.05). Although MPS-RUB removed more BSA from the 
surface on Day 1 as compared to the NO-RUB technique, all other locations were not 









Figure 6-3: CLSM scans were analyzed to locate the fluorescently-conjugated 
proteins on the front surface, within the bulk region and on the back surface of 
lotrafilcon B - HEL (A+B); BSA (C+D) 
                   Lotrafilcon B - HEL
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Balafilcon A accumulated much higher amounts of HEL (mean 50.0 μg/lens) 
compared to BSA (mean 1.90 μg/lens) after 14 days of incubation in 125I conjugated 
protein (p<0.001) (Table 6-5). After overnight soaking, both care regimens removed 
significant amounts of both proteins from this lens type (p<0.01). After 14 days of 
incubation, HEL was more efficiently removed from balafilcon A as compared to the 









 removed 31.7%, 
which was similar compared to MPS-RUB (30.7%) and MPS-NO-RUB (29.2%). The three 
cleaning procedures showed overall similar protein removal efficiencies for both BSA 
and HEL (p>0.69) (Table 6-5). 
 
Table 6-5: Total amount of HEL and BSA sorbed to balafilcon A after 1 and 14 





 (Mean (μg) ± 95% confidence interval)  
 










RINSE (a) 42.71±1.93 50.00±0.14 (b), (c), (d) 0.63±0.08 1.90±0.37 (b), (c), (d) 
MPS-NO-RUB (b) 8.08±0.39 19.31±0.99 (a) 0.24±0.05 1.35±0.31 (a) 





(d) 8.18±0.47 20.08±1.69 (a) 0.21±0.03 1.30±0.31 (a) 
 
*Overall differences between treatments (p<0.05), using the combined time points. 
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Imaging results of the fluorescently conjugated protein indicated a higher HEL 
density inside the matrix region compared to the surface of balafilcon A following the 
RINSE procedure at both time points (p<0.001) (Figures 6-4A+B). All three cleaning 
techniques removed significant amounts of HEL from both the surface and bulk 




removed more HEL from the surface of balafilcon A 
on Day 1 compared to the MPS applications (p<0.02), however on Day 14 all care 
regimens performed similarly for both surface and bulk regions (p>0.09).  
BSA showed an equal distribution throughout the balafilcon A material at both 
time points following the RINSE procedure (p=1.0), as shown in Figures 6-4C+D. All 
cleaning procedures removed significant amounts of BSA from the surface and the 





as compared to both MPS applications (p<0.001), which were not 
different to each other on Day 1 (p=1.0). Small but significant differences could be 
seen on the lens surface and within the matrix between both MPS procedures on Day 





Figure 6-4: CLSM scans were analyzed to locate the fluorescently-conjugated 
proteins on the front surface, within the bulk region and on the back surface of 
balafilcon A - HEL (A+B); BSA (C+D) 
                   Balafilcon A - HEL
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6.5 Discussion 
Current soft contact lens care regimens have been evaluated for their efficiency 
against both microbial and tear film deposition on various soft lens materials.40,62-69 
Both ex vivo and in vitro studies have demonstrated material specific sorption profiles 
and confirmed differences between care regimens for removing non-pathogenic (e.g. 
lipids, proteins) 40,62,66-69 and microbial (e.g. bacteria and fungi) 62-65 components from 
the lens. Furthermore, manual lens rubbing reduces the appearance of visual 
deposition by removing general tear film deposition and cosmetics from the lens 
HH, as compared with soaking alone.70,71 A clinical study 
conducted by Nichols 70 determined visual deposition on patient-worn SH lenses after 
using various MPS in a rub and no-rub application. The subjective grading method 
demonstrated an overall reduction in lens “haze” for manually rubbed lenses that 
were cleaned using either COMPLETE® MoisturePLUS or Opti-Free Express. Cho et al.71 
reported similar results from an in vitro study investigating ionic high water pHEMA-
based lens materials that were artificially deposited with albumin, hand cream and 
mascara. Lenses that were not rubbed prior to the soaking process showed similar 
levels of deposition regardless of the rinsing duration. In contrast, all four MPS 
systems investigated removed significant amounts following extensive lens rubbing.71 
While both of the above studies clearly describe differences between care 
regimens and their method of utilization, it still remains unclear if the deposited 
species were removed primarily from the lens surface or also from the central or 
“bulk” lens region. Of particular interest to us was the impact of care regimens and 
rubbing on the removal of tear film proteins, and whether such proteins are removed 
differentially from the surface or bulk locations. Therefore, the purpose of this study 
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was to determine the efficiency of various contact lens care regimens on the removal 
of two typical tear film proteins lysozyme (HEL) and albumin (BSA), which differ 
markedly in size, charge and concentration.  
As shown in previous studies,59,61 the protein distribution profile for BSA and 
HEL differs significantly between lens materials. The pHEMA material etafilcon A (FDA 
group IV) allowed both proteins to penetrate the lens matrix, while the high refractive 
index coating and/or the properties of the matrix of the lotrafilcon B SH material 72 
(FDA group I) minimized protein penetration into the material, with both proteins 
primarily being deposited on the surface region.59,61 It may be assumed that protein 
sorbed onto the lens surface would be easier to remove than protein penetrating the 
lens matrix. However, results from the current study showed no change in the overall 
HEL amount (by radiolabeling) and distribution profile (by CLSM imaging) on the 
lotrafilcon B material after overnight soaking using a RUB or NO-RUB application 
(Table 6-4 and Figures 6-3A+B). BSA amounts were slightly reduced by 11 to 14% for 




 systems (Table 6-4) and the CLSM 
results confirmed that BSA was removed primarily from the bulk and not from the 
surface region (Figures 6-3C+D).  
Etafilcon A allowed both BSA and HEL to fully penetrate the lens matrix over 





significant amounts of 15.8 to 24.3% for lysozyme and 55.5 to 62.4% for BSA from 
both the lens surface and bulk regions (Table 6-3 and Figures 6-2A-D). When 





substantially more HEL from the surface region of etafilcon A than either MPS method 
(Table 6-3 and Figures 6-2A+B). This phenomenon was not observed with BSA, which 
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deposited substantially less than HEL (Table 6-3). The high levels of deposition of the 
positively charged HEL on ionically charged materials such as etafilcon A has been 
shown previously.35,58,73 
Our results would suggest that both proteins were less tightly bound when 
sorbing to the surface of etafilcon A (Figures 6-2A-D) as compared to the lotrafilcon B 
material (Figures 6-3A-D), which showed no - or minimal - protein removal from the 
surface following any of the cleaning procedures. These findings were also confirmed 
in the quantitative results, which showed a higher percentage of protein removal for 
etafilcon A compared to lotrafilcon B (Tables 6-3, 6-4) This may be due to the 
conformational state of the proteins which were sorbed to the more hydrophilic 
surface (etafilcon A), compared to the more hydrophobic surface (lotrafilcon B) 
typically exhibited by SH materials.74 Previous studies have already determined 
changes in secondary structure for HEL and BSA when depositing on contact lenses 
and show a higher denaturation rate for proteins sorbed to SH materials, as compared 
to pHEMA materials.54,55,60,67,75 Furthermore, denatured proteins typically bind more 
tightly to surfaces as compared to native proteins,3,47,54 which may explain our 
difficulties in removing either protein from lotrafilcon B. Thus, our data would 
suggest that when HEL deposits on lotrafilcon B it is extremely difficult to remove, 
regardless of the type of protein or care regimen employed. In comparison, BSA sorbs 
to a lesser extent and is marginally easier to remove.  
The balafilcon A material is surface modified using a plasma oxidation method, 
which results in hydrophilic silicate islands distributed over the lens surface.76 This 
study showed that this surface modification procedure was no barrier for either 
protein, as they both fully penetrated the entire matrix (Figures 6-4A-D). In 
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comparison to the increased surface build up of both proteins seen on lotrafilcon B, 
balafilcon A accumulated slightly more HEL in the lens matrix as compared to the 
surface (Figures 6-4A+B), but showed an almost even distribution for BSA (Figures 6-
4C+D). The highly porous and hydrophilic structure of balafilcon A 77-79 allowed easy 
ingress of both proteins, particularly the smaller HEL, and appeared to allow relatively 
easy removal of either protein deposited using any of the care regimens investigated, 
on both the surface and from within the bulk region. The quantitative experiment 
showed the highest HEL reductions on this material, with 58.4 to 61.4% removal after 
overnight soaking using any of the three treatments (Table 6-5), which was similarly 
reflected by the CLSM imaging data showing an equal reduction throughout the 
balafilcon A material (Figures 6-4A+B). The results for BSA show removal efficiencies 





differences were only seen with the fluorescence imaging technique (Figures 6-3C+D). 
The amount of protein removal from the lens materials investigated in this 
study may be compared to previous findings from both Franklin 39 and Jung,69 who 
investigated pHEMA-based materials only. Franklin incubated FDA groups I, II and III 
in an artificial tear solution containing various proteins and lipids. Lenses were 
manually rubbed with various single and multipurpose solutions and the protein 
content was determined using fluorescence spectroscopy. Franklin reported a protein 
reduction of 27 – 45% for MPS care regimens,39 which is in close agreement with 





 and MPS regimens. In Jung’s in vitro study, which examined FDA groups I to IV, 
proteins were extracted and quantified using a protein assay. The results for FDA 




 as compared to 
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the PHMB-based MPS system, which is in agreement to the results from our study 
using etafilcon A as our FDA group IV lens. 
The protein removal efficiency in our study, as evidenced by the radiolabeled 
results, ranged from 2.9 – 62.4%, which suggests that not only do care regimens 
impact the removal efficiency, but that this removal is also markedly influenced by the 
specific characteristics of the lens materials investigated.  
As described above, two recent studies have shown that rubbing lenses 
reduces visible deposition, in both in vitro and in vivo studies.70,71 In this current 
study, relatively minor differences between deposition of two common tear film 
proteins were demonstrated, using an MPS system in a RUB or NO-RUB format. 
Potential reasons why this in vitro study was not able to mimic previous results is that 
this is the only study to-date to quantify protein removal from SH materials using RUB 
versus NO-RUB methods. The Nichols’ paper 70 examined the removal of visible tear 
film deposits from a single SH material (galyfilcon A), which was not examined in this 
study. The study by Cho and colleagues 71 examined visible deposition, including 
albumin, but used an FDA group IV material (ocufilcon D) that was also not examined 
in this study. One potential issue to consider relative to patient-use of such systems is 
that our lab-based experiment used nitrile-gloved hands for the RUB technique. 
Although the gloves had textured finger tips to improve grip, potential differences to 
ungloved-hands may occur. Another limitation of this in vitro experiment is that the 
lenses were incubated in the protein solution alone, which does not provide the 
intermittent surface-drying that occurs between blinks in in vivo studies, and which 
may have impacted on the deposition results. In reality, a follow-up ex vivo study in 
which lenses are harvested and examined for deposited proteins from a clinical study 
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in which human subjects use an MPS in a RUB and then NO-RUB format is required to 
unequivocally demonstrate differences between these formats. Although the 
differences in protein removal between our two techniques using MPS in a RUB and 
NO-RUB application are minor, it must be considered that this may be entirely 
different for the removal of lipids, microorganisms 80,81 and other debris.  
The use of lysozyme and albumin in single protein solutions describes the 
interaction between the protein and material of interest, however, this sorption 
behavior may change with the addition of an artificial tear solution which includes 
more proteins, lipids, mucins and ions. A competitive process of protein adsorption 
and desorption is expected, as smaller proteins get replaced by proteins with higher 
surface affinity.43  
Biocompatible materials tend to bind proteins relatively loosely, and these 
proteins are often easy to remove, as they maintain their conformation. This 
compares with “less biocompatible” surfaces, which are typically more hydrophobic 
and have a tendency to denature proteins over time, potentially stimulating 
inflammatory responses in the biological host.54,82-88 Future work within the contact 
lens arena should focus on the development of surfaces that maintain protein activity 
and allow for easier removal of deposited tear film components, possibly by 






The efficiency of protein removal varied greatly between contact lens materials, 





removed significantly higher amounts of HEL and BSA from etafilcon A and 
balafilcon A as compared to lotrafilcon B. Comparisons between care regimens 




 system as compared to MPS RUB or 
NO-RUB, which showed negligible differences between these preserved systems.  
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In the following chapter, CLSM is applied to investigate the sorption profile of 
albumin to hydrophilic and hydrophobic intraocular lens materials. Protein 





7. DETERMINATION OF ALBUMIN SORPTION TO 
INTRAOCULAR LENSES BY RADIOLABELING AND 
CONFOCAL LASER SCANNING MICROSCOPY 
7.1 Brief overview 
 The crystalline lens is surrounded by an elastic capsular bag and is located in 
the posterior chamber of the eye. With age, the lens progressively lose clarity and 
cataract develops. This finally results in vision loss. During cataract surgery, this 
opaque lens is removed and replaced by an intraocular lens (IOL). As long as the 
capsular bag remains intact, the IOL is placed inside the capsular bag, but in the case 
of a damaged or unstable bag, various lens designs allow the IOL to be placed in the 
anterior chamber (AC) of the eye.1 In general, the success rate and biocompatibility of 
IOLs is very high, with less than 1% adverse events following cataract surgery.2  
The first reported extracapsular cataract extraction was performed in 1747, 
however it took another 200 years until the first IOL was successfully implanted.1 Early 
trials to implant glass lenses failed, as they were too heavy and sank down into the 
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lower portion of the capsule, but with the invention of poly(methyl methacrylate) 
(PMMA), the first realistic biomaterial for IOLs was found. 1 
The most common type of cataract is “age-related” and affects patients of - 
typically - 65 years and older. Other types of cataract are “congenital cataract”, which 
affects newborn babies or children who develop it in the first years of life, “traumatic 
cataract”, caused by an injury of the eye or “secondary cataract”, which occurs in 
conjunction with certain systemic diseases such as diabetes or with local ocular 
conditions such as chronic uveitis.3 Other less common forms of cataract may be 
caused by certain drugs, due to metabolic disorders or poor nutrition. In addition to 
their application in cataract surgery, IOLs are used to correct high levels of refractive 
myopia or hyperopia. For this phakic surgery an additional IOL is implanted in the 
anterior or posterior segment of the eye, without restricting accommodation of the 
crystalline lens. Common keratorefractive surgeries such as LASIK (Laser-assisted in 
situ keratomileusis) or PRK (Photorefractive keratectomy) reshape the cornea, which 
limits these techniques to moderate refractive errors only, as the amount of tissue to 
be removed controls the refractive correction. The implantation of an IOL in the 
phakic eye maintains the asphericity of the cornea and has a similar predictable 
refractive outcome as compared to keratorefractive surgeries.1 Image 7-1 shows the 





Figure 7-1: Hydrophilic acrylic, PMMA and silicone IOL 
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Purpose: To determine albumin adsorption profiles and penetration depth of 3 
intraocular lens (IOL) materials over time using confocal laser scanning microscopy 
(CLSM) and radiolabeling. 
Methods: Poly(methyl methacrylate) (PMMA), silicone, and foldable hydrophilic 
acrylic IOLs were incubated in 0.5 mg/ml bovine serum albumin (BSA) for 1, 7, and 14 
days. The BSA was conjugated with lucifer yellow VS to allow identification of the 
protein location by fluorescent imaging with CLSM. Next, the protein uptake was 
quantified using 2% 125I-labeled BSA. 
Results: Confocal laser scanning microscopy showed increasing BSA uptake for 
silicone and PMMA IOLs after 14 days of incubation (P<0.05), with an apparent 
penetration depth of 8.7 ± 1.9 μm (SD) and 9.2 ± 1.4 μm, respectively. For hydrophilic 
acrylic IOLs, BSA was detected at a depth of 38 ± 7.4 μm after 1 day, followed by an 
increase to 192.7 ± 16.2 μm after 14 days. Despite the penetration depth into the 
hydrophilic acrylic IOLs, quantitative results confirmed that PMMA and hydrophilic 
acrylic deposited significantly less BSA (mean 278.3 ± 41.7 ng and 296.5 ± 33.1 ng, 
respectively) than silicone IOLs (mean 392.6 ± 37.6 ng) (P<0.05). 
Conclusions: Silicone and PMMA IOL materials showed BSA sorption near the 
lens surface only, while BSA penetrated deep into the hydrophilic acrylic IOL matrix. 
Combining the qualitative CLSM method and quantitative radiolabeling technique 
provided detailed information on protein interactions with implantable biomaterials. 
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7.3 Introduction 
In 2006, the rate of cataract surgery in the US was 6500 per 100 000 people, 
which is expected to increase over time due to the aging population.4,5 In addition to 
their use following cataract extraction, intraocular lenses (IOLs) are increasingly used 
in phakic eyes to correct high levels of refractive error6-8 and in pediatric aphakia.9 As 
the average age of the patients declines, it is possible that the IOL will remain in situ 
for several decades. Thus, the requirements for biocompatibility and biostability, 
including chemical, mechanical and optical long-term performance, increase.10  
The biomaterials used for IOLs can be generally categorized into two broad 
groups, being acrylic polymers and silicone. The acrylic group may be further sub-
divided into rigid polymethyl methacrylate (PMMA), foldable hydrophobic acrylic and 
foldable hydrophilic acrylic (hydrogel) materials.11,12 The water content for most IOL 
materials is <1%, with the exception of hydrophilic hydrogels, which have water 
contents ranging from 18-38%.13  
The immunological response of the eye following cataract surgery may be 
impacted by the incision size, which is directly related to whether the IOL can be 
folded prior to insertion.11 Smaller incisions cause less damage to the blood-aqueous 
barrier (BAB), lower amounts of induced corneal astigmatism and higher resistance to 
leakage of the aqueous humour (AH). 14 Following insertion, the IOL is directly 
exposed to the AH, which consists largely of glucose, ascorbate, inorganic ions, 
various peptides and proteins.15 The majority of AH components are present in the 
blood serum and enter the AH by leaking through the blood vessels.16 The total 
protein concentration in the AH is approximately 0.7 mg/ml, with albumin being the 
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most abundant protein, accounting for approximately 50% of the total content.17 
Studies have shown that the AH composition changes with eye disease or following 
cataract surgery, due to the breakdown of the BAB.17-20 
This breakdown in the BAB increases cell and protein levels in the AH. As a 
result, within the first days post surgery, inflammatory cells can be observed on the 
IOL surface.21 In cases where significant lens epithelial cell (LEC) growth is observed 
over the anterior IOL surface, fewer inflammatory cells are found in the anterior 
chamber, suggesting “superior” biocompatibility.14,21,22 Different levels of foreign-body 
response have been reported with different materials, with fewer inflammatory cells in 
the AH with poly (hydroxyethyl methacrylate) (pHEMA) or hydrophobic acrylic 
materials compared to PMMA or silicone IOLs.12,14,21 Protein sorption from the AH to 
the IOL occurs immediately after the implant is exposed to the AH, and this protein 
coating influences subsequent cell adhesion.23-26 
In vitro and ex vivo studies have investigated the interaction between various AH 
proteins and IOL materials. Johnston and coworkers found differences in albumin and 
fibronectin sorption onto PMMA and hydrophobic acrylic lenses in vitro,27 and 
concluded that incubation time, protein concentration, protein type and material 
composition influenced the individual uptake. Explanted IOLs have been investigated 
by Linnola et al.28 using immunohistochemical staining. They found significantly more 
fibronectin and vitronectin on acrylic lenses compared to silicone or PMMA. However, 
the impact of these AH proteins on the biocompatibility of IOL lenses is complex and 
still not fully understood. In addition, studies to-date have only estimated the total 
amount of the deposited protein, but cannot describe their location on the lens. This 
factor may be important, as the response of the eye to the implant may differ 
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depending upon whether the proteins are sorbed to the surface or absorbed into the 
bulk of the lens. Additionally, these surface-located proteins may undergo different 
conformational changes.  
In this in vitro study, confocal laser scanning microscopy (CLSM) was used to 
determine the location of albumin on three distinctly different IOL materials and a 
radioactive technique quantified the amount of albumin deposition.   
 
7.4 Methods 
PMMA, silicone and foldable hydrophilic acrylic IOLs were investigated in this 
study, whose material properties and dimensions are summarized in Table 7-1.  
 
Table 7-1: Dimensions and properties of the IOLs 
 Power Optic Ø ; Length 
Water 
content Number of pieces 
Hydrophilic Acrylic 
(B&L Akreos Adapt) 
+21.5 D – 
+26.0 D 6.0 mm ; 10.70 mm 26% 1 piece 
PMMA 
(B&L EZE-55) 
+21.00 D 5.5 mm ; 12.75 mm <1% 1 piece 
Silicone 
(B&L Ll61SE) 
+20.50 D 6.0 mm ; 13.00 mm <1% 3 piece 
 
The bovine serum albumin (BSA) used in this study had a purity of 99% 
(agarose gel electrophoresis) and a molecular weight of 66 kDa (Sigma-Aldrich St. 
Louis, MO). The shape and physicochemical properties of albumin from human and 
bovine serum are very similar and are expected to behave in an analogous manner.29-31 
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The IOLs were incubated in 2 ml of 0.5 mg/ml of BSA, which was either 
conjugated to a fluorescent dye or a radioactive tracer (for conjugation methods see 
below). The incubation was undertaken in amber vials, with the lenses hung on plastic 
threads to prevent them from sinking to the bottom of the glass vial, thus ensuring 
adequate exposure of the IOLs to the protein solution. The incubation was performed 
at 37ºC under constant rotation of 72 rpm. After time periods of 1, 7, and 14 days the 
IOLs were rinsed with PBS prior to further examination. 
7.4.1 Determination of albumin location 
7.4.1.1 Protein labeling 
 Prior to the lens incubation, BSA was conjugated with Lucifer Yellow VS (LY - 
Sigma-Aldrich, St. Louis, MO) to allow identification of the protein location using 
fluorescent imaging on the CLSM. Briefly, 100mg BSA in 0.05 M borate buffer (pH 8.5) 
and 0.04 M NaCl (10 mg/ml) was prepared. LY is water soluble and thus 4mg was 
dissolved in 0.5ml of borate buffer (pH 8.5). The LY solution was added to the BSA 
solution and was gently stirred for one hour in the dark. Unbound LY was removed 
using a Sephadex G25 column (Amersham Biosciences, Baie d’Urfe, QC). Following 
this, dialysis against PBS using a 20 kDa molecular weight cutoff dialysis cassette 
(Pierce, Rockford, IL) was performed, until only minute amounts of unbound LY were 
detected with a fluorescence spectrophotometer. The fluorescent labeling efficiency 
was calculated by determining the BSA concentration in the solution using the DC 
Protein Assay (Bio-Rad, Hercules, CA) and measuring the absorbance at 415nm (which 
is the maximum absorbance for LY). The degree of labeling (DOL) was 3.2, indicating 
that on average, 3.2 dye molecules was bound per molecule of protein (Appendix A). 
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Prior to incubation, the BSA-LY solution was sterilized using 0.2 μm polyethersulfone 
syringe filtration (VWR, Mississauga ON).  
The IOLs were incubated in BSA-LY with two replicates used for each condition 
and time point. Additional lenses (used as controls) were incubated in phosphate 
buffered saline (PBS) for seven days, or in PBS containing the LY dye for one day.  
7.4.1.2 CLSM imaging 
The CLSM Zeiss LSM 510 Meta (Zeiss Inc. Toronto, Canada) was used to image 
the fluorescently labeled BSA on the IOLs, using a laser diode with a wavelength of 
405nm for excitation and a long pass filter of >505nm for emission. The IOLs were 
placed in microscopy chamber slides filled with PBS, and CLSM scans were taken in 
single micron steps, captured with a 40x water Apochromat objective. To obtain 
comparable results over time, appropriate settings for detector gain and laser 
intensity were determined via a number of preliminary-tests and these remained 
constant throughout the experiment.  
Each IOL was scanned at four random locations with a scan depth of up to 230 
μm. Three dimensional images were constructed from each scan and for each of these 
a further four random locations were chosen to collect intensity profile scans, that 
were measured perpendicular to the surface into the lens matrix (Figures 7-2 (A+B)). 
In total, 32 measurements were used to calculate the sorption depth of the protein for 






































































































7.4.3 Determination of albumin stability 
A major concern when undertaking studies using conjugated proteins is that the 
properties of the protein could be markedly changed by the labeling process.34 In this 
study, native and denatured BSA were evaluated with gel electrophoresis to detect 
differences between conjugated and unconjugated BSA and to confirm the stability of 
the BSA-LY during the incubation period. Furthermore, the potential impact of the IOL 
material itself on the protein solution required investigation. 
7.4.3.1 Native polyacrylamide gel electrophoresis (PAGE) 
As a protein unfolds different amino acids are exposed, resulting in a different 
net surface charge. Native PAGE electrophoresis can detect the alterations in surface 
charge by changes in the relative mobility of the protein along the electrophoresis 
gel. Samples were prepared in 125 mM Tris-HCl, pH 6.8, 10% glycerol and 0.001% 
bromphenol blue. In-house native PAGE was performed in 7% polyacrylamide gel (29% 
acrylamide, 1% N N’-methylenebisacrylamide), 375 mM Tris-HCl, pH 8.8 with 4% 
stacking gel (125 mM Tris-HCl, pH 6.8). The running buffer was 25 mM Tris, 191 mM 
glycine, pH 8.6. Samples from the BSA solutions (4 μl) were removed at various times 
and added to each well of the PAGE. Gels were run at 150 V for two hours, followed 
by staining in BioSafe Coomassie Stain (Biorad, Hercules, CA). The protein standard 
used for this gel was Native PAGE Molecular weight Markers™ (Invitrogen, Burlington, 
ON). 
7.4.3.2 Denatured PAGE 
To gain more detailed information regarding potential differences in size 
between the conjugated and unconjugated BSA samples, a high resolution denatured 
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sodium dodecyl sulfate (SDS) gel was run. Samples were solubilized in 250mM lithium 
dodecyl sulphate (LDS) (Invitrogen, Burlington, ON) plus 100 mM dithiotheritol (DTT) 
and heated at 70ºC for 10 minutes. Following this, 0.8 μl of each sample was loaded 
onto a parafilm-covered template for loading with a 12 X 0.3 μl comb. The protein 
mass loaded ranged from 0.028 - 0.11 μg. All samples were subjected to SDS-PAGE on 
4-15% gradient gels with a 13 mm stacking zone and 32 mm gradient zone on an 
automated minigel system (Amersham Pharmacia Biotech PhastSystem™, Baie d’Urfe, 
PQ) using the manufacturer’s specified conditions. The gel was run for 20 minutes at 
150V / 10mA, followed by staining in BioSafe Coomassie Stain. The protein standards 
used for this gel were ChemiChrome™ (Sigma-Aldrich St. Louis, MO) and SeeBlue® 
(Invitrogen, Burlington, ON). 
Statistical analysis of the protein uptake on the IOLs was performed using 
repeated measures ANOVA analysis of equal variance (significance level p<0.05). For 
the CLSM data, the background noise inside the lens matrix was calculated for each 
material and the width of the fluorescence intensity band was measured, starting at 
an elevation of 1.5x from the background noise.  
 
7.5 Results 
7.5.1 Albumin location 
Analysis of the CLSM scans showed an increase in BSA sorption over the 
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significantly change over the study period (p>0.05). After 14 days of incubation in 0.5 
mg/ml of BSA, the silicone IOL sorbed 392.6±37.6 ng, PMMA 278.3±41.7 ng and the 
hydrophilic acrylic 296.5±33.1 ng. The surface adsorption of BSA for the IOLs was 
calculated to be 660 ng/cm2 and 556 ng/cm2 for the PMMA and hydrophobic silicone 
IOLs respectively. The surface coverage for the hydrophilic acrylic lens could not be 
determined, as not all the BSA was surface sorbed.  
7.5.3 Protein stability: Native PAGE 
Samples run on native PAGE showed only minor differences in the relative 
mobility for conjugated and unconjugated BSA, as seen in Figure 7-5.  
The conjugation of the LY dye to the BSA resulted in a slightly more negatively 
charged protein, as seen by the faster migration in the gel. However, no difference in 
mobility could be seen in the BSA-LY at 37ºC from day one to day 14, indicating that 
the protein in the solution was relatively stable over time (Figure 7-5, lanes: 7, 8, 15, 
16) Furthermore, keeping the conjugated protein at 37ºC did not induce any changes 
compared to 4ºC (Figure 7-5, lanes 8, 9, 16). To demonstrate that conformational 
changes in the protein would result in mobility shifts, BSA samples were heated to 
62ºC or 72ºC for 5 minutes. Multiple bands can be seen as a result of the partially 
unfolded protein and increasing aggregation (Figure 7-5, lanes 11, 12). Investigation 
of the solutions after the incubation showed the same protein mobility, indicating that 
the IOL material had no impact on conformation and stability of the protein (Figure 7-
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(450 kDa), which is synthesized in the cell and plays a key role in wound healing and 
cell adhesion.28,38-41 However, the most abundant protein in the AH is serum 
albumin,15,20,42 which enters the AH by leaking through the blood vessels and is part of 
the biofilm that covers the IOL immediately following insertion.23-26 A competitive 
process of protein adsorption and desorption occurs, as smaller proteins get replaced 
by proteins with higher surface affinity, including glycoproteins such as fibronectin.43 
The protein albumin is believed to increase biocompatibility, is sometimes applied as 
a coating on blood contacting biomaterials to minimize the adsorption of platelets 
and is widely thought to have sufficient surface affinity to avoid the Vroman effect.44,45 
To gain a greater understanding of the interaction between IOLs and proteins, 
we determined both the location and amount of accumulated BSA on different types 
of IOLs. To our knowledge, this is the first study of its kind to report on the location 
of BSA on IOLs, which may be of significance, as the location of the serum albumin 
could potentially modify subsequent cell adhesion.45-48 While BSA was used in this 
study, primary and secondary structures are very similar to human serum albumin 29-31 
and therefore it can be assumed that its properties can be approximated by BSA. 
Native albumin has a helical structure, but under unfavorable conditions such 
as heat or when adsorbing to solid surfaces, the protein starts to unfold and beta 
structures can be detected.49-51 At a temperature of >45°C the changes in BSA structure 
are partially irreversible and by heating the protein to 62°C a loss of approximately 
10% in helical structure has been reported.49 In this study, we heated the BSA to 62°C 
and 72°C for five minutes and the typical appearance of multiple bands of the 
denatured protein could be seen in the native gel (Figure 7-5). This indicates that the 
native gel can detect small changes of ≤10% in protein structure.  
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It is known that conjugation with a fluorescent tracer has potential to change 
size and weight, relative molecular charge, and isoelectric point of the protein.34 
However, as demonstrated in the SDS PAGE (Figure 7-6), overall differences between 
the conjugated and unconjugated BSA were small, with approximately 5% difference 
being detected 
In this study, confocal laser scanning microscopy showed protein sorption 
solely on the surface of PMMA and silicone IOL materials (Figures 7-2A and 7-3A). 
However, the hydrophilic acrylic IOL material contains 26% water and therefore clearly 
has a sufficient pore size for the BSA (which has a diameter of approximately 55Å52) to 
slowly penetrate into the lens matrix over time (Figures 7-2B and 7-3B) The amount of 
BSA that sorbed onto the silicone IOL was greater than that measured on the PMMA 
and hydrophilic acrylic IOLs (Figure 7-4). A typical albumin monolayer on solid 
surfaces is between 150-200 ng/cm2.44,53,54 As the CLSM results show, the BSA sorbed 
onto the PMMA and silicone IOLs could not enter the polymer matrix, and thus the 
total amount of BSA deposited (as calculated by the radiolabel method) is on the 
surface alone, at 556 ng/cm2 and 660 ng/cm2 respectively, which significantly 
exceeds a monolayer coverage.44,53,54  
An in vitro study conducted by Johnston et al.27 quantified the protein uptake to 
PMMA and hydrophobic acrylic IOLs. After seven days of incubation they found 
albumin levels of 205 ng/cm2 for PMMA and 173 ng/cm2 for hydrophobic acrylic, 
which is slightly lower than our data. They further reported that the inflammatory 
post-surgical response can depend on the dynamic of the protein layer, because 
irreversible surface-bound proteins are more likely to denature. Although we could 
confirm that the BSA in the solution did not denature over the time period 
182 
investigated, studies have shown that BSA undergoes conformational changes after 
adsorbing to hydrophobic surfaces such as PMMA.50,55,56 A study by Pokidysheva et al.26 
found albumin concentrations of 220-460 ng/cm2 on different IOL materials after less 
than 30 minutes of exposure to 1 mg/ml of protein. They reported higher protein 
levels, and more irreversibly adsorbed albumin, for HEMA-based compared to PMMA 
lenses. 
Results from this study suggest that the amount of BSA accumulated on the 
surface of PMMA and silicone is >100 times larger compared to the BSA found on the 
hydrophilic acrylic surface. This might be correlated to the rate of posterior capsular 
opacification and LEC growth over the anterior IOL surface, which is significantly 
higher for hydrophilic acrylic compared to PMMA, silicone and hydrophobic acrylic 
materials.57-59 This may be due to differences in the denatured state of the protein. 
However, further studies are necessary with cell adhesion proteins to confirm that this 
is the case.  
Significantly higher levels of inflammatory cell deposits on the anterior lens 
surface have been reported for PMMA,21 silicone 14 and hydrophobic acrylic 60-62 
materials compared to hydrophilic IOLs. These findings suggest that the dense 
protein layer on the surface could increase cell adherence, which is less pronounced 
with hydrophilic materials. Furthermore, the porous structure of hydrophilic acrylic 
lenses could be responsible for the higher rates of calcification, compared with that 
reported for silicone and PMMA materials.63 
In this work we have shown that albumin sorption profiles strongly depend on 
the type of IOL material investigated. In future work, CLSM could provide useful 
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information by locating the sorption profile of fibronectin and vitronectin, as they are 
known to significantly impact cell adsorption to the intraocular lens material. 
 
7.7 Conclusions 
The biocompatibility of IOLs depends on various factors, such as design, 
material type, surgery technique, extend of the BAB breakdown, ocular health, etc. 
Using CLSM we were able to image albumin distribution on PMMA, silicone and 
hydrophilic acrylic IOLs. Dense surface layers were found for PMMA and silicone 
materials with 393 and 278 ng per lens respectively. In contrast, the hydrophilic 
acrylic IOL material allowed the protein to penetrate deep into the lens matrix over 




8. GENERAL DISCUSSION AND CONCLUSIONS 
The release of soft lenses in the early 1970’s resulted in a rapid increase in the 
use of contact lenses to correct vision, and has grown to approximately 125 million 
wearers today.1 Although most soft contact lenses need to be replaced either daily, bi-
weekly or monthly, ocular complications due to tear film deposition on lenses are still 
frequently reported.2 Silicone hydrogel lenses are highly gas permeable and therefore 
provide sufficient amounts of oxygen to the cornea to prevent hypoxia related 
complications. Nevertheless, a higher risk for inflammatory events has been reported 
if SH lenses are continuously worn for up to 30 days and nights, as compared to 
pHEMA-lenses worn for up to 7 days and nights.3 
To provide a better understanding of tear film deposition rates on contact 
lenses, a number of laboratory-based assays and imaging techniques have been 
applied in the past to determine the composition and quantity of the deposit.4 The 
disadvantage of most imaging techniques is that they can describe deposition on the 
outer material surface only, but cannot scan deeper than a few micron into the 
matrix. In this research work, confocal laser scanning microscopy was used, which 
allows image scanning up to a few hundred microns into the material. To visualize 
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proteins on the surface and in the material matrix of either contact lenses or 
intraocular lenses, proteins were conjugated with fluorescent probes.  
The conjugation of bovine serum albumin (BSA) with 5-(4,6-Dichloro-s-triazin-2-
ylamino)fluorescein hydrochloride (DTAF), contact lens incubation and CLSM imaging 
techniques were described in detail in Chapter 3. The pHEMA-based material etafilcon 
A and the surface-coated silicone hydrogel material lotrafilcon B were incubated in the 
protein solution for one and seven days and the Zeiss LSM 510 Meta was used to 
detect the conjugate on the surface and inside the lenses. An even protein 
distribution throughout the material was found for etafilcon A, but protein sorption 
was mainly detected in the outer surface region for lotrafilcon B. Gel electrophoresis 
verified that the conjugated BSA solution contained no smaller protein fractions, 
which may have impacted the results. Furthermore, two scans of the same sample 
location verified only minor loss in fluorescence (photobleaching). This provided 
confidence in the protocols for protein conjugation and image acquisition. 
In the next study, BSA was conjugated to either DTAF, rhodamine B 
isothiocyanate (RITC) or lucifer yellow VS dilithium salt (LY) and sorption profiles to 
different contact lens materials were compared (Chapter 4). In separate experiments, 
etafilcon A, lotrafilcon B and two other SH materials, balafilcon A and senofilcon A, 
were either incubated in the conjugated protein solutions or in solution that 
contained solely the fluorescent probe but no protein. Comparisons between uptake 
patterns on different contact lens materials suggested a noticeable impact from the 
probe to the sorption behaviour of the BSA. While for etafilcon A, sorption patterns of 
the dye solution only and the conjugates were in agreement, the uptake curves for 
senofilcon A were markedly different. In some cases, conjugated protein showed a 
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very similar sorption curve to the dye alone, which strongly suggests that the probe 
had an impact on the protein sorption behaviour. Results from this experiment lead 
to the conclusion that not every dye is suitable to study protein sorption to 
biomaterials, particularly if the material surface has different properties compared to 
the bulk (e.g. due to surface treatment). LY appeared to cause the least amount of 
impact on the BSA sorption profile and was therefore used in the following 
experiments. 
The major tear film protein lysozyme was investigated in Chapter 5. The 
protein was either conjugated with fluorescein isothiocyanate (FITC) or LY and the 
protein accumulation to nine different pHEMA-based and SH contact lens materials 
was determined. A similar CLSM technique, as described for BSA in Chapter 4, was 
applied to compare the protein profile after one day of incubation. Quantitative 
results obtained from the incubation in radiolabeled lysozyme were combined with 
the confocal scans to describe the amount of protein throughout the lens material. 
The results showed that lysozyme penetrated into almost every contact lens material 
within 24 hours. The exceptions were the surface coated materials lotrafilcon A and 
lotrafilcon B, which showed protein accumulation on the surface, but either no (with 
lotrafilcon A) or only minor (with lotrafilcon B) penetration into the matrix. 
The two fluorescent probes used for conjugation showed only small differences 
for the lysozyme sorption pattern to most lens types, except for the two silicone 
hydrogel lenses galyfilcon A and senofilcon A. A strong fluorescent signal was 
detected on the lens surface when incubated in FITC-lysozyme but an almost even 
distribution could be seen for LY-lysozyme, particularly for senofilcon A. The internal 
wetting agent PVP is incorporated in both materials and may have interacted with the 
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fluorescein-based dye, by either binding this conjugate to the material or by 
enhancing the fluorescent emission strength.  
The efficiency of contact lens care regimens on protein removal was imaged 
and quantified in Chapter 6. Results from CLSM and radiolabeled data show clearly 
that protein sorption profiles depended on the protein type (lysozyme or albumin) but 
also on the contact lens material and the care regimen chosen. In general, hydrogen 
peroxide removed slightly more lysozyme from the lenses compared to MPS systems. 
In most cases similar levels of protein were found on the lenses when cleaned with 
the MPS regimen, independent of whether they were manually rubbed or not before 
overnight soaking. CLSM confirmed lysozyme removal primarily from the lens matrix 
for lotrafilcon B, but not the surface. This was different for etafilcon A, which showed 
reduced amounts of protein at the surface region after cleaning, indicating that 
lysozyme was more loosely bound to this material. This suggests that the more 
denatured protein on the SH surface was bound more strongly than the less 
denatured protein on etafilcon A.5  
Interactions between intraocular lenses (IOL) and BSA were examined in 
Chapter 7. Data obtained from the investigation of PMMA, silicone and hydrophilic 
acrylic IOL materials confirmed protein sorption to the surface of PMMA and silicone, 
but a steady increase in penetration into a hydrophilic acrylic IOL. Nevertheless, the 
silicone-based IOL accumulated higher levels of protein compared to the hydrophilic 
acrylic and the PMMA materials. 
The emission data obtained from the CLSM measurements were presented in 
different ways. In Chapters 3 and 5, the regions for front surface, back surface and 
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bulk were predefined using the average of either 5 μm for the surfaces or 30 μm for 
the central matrix region. In Chapters 4 and 5 sorption curves were compared 
graphically, while Chapter 4 provided additional quantitative information. In Chapter 
6, albumin sorption to IOL materials was described by the signal depth, as these 
samples had thicknesses of >1mm and exceeded the maximum scanning depth of the 
CLSM. Although the data assessment was partly automated, a subjective component, 
for example to determine the surface peaks, was necessary.  
For future work, a different method could be applied to analyze the CLSM 
intensity plots using general bilinear models, as suggested by Buchwald.6 In an 
example, Statistica 8.0 was used to fit two individual linearized biexponential curves 
(a) to the front and back surface of the lens scan and a linear regression line (b) to the 
central lens region (Correlation coefficient R>0.98). Curves were fitted to two material 
types, etafilcon A and lotrafilcon B following their incubation in BSA conjugated with 
LY.  
 
Function for the bilinear model: 
(a) ln /  /   
(b)    
 
The bilinear model requires the following parameters: 
 
dependent variable; independent variable;  
transition between the two linear portions; Euler's number 2.718 ; 
1 and 2 slopes prior to 1  and after the transition ( 2); 
c  shift along the horizontal axis t;   shift along the vertical axis y 
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Figure 8-1: Protein sorption to etafilcon A is described by fitting linearized 
biexponential models to front and back surface regions and a linear regression 
line to the central matrix 
 
 
Figure 8-2: Protein sorption to lotrafilcon B is described by fitting linearized 
biexponential models to front and back surface regions and a linear regression 
line to the central matrix 
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After fitting the three functions to the intensity plots, a number of parameters 
can be chosen to determine differences between sorption curves. The parameters of 
the biexponential curves describing the smoothness of the transition  and the two 
slopes 1 and  2  can be used to perform statistical analysis for comparisons 
between curve progressions. The slopes 2  of the front surface or 1  of the back 
surface could differentiate between surface deposited proteins (Figure 8-2) and 
proteins that penetrate the full matrix (Figure 8-1). Different levels of fluorescence 
intensity in the surface region can be compared using parameter , to identify 
changes e.g. between time points. Furthermore the material thickness can be 
estimated by calculating the separation between the parameters c for the front and 
back surface. Parameter  of the linear regression line can further compare intensity 
changes within the central matrix over time.  
This automated curve fitting could reduce the subjective component and may 
require less time for data processing and analysis.  
 
In addition to the use of mathematical models to examine data obtained from 
studies such as those conducted in this thesis, there are several other areas that 
could be considered in future. 
The use of fluorescent probes to locate proteins has successfully been applied 
to various research areas because of their lack of toxicity, high sensitivity, low cost 
and ease of use. Most fluorescent probes are highly pH sensitive and their emission 
intensity strongly depends on the microenvironment. When using fluorescent probes 
in materials research, pH sensitivity, as well as charge components should be 
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considered, when evaluating sorption curves. This limitation requires a number of 
preliminary tests investigating dye-uptake into the material and the addition of a 
quantitative method such as radiolabeling.  
In this thesis, single protein solutions were used to determine sorption 
patterns of albumin and lysozyme to different pHEMA-based and SH materials. 
Although the results provide useful model data, it remains unclear how protein 
sorption behaviour changes with the addition of other components from the tear film, 
or, when investigating IOLs, the addition of components from the aqueous humour. A 
process of competitive uptake can be expected and it needs to be clarified, whether 
or not the conjugated fluorescent probe impacts these results.  
With the use of multiple fluorescent probes competitive sorption of two or 
more different proteins to biomaterials could be investigated. However, this requires 
dyes with differing excitation/emission wavelengths, but similar binding affinities to 
the materials. None of the dyes should show specific surface affiliation and the 
uptake pattern for one dye should not significantly change under the presence of a 
second dye. Finding suitable probes will be difficult, specifically when investigating 
SH contact lenses with complex material compositions and surface modifications, as 
demonstrated in Chapter 4. To prove the reliability of the protein data, the 
fluorescent probes must be conjugated to both proteins and the sorption with each 
must be compared.  
It is generally believed that the protein on the material surface is more 
denatured than that of the protein located in the material matrix. However, future 
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studies should investigate whether or not this is true, and methods to determine the 
conformational state of protein at various locations is worthy of study.  
Finally, the advantage of CLSM to detect fluorescent conjugates throughout 
thick materials may also prove useful when studying biomaterials for drug uptake and 
release. CLSM could provide useful information on the location of the specific drug 
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Molar Extinction Coefficient and Degree of Labeling 
 
Determine the molar extinction coefficient (M-1cm-1)  
Measure the average absorbance at 280nm for a known protein solution  













Determine the Degree of Labeling (DOL) 
 
 
On average, how many dye molecules are attached to one protein molecule? 
 
Mix 100 μl of the conjugate with 900 μl of PBS to get 1ml solution and measure the 
absorbance of the labeled protein at 280nm and the maximum absorbance peak of 
the fluorescent probe using a UV Spectrophotometer. (The result should be between 
0.1 and 1.0. If it is higher, the solution must be diluted and the dilution factor in the 
calculation changes.)  
  
  
Concentration of protein (M) = Absorption at 280 – Absorption (fl. dye) * correction Factor *10 (dilution factor) 
                                                                      Molar extinction coefficient of protein 
 
 
Or determine mg/ml using DC Protein Assay (Bio-Rad, Hercules, CA, USA).                
e.g.  3.22mg/ml = 3.22/66000=4.889*10-5 M 
 




    
Moles dye per mole protein  =                          Absorption (fl. dye)                                  * 10 (dilution factor)  
                Molar extinction coefficient of fluorescent probe* protein concentration  
 
 
Fluorescent probe Extinction coefficient (M-1cm-1)  at (nm) (approximately max absorbance)  
DTAF 43538     492 
RITC 105789     534 


































Sorption profile of unconjugated Lucifer Yellow to different contact lens 
materials over time (Chapters 4 & 5) 
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Lysozyme uptake into different contact lens materials over time (Chapter 5) 
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